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ABSTRACT
In this study the following aspects have been worked out by studying the genetics of
midecamycin biosynthesis as a model system to elucidate the biosynthesis of sugar
components in 16-membered macrolides and to acquire tools for the production of new
hybrid macrolide antibiotics.
1. By sequentially screening a genomic library in the cosmid vector pKU206 via two
homologous gene probes which were detected by PCR, the midecamycin biosynthetic
(mid) gene cluster has been identified in the isolated ca. 74 kb DNA in the genome of S.
mycarofaciens, falling into two regions.
2. About 10 kb DNA from the cosmid Smyc-LC1 and ca. 7 kb DNA from the cosmid
Smyc-LC3 were sequenced contiguously. The remaining regions of these two cosmids
were partially sequenced to get further information on extension and informational
contents of the cluster. Among them, 10 genes with complete reading frames and 14
genes incomplete were identified, all of which are necessary for midecamycin
biosynthesis. The region of genes responsible for mycarose biosynthesis was found in
Smyc-LC1. A complete set of genes for the biosynthesis and transfer of mycaminose
was identified. The organisation of the overall mid gene cluster revealed that, similar to
other macrolide gene clusters, the PKS genes are flanked by two regions containing
genes encoding enzymes for sugar biosynthesis, with others for resistance, regulatory,
and sugar or lactone modification.
3. The genes, midC, midH, midK and midI, were characterised by heterologous expression
of these enzymes. MidC and MidH were over-produced as soluble proteins in E. coli
both in native form and as His-tag fusion. Soluble proteins His-tag-MidK and His-tag-
MidI were detected only by Western blotting in low quantities.
4.  To characterise the postulated function of MidH (3,4-isomerase) and MidC (3-
aminotransferase), the products of a coupling enzymatic reaction to convert dTDP-D-
glucose by RmlB (4,6-dehydratase), MidH and MidC were analysed by HPLC and LC-
MS. It has been confirmed that the MidC protein is responsible for transamination to
form dTDP-amino-6-deoxy-D-glucose.
ZUSAMMENFASSUNG ix
ZUSAMMENFASSUNG
In dieser Arbeit wurden die folgenden Aspekte der Genetik und Biosynthese des Makrolids
Midecamycin ausgearbeitet, um die Mechanismen der Makrolidzuckersynthese zu klären
und Handwerkszeuge für die Herstellung hybrider Makrolide zu liefern.
1. Durch sequentielles Screening einer genomischen DNA-Bank im Cosmidvektor
pKU206 durch zwei homologe PCR-amplifizierte Genproben wurden zwei Regionen
von insgesamt ca. 75 kb DNA isoliert, die die gewünschten Anteile des Midecamycin
(mid) Genclusters enthielten.
2. Ca. 10 kb DNA aus Cosmid Smyc-LC1 und ca. 7 kb DNA aus Smyc-LC3 wurden
komplett sequenziert. Die übrigen Regionen wurden durch partielle Sequenzierung
charakterisiert, um weitere Informationen über Struktur und Genverteilung zu erhalten.
Unter den Genen wurden 10 komplette und 14 unvollständige Leserahmen identifiziert,
die für die Midecamycin-Biosynthese notwendig sind. Die Region der Mycarose-
Biosynthesegene wurde auf Smyc-LC1 gefunden. Das komplette Set der Gene für
Biosynthese und Transfer der Mycaminose wurde kloniert. Die Organisation des mid
Genclusters ist ähnlich wie in andern Makroliden zu beiden Seiten der zentralen PKS
Gene mit zwei gemischten Gruppen von Zucker-, Acylierungs-, Resistenz- und
Regulatorgenen strukturiert.
3. Die Genen, midC, midH, midK und midI, wurden durch heterologe Expression
charakterisiert. MidC und MidH wurden als lösliche Proteine in E. coli überproduziert,
jeweils in nativer und His-tag fusionierter Primärstruktur. Die ebenfalls löslichen His-
tag  Proteine MidK und MidI wurden nur in geringer Menge gebildet und über
Westernblot   nachgewiesen.
4. Um die postulierten Funktionen der MidH (3,4-Isomerase) und MidC (3-
Aminotransferase) nachzuweisen, wurden die Produkte eines gekoppelten Enzymtests
zur Umsetzung von dTDP-D-Glucose mit RmlB (4,6-Dehydratase), MidH und MidC
mittles HPLC und LC-MS Techniken ausgewertet. Es wurde bestätigt, daß das MidC
Protein verantwortlich ist für die Transaminierungsreaktion bei der Bildung des dTDP-
Amino-6-Deoxy-D-Glucose.
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1. Introduction
1.1. Secondary metabolites and macrolide antibiotics
1.1.1. Roles of secondary metabolites in Streptomyces
Secondary metabolites are synthesized via multistep pathways leading from precursors
(usually intermediates of primary metabolism) to the specific moieties of these metabolites
(Drew et al., 1978). The majority of bioactive products (for instance, antibiotics, pigments,
alkaloids, enzyme inhibitors, and so on) of microorganisms, is generated by secondary
metabolism. This part of the metabolic machinery of microorganisms may play no essential
role in the vegetative development of the producing organisms, but seems to convey
advantages to the pertinent species with regard to its long-term survival in the biological
community and environment (Vining, 1992).
Actinomycetes, to which the streptomycetes belong, are well known for the synthesis of a
broad range of biologically active secondary metabolites with antibacterial, anti-viral, anti-
tumor and immuno-suppressive activities. Tab. 1.1 lists a few of these compounds with
their respective activities. Understanding roles of secondary metabolites in Streptomyces
has been increased by cloning numerous genes involved in the biosynthesis of antibiotics,
pigments and other secondary metabolites (Beppu, 1996; Minas, 1997). A comprehensive
picture of their organization in clusters is emerging. Knowledge about expression of these
genes, which are not essential for growth, is of utmost importance for establishing how they
have evolved as compared to operons of primary biosynthetic genes. Furthermore,
understanding of the regulatory mechanisms controlling gene expression has relevance for
industrial over-production of these metabolites.
1.1.2. Character, structure and classification of macrolides
Macrolides are a class of antibiotics that contain a macrocyclic lactone ring (Omura, 1984)
composed  of  a  polyketide-derived    backbone  to  which  one,  two  or   three  sugars  are
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Tab. 1.1. Some medically important Streptomyces secondary metabolites
                  and their mode of action
Type   Antibiotic Producer Activity Target
b-Lactams Cephalosporin S. clavuligerus Gram +/- bacteria D-Ala metabolism in
(peptides) Cephamycin cell wall formation
Chorismic acid Chloramphenicol S. venevuelae Bacteria, Ribosome 50S subunit
Chemical Synthesis Mycoplasma
Aromatic Mithramycin S. argillaceus               Antitumor DNA intercalating or
polyketides binding agents
Tetracyclines S. rimosus Gram +/- bacteria Ribosome 30S subunit
Macroildes Erythromycin Sac. erythraea Bacteria Ribosome 50s subunit
Rapamycin,  S. hygroscopicus Immunosuppressants T-cell differentiation
FK506
commonly attached. They are produced as secondary metabolites by mycelium-forming
soil bacteria from the order Actinomycetales; the majority are from members of the genera
Streptomyces, Micromonospora and Saccharopolyspora (Nakagawa et al., 1984).
Macrolide antibiotics are widely used as anti-infective, immuno-supressive, insecticidal,
and parasiticidal agents  in the clinic or for agricultural purposes. The known mechanism of
the biological function of the main group of classical macrolides (erythromycin, tylosin,
etc.) is to bind to the peptidyltransferase center of the 50S subunit of the bacterial ribosome,
thereby inhibiting bacterial protein synthesis (Gale et al., 1981). Other macrocyclic
lactones, like polyenes and avermectin, have different modes of action.
Macrolides are conveniently divided into different groups according to the atom numbers
of the formation of lactone rings (Omura, 1984). They are composed of 12 to 16 atoms, so-
called 12-membered macrolides (e.g., methymycin); 14-membered macrolides (e.g.,
erythromycin and oleandomycin); and 16-membered macrolides (e.g., tylosin, spiramycin,
carbomycin and midecamycin) (Fig. 1.1).
    3
R1             R2
 
Fig. 1.1. Examples of macrolides. Structures of one 14-membered (erythromycin) and four 
              16-membered macrolides (tylosin, midecamycin, spiramycin and carbomycin).
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1.2. Cloning of erythromycin and tylosin biosynthesis genes
Large numbers of macrolides have been structurally isolated and some of them have been
in practical use for many years, but cloning and genetic analysis of biosynthesis genes have
only been extensively studied for erythromycin and tylosin. The molecular biology of
picromycin, carbomycin, spiramycin and midecamycin has also been studied but at a much
lower level. In the cases of erythromycin and tylosin, the biosynthesis genes are
demonstrated to be clustered among one or more resistance-determining genes in the
chromosome. Therefore, cloning of the resistance genes has allowed the isolation of large
segments of adjacent DNA.
For cloning of erythromycin biosynthesis genes, the ermE gene, that determines macrolide-
lincosamide-streptogramin B (MLS) resistance in the erythromycin-producing strain Sac.
erythraea, was first used as a hybridization probe to identify linked genomic fragments
from Sac. erythraea (Stanzak et al., 1986). The first biosynthesis gene identified  in the
cluster was eryG, which encodes the O-methyltransferase catalyzing the last step of the
pathway (Weber et al., 1989). The isolation of the erythromycin gene cluster (ca. 54 kb;
Fig. 1.2) has been completed (Dhillon et al., 1989; Donadio et al., 1991; 1992; Vara et al.,
1989; Weber et al., 1990), and the nucleotide sequence of all the genes in the cluster has
been revealed (Cortes et al., 1990; Dhillon et al., 1989; Donadio et al., 1991; Gaisser et al.,
1997; 1998; Haydock et al., 1991; Salah-Bey et al., 1998; Summers et al., 1997; Weber et
al., 1991). This macrolide, according to the present knowledge, requires approximately 30
enzymatic steps for its construction.
The first gene in tylosin biosynthesis, designated as tylF, encoding macrosin O-
methyltransferase that acts at the last step in the pathway in S. fradiae (Fishman et al.,
1987), was isolated and cloned by using a reverse genetics approach, which employed a
partially degenerated oligonucleotide probe derived from a portion of the N-terminal
sequence obtained from the purified enzyme (Bauer et al., 1988). Evidence shows tylosin
biosynthetic and self-resistance genes are closely linked in the genome of Streptomyces
(Beckmann et al., 1989). Four different resistance genes, tlrA, tlrB, tlrC and tlrD, have
been  cloned  from S.  fradiae  (Baltz & Seno, 1988;  Birmingham et al., 1989;  Zalacain  &
                                                                                                                                                 5
Fig. 1.2. Organisation of the ery cluster of Sac. erythraea and pathway for the formation of
erythromycin. Top: arrows, each aligned along the direction of the transcription, indicate the open
reading frames of the cluster (not drawn to scale). Bottom: only the macrolide portion of the
pathway is illustrated. The proposed pathways for 6-deoxysugar formation see Section 1.4.
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Cundliffe, 1991) in which tlrB and tlrC are located at the two ends of the cluster
(Beckmann et al., 1989) and tlrD is within a region of the cluster (Gandecha et al., 1997).
More recent analysis shows that the tylosin gene cluster, which covers about 85 kb in the
genome of S. fradiae, contains over 40 genes, including and surrounding the  tylG  (PKS-
encoding)  sub-cluster.  This  large  interval  segment is flanked by tlrB and tlrC, and has
originally been mapped into 13 different loci (tylA to tylM) according to the results of co-
synthesis studies with idiotrophic mutants blocked at different steps in tylosin biosynthesis
(Baltz et al., 1983) (Fig. 1.3). The five tylG genes occupy ca. 41 kb (acc. no. U78289). The
tylIBA region, in which 11 genes cover about 14.8 kb, is located between tylG and tlrC
(Merson-Davies & Cundliffe, 1994; Butler et al., 1999). The tylLM region is located
downstream of tylG, showing five genes which are mainly involved in mycaminose
biosynthesis and attachment (Gandecha et al., 1997). The tylCK region, in which five genes
have recently been found in a 7 kb region, is adjacent to the left side of tylLM,. These genes
are involved in mycarose biosynthesis and attachment (acc. no. AF147704). The remaining
region, tylEDHFJ, is located at the left side of the cluster, and recently, the sequence of
11.9 kb of this region has been shown to include 11 orfs, 10 of them belonging to the
biosynthetic cluster, which is involved in mycinose biosynthesis and attachment (Fouces et
al., 1999). Of particular interest in the tylosin gene cluster is the presence of at least five
candidate regulatory genes: tylP encodes a g-butyrolactone signal receptor for which tylQ is
the probable target; tylQ is a transcriptional regulator; tylS and tylT encode pathway-
specific regulatory proteins of the Streptomyces antibiotic regulatory protein (SARP)
family (Wietzorrek & Bibb, 1997); tylR has been shown by mutational analysis to control
various aspects of tylosin production, thereby designated as a global regulator (Bate et al.,
1999). The regulatory genes identified here probably control tylosin biosynthesis in cascade
fashion and might form a link to the control of sporulation. In contrast, other antibiotic
biosynthetic gene clusters are not known to contain multiple pathway-specific regulators,
and no regulatory genes are present in the erythromycin gene cluster.
7Fig. 1.3. Organisation of the tyl cluster of S. fradiae and pathway for the formation of tylosin.
Top: arrows, denote the open reading frames of the cluster (not drawn to scale). Bottom: only the
macrolide portion of the pathway is illustrated. The proposed pathways for 6-deoxysugar formation
see Section 1.4.
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1.3. Biosynthesis of macrolide lactones
1.3.1 Basis of fatty acid and polyketide biosynthesis
The early stages in both fatty acid and polyketide biosynthesis are catalyzed by enzymes,
referred to collectively as fatty acid synthases (FASs) and polyketide synthases (PKSs), that
operate on identical principles (Fig. 1.4). Simple carboxylic acids are activated as thioesters
(CoA). The acetyl unit which acts as a 'starter' is transferred via an acyl carrier protein
(ACP)   to  a  cysteine  thiol  group  at  the  active  site of  a  b-ketoacyl  synthase  (KS:  the
condensing enzyme). A malonate ('extender') unit is then transferred onto the thiol of ACP.
Thereafter, the KS catalyzes the condensation of the two acid residues to give a b-ketoacyl
C4 intermediate attached to ACP. At this point the pathway to fatty acids and polyketides
usually diverges. In the fatty acid pathway, the b-ketoacyl C4 intermediate is acted upon
successively by a b-ketoacyl reductase (KR), a dehydrase (DH) and an enoyl reductase
(ER) to generate a fully reduced acyl C4 intermediate that will normally be returned to the
active-site cysteine of KS to serve as the starter unit for another round of extension and
reduction. In the pathway usually followed by PKSs, the b-ketoacyl C4 intermediate is not
automatically reduced; instead it is transferred directly to the active-site cysteine of KS,
where it serves as the starter unit for condensation with a second ACP-borne extender unit.
The condensation yields a b,d-diketoacyl C6 intermediate attached to the ACP, and then
this intermediate can in turn be transferred to the vacant active site on the condensing
enzyme for further extension of the polyketide chain. Evolutionarily it is more logical to
regard FASs as a special case of PKSs, since the basic mechanisms are all identical and
catalysed by enzymes all in common families and the PKSs already can contain modules
with full b-ketoreduction capacity.
PKSs usually can be subdivided into two types: type I, a modular PKS of complex
polyketide, consists of several large multifunctional proteins carrying a separate active site
for each individual enzyme-catalyzed reaction in the pathway; type II, the aromatic PKS,
consists of a group of separate proteins with iterative active sites for enzyme-catalyzed
reactions (Katz & Donadio, 1993). Information about type I PKSs has been obtained from
sequence  analysis of  the cloned genes from Sac. erythraea  (Cortes  et al., 1990;  Donadio
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Fig. 1.4. A schematic diagram of fatty acid and polyketide biosynthesis. The first four reactions
are common to both pathways; the subsequent reactions in route A lead to polyketides, and in route
B to fatty acids. Circle represents the synthase complex; ACP is the acyl carrier protein, on which
SH is the functional thiol on the 4'-phosphopantetheinyl prosthetic group of the protein. KS is the
condensing enzyme, on which SH is the cysteine thiol group at the active site of the enzyme.
Enzymes: 1, acetyl transferase; 2, acyl transferase; 3, malonyl transferase; 4, b-ketoacyl synthase; 5,
ketoreductase; 6, dehydrase; 7, enoylreductase.
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et al., 1991) and S. avermitilis (MacNeil et al., 1992b), which reveals that there is a
separate set of active sites (a 'module'; Donadio et al., 1991) for each round of carbon chain
assembly and appropriate reduction. The genetic organization and enzyme function in the
biosynthesis of the polyketide aglycone of erythromycin is reviewed below.
1.3.2. Synthesis of macrolide lactone via type I PKSs
As described above, complex polyketides, which include the aglycone components of
macrolides, are synthesized through the successive condensation of activated acetate,
propionate or butyrate units which are either directly extended or followed by reduction at
the b-keto carbon to varying degrees. In the synthesis of the macrocyclic lactones of the
well-known macrolides, starter units are commonly acetate (oleandomycin, midecamycin,
spiramycin) or propionate (erythromycin and tylosin), and extender units for C2, C3 and C4
chains are likely to arise from malonyl-, methymalonyl- and ethylmalonyl-CoA,
respectively. Classical lactone rings contain an even number of atoms: 12- (e.g.,
methymycin), 14- (e.g., erythromycin, oleandomycin and pikromycin) and 16-membered
rings (e.g., midecamycin, spiramycin and tylosin), resulting from the successive
condensation of 5, 6 and 7 extender units, respectively (Omura et al., 1984).
The nucleotide sequence of the genes for the lactone of erythromycin supports the
organization of the modular type I PKSs that is composed of a few very large
multifunctional enzymes, each composed of modules containing all the activities required
in a single round of synthesis (Cortes et al., 1991; Donadio et al., 1991; Donadio & Katz,
1992). Corresponding to the sequence of the 6-deoxyerythronolide B (6dEB) PKS genes
(eryA), the EryA polypeptides include three proteins (EryAI, EryAII and EryAIII)
containing domains typical of fatty acid synthases: ACP (acyl carrier protein), AT
(acyltransferase), DH (dehydratase), ER (enoylreductase), KR (ketoreductase), KS
(ketosynthase) and AT (thioesterase). These are grouped into six modules where modules 1
and 2 in eryAI encode a 6-deoxyerythronolide B synthase (DEBS) subunit, DEBS1,
believed to participate in the first two steps of 6dEB synthesis. Similarly, eryAII and
eryAIII contain modules 3 and 4, and 5 and 6, respectively, encoding DEBS2 and DEBS3,
which catalyze the third through sixth cycles. For the detail processes of 6dEB synthesis
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through sequential action of the six modules, the reader is directed to Katz and Donadio
(1993).
The genes involved in the synthesis of the 16-membered lactone rings of spiramycin and
tylosin have been designated srmG and tylG in S. ambofaciens and S. fradiae. Like eryA,
the genetic organization of the PKS genes for platenolide (srmG) and tylactone (tylG)
synthesis appears to correspond to the order of the chemical reactions, both containing five
genes which are grouped into 7 modules, respectively (Kuhstoss et al., 1996). Platenolide
and tylactone undergo an identical set of post-condensation processing steps; however, the
substrates chosen for incorporation in the two pathways differ in some steps. For example,
the first reaction in platenolide synthesis involves the condensation of an acetyl-CoA and a
malonyl-CoA, while in tylactone synthesis, the corresponding substrates are propionyl-CoA
and methylmalonyl-CoA (Omura et al., 1975a,b; 1979; Marsden et al., 1994). In other type
I polyketides, amino acids, aromatics or short branched-chain fatty acids can be used as
starter units, e.g., branched chains, an isobutyryl-CoA or 2-methylbutyryl-CoA used in
avermectin (MacNeil et al., 1992a, b).
1.4. Biosynthesis of 6-deoxysugars
1.4.1. 6-Deoxysugar genes found in antibiotic biosynthesis
In nature, a wide variety of deoxysugars are found in lipopolysaccharides, glycoproteins,
glycolipids and many secondary metabolites (Liu & Thorson, 1994; Piepersberg, 1994).
The deoxysugars belong to an important class of carbohydrates and exhibit various potent
and interesting biological activities (Williams & Wander, 1980). These compounds are
formed from common monosaccharides by replacement of one or more hydroxyl group(s)
with hydrogen(s). Such a substitute generally induces dramatic variation in biological
function, and in many cases, these unusual sugars have been shown to be indispensable for
the activity of the parent molecule (Weymouth-Wilson, 1997).
In the past few years, sequencing and analysis of various antibiotic biosynthetic gene
clusters and the correlation of blocked mutants with phenotypes have provided critical
evidence allowing the identification of a number of complete sugar biosynthetic gene
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clusters, for instance, L-streptose biosynthetic cluster in streptomycin (Distler et al., 1992);
L-daunosamine biosynthetic cluster in daunorubicin biosynthesis (Otten et al., 1997); D-
desosamine and L-mycarose biosynthetic clusters in erythromycin biosynthesis (Gaisser et
al., 1997; Summers et al., 1997; Salah-Bey et al., 1998); D-desosamine and L-oleandrose
biosynthetic clusters in oleandomycin biosynthesis (Salas, personal communication; Olano
et al., 1998); D-mycaminose, D-mycinose and L-mycarose biosynthetic clusters in tylosin
biosynthesis (Merson-Davies & Cundliffe, 1994; Gandecha et al., 1997; Fouces et al.,
1999). The recent advances also include the identification of some genes needed for the
production of deoxysugar components in avilamycin of S. viridochromogenes Tü57
(Gaisser et al., 1997), mithramycin of S. argillaceus (Lombó et al., 1997), nogalamycin of
S. nogalater (Torkkel et al., 1997). The structure of these sugars is shown in Fig. 1.5.
1.4.2. Genetics of 6-deoxysugars in erythromycin and tylosin biosynthesis
Two extensively studied examples, erythromycin and tylosin, have received a leading
position in the genetic analysis of 14-membered and 16-membered macrolactone
antibiotics, not only because of their well-studied PKSs and PKS-encoding sub-clusters but
also because of the identification of almost all pathway-specific genes of appended sugars
(Merson-Davies & Cundliffe, 1994; Gandecha et al., 1997; Gaisser et al., 1997; Summers
et al., 1997; Salah-Bey et al., 1998; Fouces et al., 1999).
Erythromycin contains two 6-deoxyhexoses, L-mycarose first attached to the C3-OH of the
aglycone 6-deoxyerythronolide B, and D-desosamine then attached to C5-OH of the
aglycone. Tylosin contains three 6-deoxyhexoses, D-mycaminose as the first sugar added to
C5-OH of  tylactone, D-mycinose then added to C23-OH of tylactone, and L-mycarose
finally substituted onto C4-OH of mycaminose. According to the pathway analysis and
protein similarity of several identified 6-deoxysugar genes in antibiotic biosynthesis, a
common pathway of these sugars is deduced as follows: the first two steps are believed to
be the synthesis of dTDP-D-glucose and its conversion into dTDP-4-keto-6-deoxyglucose,
catalysed respectively by dTDP-glucose synthase and dTDP-glucose dehydratase; thus,
dTDP-4-keto-6-deoxyglucose is a common intermediate before the pathway divergance
(Piepersberg, 1994). For the L-mycarose production in erythromycin biosynthesis,  the eryB
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Fig. 1.5. Structure of selected deoxysugars. These sugars participate in the biosynthesis of
antibiotics described in the text.
genes contribute to the pathway (see next Section 1.4.3). The genes involved in the D-
desosamine pathway have been identified as the eryC genes: the eryCII product may be
responsible for 3,4-isomerase of dTDP-4-keto-6-deoxyglucose, then eryCI for C-3
transamination, and eryCIV for C-4 dehydration, eryCV for C-4 reduction, eryCVI for N-
methyl transfer and eryCIII for glycosyl transfer (Gaisser et al., 1997; Salah-Bey et al.,
1998) (Fig. 1.6). For the production of D-mycaminose involved in tylosin biosynthesis,
tylMIII was recently identified as 3,4-isomerase (acc. no. X81885), then tylB for C-3
transamination, tylMI for N-methyl transfer, and tylMII for glycosyl transfer (Gandecha et
al., 1997) (Fig. 1.6).
1.4.3. Mechanism elucidation of some deoxysugar biosynthetic enzymes
It is evident that our knowledge of the biosynthesis of deoxysugars, especially their
genetics and pathways, has accumulated rapidly over the past few years (Kirschning et al.,
1997; Liu & Thorson, 1994). A number of important deoxysugar biosynthetic genes have
been cloned and identified, and mechanistic studies of the expressed enzymes have
provided fresh insights into deoxysugar biosynthesis.
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Fig. 1.6. Proposed pathways for dTDP-desosamine synthesis in the erythromycin gene cluster
and dTDP-mycaminose synthesis in the tylosin gene cluster. They all start from the common
intermediate, dTDP-4-keto-6-deoxyglucose (I).
A earlier example is that in vitro characterization of several TDP-D-glucose 4,6-
dehydratases (TDPGDH; EC 4.2.1.46) from the erythromycin-producing strain Sac.
erythraea  (Vara & Hutchinson, 1988),  from  the  daunorubicin- and   baumycin-producing
organisms Streptomyces sp. C5, and from the daunorubicin-producing strain S. peucetius
ATCC 29050 (Thompson et al., 1992). These TDPGDHs were purified to homogeneity or
near to homogeneity and showed requiring NAD+ as a cofactor. The N-terminal amino acid
sequences of the TDPGDHs from Sac. erythraea and S. peucetius were similar, whereas the
enzyme from Streptomyces sp. C5 contained a different N-terminal amino acid sequence
from either of the other two enzymes (Thompson et al., 1992).
A recent notable case is the identification of a set of genes (the cluster strO-stsABCDEFG)
that encode proteins for streptomycin production in S. griseus (Ahlert et al., 1997).
Sequence analysis revealed that StsA and StsC proteins are members of a new class of
aminotransferases that are used mainly in carbohydrate biosynthetic pathways. Purification
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of the StsC protein permitted unambiguous assignment of StsC as the L-glutamine:scyllo-
inosose aminotransferase, which catalyzes the first cyclitol transamination reaction in the
biosynthesis of the streptidine subunit of streptomycin. Because genes related to stsA and
stsC also occur in actinomycete producers of other diaminocyclitol aminoglycosides such
as neomycins, kanamycins and hygromycin B, the StsA and StsC proteins may be
considered as representatives of aminoglycoside-specific aminotransferases.
Another significant example is the recent determination of  the function of the eryBVII gene
in erythromycin biosynthesis (Kim et al., 1999). The eryBVII was overexpressed in E. coli
strain and the crude enzyme was able to convert TDP-6-deoxy-L-threo-D-glycero-4-
hexulose into the epimerized product. It is not clear at this point whether the epimerization
occurs at C-5 and /or C-3. However, since the configuration of the hydroxyl group at C-3 in
TDP-6-deoxy-L-threo-D-glycero-4-hexulose is not changed in TDP-L-mycarose, and thus
the EryBVII enzyme may catalyze the epimerization at C-5 only. According to this
experiment, the biosynthetic route of TDP-L-mycarose from TDP-6-deoxy-L-threo-D-
glycero-4-hexulose, or of dTDP-L-mycarose from dTDP-4-keto-6-deoxyglucose, requires
at least four chemical transformations, as proposed by Gaisser et al. (1998) and Summers et
al.(1997). They would be the epimerization at C-5 (EryBVII), the deoxygenation at C-2 (?),
the methylation at C-3 (EryBIII) and the reduction at C-4 (EryBIV) (Fig. 1.7).
Fig. 1.7. Possible biosynthetic pathway of TDP-L-mycarose in Sac. erythraea from TDP-6-
deoxy-L-threo-D-glycero-4-hexulose (II).
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1.5. Aims of the present study
This study belongs to a project designed to first elucidate basic mechanisms of the
biosynthesis and transfer of sugar residues present on macrolide compounds. Secondly, this
knowledge should be used to produce new hybrid macrolide antibiotics by re-targeting
sugar residues on heterologous lactones. The particular target of this work was cloning of
the gene cluster from a 16-membered macrolide producing strain. The aims of the research
were:
(1) to clone the gene cluster of midecamycin biosynthesis from S. mycarofaciens.
(2) to identify genes involved in mycaminose and mycarose biosynthesis from the
       midecamycin biosynthetic gene cluster.
(3) to over-express the 6-deoxysugar genes in E. coli and S. lividans.
(4) to in vitro analyse the expressed protein function.
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2. Materials
2.1. Chemicals and enzymes
Antibiotics
    Ampicillin Roche, Mannheim
    Chloramphenical Serva, Heidelberg
    Kanamycin Serva, Heidelberg
    Midecamycin Sigma, Deisenhofen
    Thiostrepton Squibb and Sons, Princeton, USA
Chemicals p.A. quality
Fluka, Buchs, CH
Merck, Darmstadt
Roth, Karlsruhe
Serva, Heidelberg
Sigma, Deisenhofen
Enzymes
    Alkaline Phosphatase (calfs intestine) Roche, Mannheim
    DNA-Polymerase I Klenow-Fragment Life Technologies, Eggenstein
    Lysozyme Serva, Heidelberg
    Protease Inhibitor Set Roche, Mannheim
    Restriction enzymes New England Biolabs, Schwalbach
Roche, Mannheim
Life Technologies, Eggenstein
Promega-Serva, Heidelberg
    Ribonuclease A Sigma, Deisenhofen
   Taq DNA ploymerase Life Technologies, Eggenstein
    T4-DNA ligase Life Technologies, Eggenstein
    Vent DNA polymerase New England Biolabs, Schwalbach
Media Components
Difco, Detroit, USA
Merck, Darmstadt
Oxoid, Wesel
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Roth, Karlsruhe
Kits
Bio-Rad Protein Assay Kit Bio-Rad, München
BM Chromogenic Western Blotting Kit Roche, Mannheim
    QIAquick PCR Purification Kit Qiagen, Hilden
    QIAprep Spin Miniprep Kit Qiagen, Hilden
NucleoSpin Extract Macherey-Nagel, Düren
    Rediprime Random Primer Labeling Kit Amersham Buchler, Braunschweig
Thermosequenase Cycle-Sequencing Kit Pharmacia, Freiburg
Other materials
    a-32P-dCTP Amersham Buchler, Braunschweig
    Hybond-N+ Membrane Amersham Buchler, Braunschweig
    Hybond-P Membrane  Amersham Buchler, Braunschweig
    Membrane filters BA 85 (0.45 mm) Schleicher & Schuell, Dassel
    3MM Whatman Biometra, Göttingen
    X-ray film Hyperfilm-MP  Amersham Buchler, Braunschweig
    X-ray film Hyperfilm-b-max Amersham Buchler, Braunschweig
2.2. Media and Buffers
2.2.1. Media for cultivation of E. coli
LB medium (Miller, 1972)
Difco Tryptone 10 g/l
Difco Yeast extract            5   g/l
NaCl 5 g/l
LB agar
LB medium
Agar 15 g/l
SNA: Soft Nutrient Agar (Hopwood et al., 1985)
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Difco Nutrient Broth 8 g/l
Difco Bacto Agar 3 g/l
SOB (Hanahan,1983)
Difco Tryptone 20 g/l
Difco Yeast extract 5 g/l  
NaCl 0.58 g/l
KCl 0.19 g/l
     After autoclaving, supplemented with:
MgCl2 C 6 H2O (1M) 10 ml/l
MgSO4 C 7 H2O (1M) 10 ml/l 
SOC (Hanahan, 1983)
Glucose 3.6 g/l
in SOB
2.2.2. Media for cultivation of Streptomyces
EP1 (erythromycin production) (Salah-Bey et al., 1998)
Solulys L corn steep liquor 5 g/l  
Defatted soya flour 10 g/l
CaCO3 2  g/l
NaCl 5 g/l 
pH 6.8
              After autoclaving, supplemented with:
Glucose 15 g/l
EP2 (erythromycin production) (Salah-Bey et al., 1998)
Defatted soya flour 10 g/l
CaCO3 2 g/l
CoCl2 C 6 H2O 1 mg/l
pH 6.8-7.0
   After autoclaving, supplemented with:
Glucose 20 g/l
ISP2 (according to the International Streptomyces Project)
Difco Yeast Extract 4 g/l
Difco Malt Extract 10 g/l
Difco Dextrose 4 g/l
Agar 20 g/l
 SMA (Distler et al., 1985)
Soybean powder 20 g/l
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Mannitol 20 g/l
Agar 20 g/l
Tap water used
SPMR (Babcock & Kendrick, 1988)
Sucrose                                               103 g/l
MgCl2 C 6 H2O 10 g/l
Glucose 5 g/l
Difco yeast extract 5 g/l
TES buffer, pH7.6 (1M) 20 ml/l
Trace elements solution* 2 ml/l
 Difco-Bacto agar 22 g/l
   After autoclaving, supplemented with:
CaCl2 C 2 H2O (5M) 2 ml/l
*Trace elements solution (Hopwood et al., 1985)
ZnCl2 0.04 g/l
FeCl2 C 6 H2O 0.2 g/l
CuCl2 C 2 H2O 0.01 g/l
MnCl2 C 4 H2O 0.001 g/l
Na2B4O7 C 10 H2O 0.01 g/l
(NH4)6Mo7O24 C 4 H2O 0.01 g/l
Sterile filtration
TSB (Hopwood et al., 1985)
Tryptone Soja Broth (Oxoid) 30 g/l
TSB-PEG 8000 (Babcock & Kendrick, 1988)
TSB 30 g/l
PEG 8000 50 g/l
YEME (Hopwood et al., 1985)
Difco yeast extract 3 g/l
Difco peptone   5 g/l
Difco malt extract   3 g/l
Glucose 10 g/l
Sucrose                                               340 g/l
   After autoclaving, supplemented with:
MgCl2 C 6H2O (2.5M)   2 ml/l
SGYEME
A modified YEME medium.
Sucrose 110 g/l
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2.2.3. Buffers
-for isolation of plasmid DNA
Alkaline Lysis Solution (Birnboim & Doly, 1979)
     Solution I:
Glucose 50 mM
Tris/HCl, pH 8.0 50 mM
EDTA, pH 8.0 10 mM
     Solution II:
SDS 20 ml/l
NaOH 0.2 M
     Solution III:
Potassium acetate 3 M
Formic acid 1.8 M
STET buffer (Sambrook et al., 1989)
Sucrose 80 g/l
Triton X-100 50 ml/l
Tris/HCl, pH 8.0 50 mM
EDTA, pH 8.0 50 mM
Lysozyme solution (Hopwood et al., 1985)
Sucrose 0.3 M
Tris/HCl, pH 8.0 25 mM
EDTA, pH 8.0 25 mM
-for preparation of competent E. coli cells (Hanahan, 1983)
FSB-buffer
Potassium acetate, pH7.0 10 mM
KCl 100 mM
MnCl2 C 4 H2O 45 mM
CaCl2 C 2 H2O 10 mM
Hexaminecobaltchloride 3 mM
Glycerol 100 g/l
pH 6.4
Filtration
-for preparation of genomic DNA from Streptomyces (Pospiech & Neumann,
1995)
SET buffer
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NaCl 75 mM
EDTA 25 mM
Tris 20 mM
pH 7.5
TE buffer (Sambrook et al., 1989)
Tris 10 mM
EDTA 1 mM
pH 8.0
- for preparation of protoplasts from Streptomyces (Chater et al., 1982)
P-buffer
Sucrose 103 g
K2SO4 0.25 g
MgCl2 C 6 H2O 2.02 g
Trace elements 2 ml
Add H2O to 800 ml volume
Autoclave in 80 ml aliquots and supplement with:
K2HPO4 (0.5%) 1 ml
CaCl2 C 2 H2O (3.68%) 10 ml
TES (5.73%), pH7.2 10 ml
- for transformation in Streptomyces (Babcock & Kendrick, 1988)
T-buffer
Sucrose (10.3%) 25 ml
K2SO4 (2.5%) 1 ml
H2O 75 ml
Trace elements 0.2 ml
CaCl2 (0.25 M) 0.2 ml
Tris/maleicacid (1M); pH 8.0 0.5 ml
T-buffer/PEG
Polyethyleneglycol 1000 1 g
T-buffer 900 ml
- for agarose gel electrophoresis of DNA fragments (Sambrook et al., 1989)
DNA loading buffer (10 C )
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Sucrose 0.5 g/ml
EDTA; pH 8.0 160 mM
Bromophenol Blue 0.5 mg/ml
Xylene cyanol 0.5 mg/ml
TAE (50 C )
Tris 242 g/l
Glacial acetic acid                            57.1 ml/l
EDTA     0.4 g/l
pH  8.3
TBE (10 C )
Tris 108 g/l
Boricacid 61 g/l
EDTA 0.4 g/l
-for constructure of genomic libraries
Sucrose gradients (Weis, 1987)
Sucrose 100 g/l
Tris/HCl, pH 8.0 10 mM
EDTA 1 mM
NaCl 1 M
autoclaved
SM  phage dilution buffer (Boehringer's DNA packaging protocol)
Tris/HCl pH 7.5 50 mM
MgSO4 10 mM
NaCl 100 mM
gelatine 0.1 g/l
autoclaved
- for DNA-DNA hybridization (Southern, 1975)
Hybridization solution
SSC (20 C) 330 ml/l
Sodium phosphate buffer 10 ml/l
(1M), pH6.8
EDTA (0.5 M), pH 8.0 2 ml/l
SDS (10%) 50 ml/l ???
Blocking reagent 1 g/l
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Wash solution (2 C)
SSC (20 C)  200 ml/l
SDS (10%) 10 ml/l
Wash solution ((0.5 C)
SSC (20 C)  25 ml/l
SDS (10%) 10 ml/l
SSC (20 C)
NaCl 3 M
Sodium citrate 0.3 M
pH 7.2 adjust with citric acid
- for denatured polyacrylamide gel electrophoresis (Laemmli, 1970)
30% PAA solution
Acrylamide 290 g/l
N,N-methylene bisacrylamid 10 g/l
Resolving gel buffer
Tris/HCl; pH 8.9 1.5 M
SDS 4 g/l
Stacking gel buffer
Tris/HCl; pH 6.7 0.5 M
SDS 1 g/l
SDS electrophoresis running buffer (10 C )
Tris 30 g/l
Glycine 144 g/l
SDS 10 g/l
pH 8.3
Sample loding buffer (5 C )
SDS (20 g/l) 2 ml
b-mercaptoethanol 4 ml
Glycerol 2 ml
Bromophenol Blue (1 g/l in H2O) 2 ml
Gel staning solution
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Coomassie Brilliant Blue R250 1.5 g/l
Methanol 450 ml/l
Acetic acid 100 ml/l
Destaining solution
Methanol 250 ml/l
Acetic acid 100 ml/l
     -for Western blotting and detection of proteins
Western blotting buffer
Tris 98 mM
Glycine 39 mM
10% SDS 3.75 ml/l
Methanol 200 ml/l
- for sonification of expression proteins
Buffer 1
Tris/HCl, pH 7.5 50 mM
DTT 1 mM
MgCl2 10 mM
EDTA, pH 8.0 1 mM
Buffer 2
 
Potassium phosphate buffer, pH 7.2 50 mM
b-mercaptoethanol  10 mM
EDTA, pH 8.0 0.1 mM
Buffer 3
Buffer 2
PLP 50 mM
- for HPLC analysis
Reversed phase chromatography
           Running buffer A:
Potassium phosphate buffer, pH 6.0 30 mM
Tetrabutylammoniumhydrogen 5 mM
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sulphate
Acetonitril 20 ml/l
                    Running buffer B:
Acetonitril 100 %
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2.3 Bacteria, cosmids and plasmids
2.3.1. Bacteria
Tab. 2.1. Bacteria used in this study
Strain Genotype/Product Reference/Origin
E. coli BL21(DE3) ompT, hsdSB (rB
- mB
-), l prophage Studier et al., 1990
pLysS with polymerase gene, pLysS, cat
E. coli DH5a F[JS1], f80dlacZDM15, recA1, endA1, D. Hanahan, 1983
gyrA96, thi-1, hsd R17(rk
-
,mk
+), supE44,
relA1, deoR, D(lacZYA-argF)U169
E. coli JM108 endA1, recA1, gyrA96, thi, hsd R17 Yanisch-Perron
(rk
-mk
+), relA1, supE44, D(lac-proAB), et al., 1985
E. coli JM109 endA1, recA1, gyrA96, thi, hsd R17 Yanisch-Perron
(rk
-mk
+), relA1, supE44, D(lac-proAB), et al., 1985
[F’, traD36, proAB, lacIqZDM15]
E. coli JM109 endA1, recA1, gyrA96, thi, hsd R17 Yanisch-Perron
(DE3) (rk
-mk
+), relA1, supE44, D(lac-proAB), et al., 1985
[F’, traD36, proAB, lacIqZDM15], l(DE3)
E. coli XL1-Blue recA1, endA1, gyrA96, thi-1, hsdR17, Loenen & Blattner,
supE44, relA1, lac, [F' proAB, 1983
lacIqZDM15, Tn10 (tetR)]
ET12567 F-, dam13::Tn9, dcm6, hsdM, hsdR, MacNeil et al.,
recF143, zjj201::Tn10, galK2, galT22, 1992
ara-14, lacY1, xyl-5, leuB6, thi-1, tonA31,
rpsL136, hisG4, tsx-78, mtl-1, glnV44
S. lividans 66 1326 actinorhodin, prodigiosin John Innes Institute,
Norwich, UK
S. lividans 66 TK23 actinorhodin, spc-1 John Innes Institute,
Norwich, UK
S. mycarofaciens non-producing UC189B (ATCC 21454)
Heochst
S. mycarofaciens midecamycin ATCC 21454
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2.3.2. Vectors
Tab. 2.2. Plasmid and cosmid vectors used in this study
Plasmid/Cosmid Genetype, Properties and Use Reference/Origin
pAL201 bla, tsr, pUC18 ori, pJV1 ori, Hoechst Marion
Streptomyces-E. coli shuttle vector, Roussel
for transformation in Saccharopolyspora
erythraea
pDNW16RBSY derived from pUWL201 with lmbY RBS, Neußer,
His-tag, expression of lmbY gene Uni. Wuppertal
pEFBA bla, aparamycin resistance cassette, Fernandez,
for mutagenesis Uni. Oviedo
pET11a bla, lacIT7-f10, for heterologous Studier et al., 1990
expression in E. coli
pET16b bla, lacIT7-f10, His-tag, for heterologous Novagen, Heidelberg
expression in E. coli
pHM8a hyg, mini-circle, integrative into Motamedi et al., 1995
Streptomyces
pIJ4123 kan, tsr, redD, His-tag, for heterologous Takano et al., 1995
expression in S. lividans
pSL1180 bla, polylinker containing 78 recognition Pharmacia
sites, for subcloning
pSVW701 bla, T7-f10, for expression of rmlB gene Verseck, 1997
pUWL201 bla, tsr, pUC18 ori, pIJ101 ori, ermE up Wehmeier,
promoter, Streptomyces-E. coli shuttle Uni. Wuppertal
plasmid, for heterologous expression
in S. lividans
pUWL219 bla, tsr, pUC18 ori, pIJ101 ori, Wehmeier, 1995
Streptomyces-E. coli shuttle plasmid
for subcloning
pUC18 bla, lacZ-a, for subcloning Vieira & Messing,
1982
pKU206 SCP2* ori and stability, pMB1 ori, tsr, Kakinuma et al.,
bla, cos, Streptomyces-E. coli shuttle 1991
cosmid for gene library
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2.3.3. Recombinant plasmids
Tab. 2.3. New constructed plasmids for screening S. mycarofaciens genomic library
Plasmid                 Description Host strain
pLCW1 301 bp PCR fragment by primers AS2 and AS5 E. coli DH5a
(identified as midB gene) from S. mycarofaciens
in pUC18 SmaI
pLCW17 420 bp PCR fragment by primers LC6 and EryCIII/I E. coli DH5a
(identified as midI gene) from S. mycarofaciens in
pUC18 SmaI
Tab. 2.4. Recombinant cosmid plasmids constructed in this study
Cosmid plasmid                 Description Host strain
Smyc-LC1 ca. 30.2 kb fragment from partially digested E. coli JM108
S. mycarofaciens gemomic DNA with S. lividans TK23
Sau3AI in pKU206 BamHI
Smyc-LC2 ca. 22.6 kb fragment from partially digested E. coli JM108
S. mycarofaciens gemomic DNA with S. lividans TK23
Sau3AI in pKU206 BamHI
Smyc-LC3 ca. 26.3 kb fragment from partially digested E. coli JM108
S. mycarofaciens gemomic DNA with S. lividans TK23
Sau3AI in pKU206 BamHI
Smyc-LC4 ca. 29.3 kb fragment from partially digested E. coli JM108
S. mycarofaciens gemomic DNA with S. lividans TK23
Sau3AI in pKU206 BamHI
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Tab. 2.5. New constructed plasmids for sequencing
   Plasmid                         Description Host strain
pLC1-1 0.8 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
                    in pUC18 BamHI
pLC1-2 1.5 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-3 2.3 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-4 4.2 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-5 4.2 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-6 4.8 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-7 8.2 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-8 0.8 kb SstI fragment from pLC1-2 in pUC18 SstI E. coli DH5a
    pLC1-9 0.7 kb SstI fragment from pLC1-2 in pUC18 SstI E. coli DH5a
pLC1-10 4.0 kb EcoRI/HindIII fragment from pLC1-7 E. coli DH5a
in pUC18 EcoRI/HindIII
pLC1-11 2.0 kb EcoRI fragment from pLC1-7 in pUC18 E. coli DH5a
EcoRI
pLC1-12 1.0 kb EcoRI fragment from pLC1-7 in pUC18 E. coli DH5a
EcoRI
pLC1-13 0.9 kb EcoRI fragment from pLC1-7 in pUC18 E. coli DH5a
EcoRI
pLC1-14 4.2 kb BamHI/BglII fragment from Smyc-LC1 E. coli DH5a
in pUC18 BamHI
pLC1-15 2.1 kb SphI/BamHI fragment from pLC1-4 E. coli DH5a
in pUC18 SphI/BamHI
pLC1-16 1.3 kb SphI fragment from pLC1-4 in pUC18 SphI E. coli DH5a
  pLC1-17 0.7 kb SphI fragment from pLC1-4 in pUC18 SphI E. coli DH5a
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pLC1-18 1.8 kb PstI/EcoRI fragment from pLC1-10 in E. coli DH5a
pUC18 PstI/EcoRI
pLC1-19 1.5 kb PstI fragment from pLC1-10 in pUC18 PstI E. coli DH5a
    pLC1-20 0.6 kb PstI/SstI fragment from pLC1-18 in E. coli DH5a
pUC18 PstI/SstI
pLC1-21 1.2 kb EcoRI/SstI fragment from pLC1-18 in E. coli DH5a
pUC18 EcoRI/SstI
pLC1-22 1.5 kb BamHI fragment from Smyc-LC1 in E. coli DH5a
pUC18 BamHI
pLC1-23 0.2 kb PstI/BamHI fragment from pLC1-10 in E. coli DH5a
pUC18 PstI/BamHI
pLC1-24 0.4 kb PstI fragment from pLC1-10 in pUC18 PstI E. coli DH5a
    pLC1-25 1.6 kb EcoRI fragment from pLC1-4 in pUC18 E. coli DH5a
EcoRI
pLC1-26 1.4 kb EcoRI fragment from pLC1-4 in pUC18 E. coli DH5a
EcoRI
pLC1-27 0.75 kb EcoRI fragment from pLC1-4 in pUC18 E. coli DH5a
EcoRI
pLC1-28 0.55 kb EcoRI fragment from pLC1-4 in pUC18 E. coli DH5a
EcoRI
pLC1-29 0.7 kb SstI fragment from pLC1-19 in pUC18 SstI E. coli DH5a
pLC1-30 0.9 kb SstI fragment from pLC1-19 in pUC18 SstI E. coli DH5a
pLC1-31 14 kb BglII fragment from Smyc-LC1 in pUC18 E. coli XL1-Blue
BamHI
pLC1-32 5.1 kb BglII fragment from Smyc-LC1 in pUC18 E. coli XL1-Blue
BamHI
pLC2-1 8.2 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
pLC2-2 0.7 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
pLC2-3 1.5 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
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pLC2-4 5.0 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
pLC2-5 0.8 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
pLC2-6 2.0 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
pLC2-7 4.2 kb BamHI/BglII fragment from Smyc-LC2 E. coli DH5a
in pUC18 BamHI
pLC3-1 6.7 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-2 5.9 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-3 4.3 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-4 2.8 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-5 1.8 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-6 1.5 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-7 0.9 kb BamHI fragment from Smyc-LC3 in pUC18 E. coli DH5a
BamHI
pLC3-8A 1.6 kb BamHI/Eco47III fragment from pLC3-3 in E. coli DH5a
pUC18 BamHI/HincII
pLC3-9A 1.6 kb BamHI/Eco47III fragment from pLC3-3 in E. coli DH5a
pUC18 BamHI/HincII
pLC3-10 0.7 kb BamHI/SalI fragment from pLC3-3 in E. coli DH5a
pUC18 BamHI/SalI
pLC3-11 1.5 kb BamHI fragment from Smyc-LC3 in E. coli DH5a
pUC18 BamHI
pLC3-12 1.2 kb SalI fragment from pLC3-3 in pUC18 SalI E. coli DH5a
    pLC3-13 0.9 kb BamHI/HincII fragment from pLC3-3 in E. coli DH5a
pUC18 BamHI/HincII
pLC3-14 0.7 kb SalI fragment from pLC3-3 in pUC18 SalI E. coli DH5a
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pLC3-15 0.7 kb HincII fragment from pLC3-3 in pUC18 HincII E. coli DH5a
pLC3-16 1.2 kb Eco47III fragment from pLC3-3 in pUC18 E. coli DH5a
HincII
pLC3-17A 0.2 kb BamHI/SstI fragment from pLC3-6 in E. coli DH5a
pUC18 BamHI/SstI
pLC3-18A 0.6 kb BamHI/SstI fragment from pLC3-6 in E. coli DH5a
pUC18 BamHI/SstI
pLC3-18D 0.6 kb SstI fragment from pLC3-6 in pUC18 SstI E. coli DH5a
pLC3-19A 1.4 kb BamHI/BglII fragment from pLC3-4 in E. coli DH5a
pUC18 BamHI
pLC3-19B 1.4 kb BamHI/BglII fragment from pLC3-4 in E. coli DH5a
pUC18 BamHI
pLC3-20 2.3 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-21 1.7 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-22 1.7 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-23 1.4 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-24 1.4 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-25 1.2 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-26 0.8 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-27 0.6 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-28 0.6 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-29 0.4 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-30 0.4 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-31 6.0 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-32 0.45 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-33 0.45 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-34 0.4 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
pLC3-35 0.2 kb SstI fragment from Smyc-LC3 in pUC18 SstI E. coli DH5a
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  Tab. 2.6. New constructed plasmids for expression
 Plasmid                        Description   Host strain
pLCW1-22 1.3 kb PCR fragment by primers LC9 and LC10 E. coli XL1-Blue
(contaning midI gene) from Smyc-LC3 in pUC18
SmaI
pLCW1-23 1.3 kb NdeI/BamHI fragment from pLCW1-22 in E. coli BL21(DE3)
pET16b NdeI/BamHI pLysS; XL1-Blue
pLCW1-33 1.3 kb NdeI/BamHI fragment from pLCW1-22 in E. coli BL21(DE3)
pET11a NdeI/BamHI pLysS; XL1-Blue
pLCW1-41a 1.7 kb XbaI/HindIII-blunt fragment from pLCW1-33 E. coli XL1-Blue
in pUC18 XbaI/SmaI
pLCW1-41b 1.7 kb EcoRI/HindIII fragment from pLCW1-41b E. coli XL1-Blue
in pUWL201 S. lividans TK23
pLCW1-51a 1.75 kb XbaI/HindIII-blunt fragment from pLCW1-23 E. coli XL1-Blue
in pUC18 XbaI/SmaI
pLCW1-51b 1.75 kb EcoRI/HindIII fragment from pLCW1-51b E. coli XL1-Blue
in pUWL201 S. lividans TK23
pLCW1-61 1.3 kb NdeI/BamHI fragment from pLCW1-22 in S. lividans 66 1326
pIJ4123
pLCW2-1 1.2 kb PCR fragment by primers LC13 and LC14 E. coli XL1-Blue
(containing midC gene) from Smyc-LC1 in pUC18
SmaI
pLCW2-20 1.2 kb NdeI/BglII fragment from pLCW2-1 in E. coli BL21(DE3)
pET16b NdeI/BamHI pLysS; XL1-Blue
pLCW2-8 1.2 kb PCR fragment by primers LC17 and LC14 E. coli XL1-Blue
(containing midC gene) from Smyc-LC1 in pUC18
SmaI
pLCW2-21 1.2 kb NdeI/BglII fragment from pLCW2-8 in E. coli BL21(DE3)
pET16b NdeI/BamHI pLysS; XL1-Blue
pLCW2-23 1.2 kb NdeI/BglII fragment from pLCW2-8 in E. coli BL21(DE3)
pET11a NdeI/BamHI pLysS; XL1-Blue
pLCW3-1 0.8 kb PCR fragment by primers LC11 and LC12 E. coli XL1-Blue
(containing midK gene) from Smyc-LC3 in pUC18
SmaI
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pLCW3-2 0.8 kb NdeI/BamHI fragment from pLCW3-1 in E. coli BL21(DE3)
pET11a NdeI/BamHI pLysS; XL1-Blue
pLCW3-3 0.8 kb NdeI/BamHI fragment from pLCW3-1 in E. coli BL21(DE3)
pET16b NdeI/BamHI pLysS; XL1-Blue
pLCW3-6 1.2 kb XbaI/HindIII-blunt fragment from pLCW3-2 E. coli XL1-Blue
in pUC18 XbaI/SmaI
pLCW3-7 1.25 kb XbaI/HindIII-blunt fragment from pLCW3-3 E. coli XL1-Blue
in pUC18 XbaI/SmaI
pLCW3-8 1.2 kb EcoRI/HindIII fragment from pLCW3-6 E. coli XL1-Blue
in pUWL201 S. lividans TK23
pLCW3-9 1.25 kb EcoRI/HindIII fragment from pLCW3-7 E. coli XL1-Blue
in pUWL201 S. lividans TK23
pLCW3-12 0.8 kb NdeI/BamHI fragment from pLCW3-1 in S. lividans 66 1326
pIJ4123
pLCW4-1 1.3 kb PCR fragment by primers LC15 and LC16 E. coli XL1-Blue
(containing midH gene) from Smyc-LC3 in pUC18
SmaI
pLCW4-2 1.3 kb NdeI/BglII fragment from pLCW4-1 in E. coli BL21(DE3)
pET11a NdeI/BamHI pLysS; XL1-Blue
pLCW4-3 1.3 kb NdeI/BglII fragment from pLCW4-1 in E. coli BL21(DE3)
pET16b NdeI/BamHI pLysS; XL1-Blue
pLCW4-4 1.7 kb XbaI/HindIII-blunt fragment from pLCW4-2 E. coli XL1-Blue
in pUC18 XbaI/SmaI
pLCW4-5 1.75 kb XbaI/HindIII-blunt fragment from pLCW4-3 E. coli XL1-Blue
in pUC18 XbaI/SmaI
pLCW4-6 1.7 kb EcoRI/HindIII fragment from pLCW4-4 E. coli XL1-Blue
in pUWL201 S. lividans TK23
pLCW4-7 1.75 kb EcoRI/HindIII fragment from pLCW4-5 E. coli XL1-Blue
in pUWL201 S. lividans TK23
pLCW4-10 1.3 kb NdeI/BglII fragment from pLCW4-1 in S. lividans 66 1326
pIJ4123
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Tab. 2.7. New constructed plasmids for heterologous complementation
 Plasmid                    Description  Host strain
pRBS201 pJV1 ori from pAL201 instead of pIJ101 ori in E. coli XL1-blue
pDNW16RBSY
pLCW1-21 4.3 kb BamHI fragment from pLC3-3 (containing E. coli XL1-blue
midHI region) in pAL201 BamHI ET12567
pLCW1-25 1.3 kb PCR fragment by primers LC29 and LC19 E. coli XL1-blue
(containing midI gene) from Smyc-LC3 in pUC18
SmaI
pLCW1-26 1.3 kb NcoI/BamHI fragment from pLC1-25 in E. coli XL1-blue
pRBSY201 NcoI/BamHI ET12567
pLCW1-28 4.3 kb BamHI fragment from pLC3-3 (containing E. coli XL1-blue
midHI region) ligated with pLCW3-20 BamHI
(select the orientation and combine midKHI genes)
pLCW1-29 5.7 kb HindIII/EcoRI fragment from pLCW1-28 E. coli XL1-blue
in pAL201 HindIII/EcoRI ET12567
pLCW3-15 1.4 kb BamHI fragment from pLC3-6 in E. coli XL1-blue
pAL201 BamHI ET12567
pLCW3-16 0.85 kb PCR fragment by primers LC24 and LC25 E. coli XL1-blue
(containing 64 bp upstream sequence of midK, and
midK) from Smyc-LC3 in pUC18 SmaI
pLCW3-17 0.8 kb PCR fragment by primers LC28 and LC25 E. coli XL1-blue
(containing midK) from Smyc-LC3 in pUC18 SmaI
pLCW3-18 0.85 kb HindIII/BamHI fragment from pLCW3-16 E. coli XL1-blue
in pAL201 HindIII/BamHI ET12567
pLCW3-19 0.8 kb NcoI/BamHI fragment from pLCW3-17 E. coli XL1-blue
in pRBSY201 NcoI/BamHI ET12567
pLCW3-20 1.4 kb BamHI fragment from pLC3-6 (containing E. coli XL1-blue
midK region) in pSL1180 BamHI/BglII
(select the orientation of BamHI/BglII site of
recombinant plasmid located upstream midK gene)
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2.4. Oligonucleotides
Tab. 2.9. Oligonucleotides used in this study
Primer          Nucleotide sequence*                     Restriction site Gene
 AS2 5´ GCCGCCGCGTCCCATGTCGAC 3´ strE
 AS5 5´ CCCGTAGTTGTTGGAGCAGCGGGT 3´ strE
 EryCIII/H 5´ CACGCGCGGCTGCTGTGGGGACCCGAC 3´ eryCIII
 EryCIII/I 5´ CGCCGCGCAGGTCGGCAGCAGCGCGTG CAT 3´ eryCIII
    LC1 5´ GCCGCCGAATCCCATGTGGAC 3´ midB
 LC2 5´ CCCGTAGTTGTTGGAGCAGCGGGT 3´ midB
 LC6 5´ GAGGAGCCCCGGGAGGACCCGGTCGCCGA 3´ tylM2
 LC9 5´ GTCCATATGCGCGTCCTG 3´ NdeI midI
 LC10 5´ TCGGGATCCGCATGACTG 3´ BamHI midI
 LC11 5´ACACATATGTACGCCAACG 3´ NdeI midK
 LC12 5´ CGGATCCGGTCAGTTGAA 3´ BamHI midK
 LC13 5´ GAGCATCATATGAACGTGCCCTTTCC 3´ NdeI midC
 LC14 5´ CGGCGAAGATCTTTCCCTTCATTCC 3´ BglII midC
 LC15 5´ GAGGAACATATGCCAATCCCTGCCA 3´ NdeI midH
 LC16 5´ ACTCCAGATCTGGCCGGGGTGTAC 3´ BglII midH
 LC17 5´ GCGCGACATATGGAGCATAAAGTGA 3´ NdeI midC
 LC19 5´CATGGTGGATCCGCTCCGTTCGAACG 3´ BamHI midI
    LC24 5´ ACGACAAGCTTGGTGCCGACC 3´ HindIII midK
  LC25 5´ AAGCCGGATCCCGAGCTCCC 3´ BamHI midK
  LC28 5´ AAACACCCATGGACGCCAACG 3´ NcoI midK
 LC29 5´AGTCACCATGGGCGTCCTGCTGACCT 3´ NcoI midI
 LC30 5´ AGGGCAGCGCTGTCGTTG 3´ Eco47III midG
  LC31 5´ TCCTTCAGCGCTGGCTACGTC 3´ Eco47III midKH
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  LC33 5´ GCGCATATGGACTCCAGTTCG 3´ NdeI midKH
 LC35 5´CGGAGATCTCCATCGCCG 3´ BglII midG
The underlined sequences are the corresponding restriction site.
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3. Methods
3.1. Cultivation and maintenance of bacterial strains
3.1.1. Cultivation and maintenance of  E. coli
E. coli strains were generally cultivated at 37°C on LB plates or in LB liquid medium
(Miller, 1972), except for some E. coli strains containing the expressed genes that were
cultivated in LB liquid supplemented with 1 M sorbitol and 2.5 mM betaine (Blackwell et
al., 1991). Strains harboring plasmids were grown on solid or in liquid media
supplemented with the appropriate antibiotics. Unless otherwise stated, the final
concentrations of used antibiotics were: ampicillin 80 mg/ml; chloramphenicol 25 mg/ml;
hygromycin B 200 mg/ml. In the case of pUC-derived recombinant plasmids, 40 mg/ml X-
gal was added into LB plates for the blue-white selection. Cultures were stored at –20°C
3.1.2. Cultivation and maintenance of Streptomyces
Wild type strains of Streptomyces sp. were grown on SMA plates and cultivated in TSB,
YEME or SGYEME liquid media at 28-30°C for 3-5 d. For the cultivation of strains
containing plasmids, a final concentration of thiostrepton in 25 mg/ml was added to agar
plates and 15 mg/ml in liquid media. Kanamycin and hygromycin B were supplemented
into solid and liquid media with concentrations of 50 mg/ml and 200 mg/ml, respectively.
Spore suspensions were prepared according to Hopwood et al. (1985) by adding 20%
glycerol onto a well-sporulated plate and scraping off the spores from the surface of the
plate. The suspension was then filtrated through sterile  non-absorbant cotton wool to
remove mycelial remnants. The spore suspensions were stored at –20°C.
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3.2. S. mycarofaciens fermentation and product extraction
S. mycarofaciens was grown on ISP2 plates and sporulated at 28°C for 5 d. To produce a
seed culture, 10 ml of EP1 medium (Salah-Bey et al., 1998) in a 10 ´ 22 cm glass tube with
a short metal spring was inoculated with spore suspensions of S. mycarofaciens. Cultivation
was carried out at 28°C for 3 d in a rotary shaker at 230 r.p.m. Then 4.2 ml of  the seed
culture were inoculated into 60 ml of EP2 medium (Salah-Bey et al., 1998)  in a 500 ml
Erlenmeyer flask with a round metal spring. The production culture was grown for 5-7 d by
shaking (230 r.p.m.) at 28°C.
The extraction of  the fermenting broth of S. mycarofaciens was followed as in Salah-Bey
et al. (1998). The broth was separated by centrifugation and the cells were washed once
with water. The supernatant was adjusted to pH 9-10 with 1 M NaOH and extracted three
times with an equal volume of ethyl acetate. The extracts were dried by evaporation. The
residue was dissolved in an appropriate volume of dichloroform for assay.
3.3. General manipulation of DNA
3.3.1. Isolation of genomic DNA from Streptomyces
Chromosomal DNA was isolated from mycelia of Streptomyces sp. according to the
protocol of Pospiech et al. (1995) with minor modifications. The following steps were
used.
(1) Strains were inoculated in 25 ml of TSB liquid medium in 250 ml Erlemeyer flasks,
each flask containing a short metal spring. The culture was heavily aerated by rotary
shaking and grown at 28°C for 2 d to the late logarithmic phase.
(2) The mycelia were pelleted and washed twice with 10.3% sucrose.
(3)  Approximately 0.5 g of cells were resuspended in 5 ml SET buffer (see Section 2.2.3),
lysozyme was added to a concentration of 1 mg/ml and incubated at 37°C for 30-60
min.
(4)  1/10 volumes of 10% SDS and 0.5 mg/ml of proteinase K were added and incubated at
55°C with occasional inversion for 60 min.
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(5) The lysates were extracted by the addition of 1/3 volumes of 5 M NaCl and 1 volume of
chlorofrom and incubated at room temprature for 30 min with frequent inversion.
(6) The flocculant precipitate was removed by centrifugation at 4°C , 4500 rpm for 15 min.
The aqueous phase was transferred to a new tube using a blunt-ended pipette tip.
(7) The chromosomal DNA was precipitated by adding 1 volume of isopropanol,
centrifuged, washed with 70% ethanol, dried at room temperature and dissolved in 200
ml TE buffer with 2 ml of 10 mg/ml RNase.
In the case of isolation of chromosomal DNA from S. mycarofaciens for  the preparation of
the cosmid genomic library, in step (3) it was found to be better to incubate for 30 min with
2-3 gentle inversion. After step (6), the aqueous phase was extracted again by adding 1
volume chlorofrom and incubated as in step (5).
3.3.2. Preparation of plasmid DNA from E. coli
Plasmid DNA from E. coli was prepared via three methods depending on the different
application of  the DNA.
(1) Plasmid DNA to be used for cloning and sequencing was isolated from cells by using
the Miniprep Plasmid Kit (Qiagen).
(2) The boiling preparation method was used  for rapid screening of transformants
(Sambrook et al., 1989).
(3) In this work , the alkaline lysis method (Birnboim & Doly, 1979) was especially
adapted for the isolation of recombinant cosmid DNA. After the cells were lysed and
neutralized by solution I, II and III (see Section 2.2.3.), the lysates were extracted twice
with phenol/chloroform/isoamylalcohol (25:24:1) (Carl Roth, Karlruhe) and once with
chloroform/isoamyl alcohol (24:1).
3.3.3. Preparation of plasmid DNA from Streptomyces sp.
Two methods were used to isolate plasmid DNA from Streptomyces mycelia.
(1) For generally checking the recombinant transformants, the Birnbiom & Doly (1979)
method was adapted with minor modification. The cells were suspended in solution I,
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then solution II was added in the presence of 5 mg/ml lysozyme and incubated at 37°C
for 30 min.
(2) For the preparation of Streptomyces plasmid vectors, an alkaline lysis method
(Hopwood et al., 1985) was introduced with modifications (this study). An aliquot of
Streptomyces culture (1.5 ml) was harvested and the pellet was resuspended in 1 ml
lysozyme solution (see Section 2.2.3) in a 2 ml Eppendorf tube. The suspension was
incubated for 30 min at 37°C and gently mixed after the incubation. Then 500 ml of
alkaline SDS solution (0.3 M NaOH, 2% SDS) was added and, the mixture was agitated
by vortexing and incubated at 70°C for 15 min. After incubation, the mixture was
placed at room temperature for 3 min. Then 160 ml of acid phenol/chloroform (5 g
phenol, 5 ml chloroform and 1 ml H2O) was added and mixed vigorously. The mixture
was centrifuged for 2 min. The supernatant was transferred into a new Eppendorf tube
containing 140 ml of 3 M sodium acetate and 1.4 ml of isopropanol. The suspension
was mixed and left at room temperature for 5 min, and then centrifuged. The
supernatant was decanted and the pellet was dried. The pellet was then re-dissolved in
100 ml TE buffer, and 10 ml of 3 M sodium acetate and 50 ml of neutral
phenol/chloroform (saturated with TE buffer; Carl Roth, Karlsruhe) were added. The
mixture was vortexed and centrifuged. The supernatant was transferred into a new
Eppendorf tube and 100 ml isopropanol was added. The solution was mixed, left at
room temperature for 10 min and centrifuged. The pellet was dried and re-dissolved in
50 ml TE buffer with addition of 2 ml of 10 mg/ml RNase.
3.3.4. In vitro manipulation of DNA
Restriction endonucleases for DNA hydrolysis, alkaline phosphatase for removing 5'-
phosphate group from linearized DNA, Klenow fragment of DNA polymerase I for
generation of blunt end at 3'- or 5'- overhang of linearized DNA, and T4-DNA ligase for
ligation of DNA fragments were routinely used according to the manufacturer's
specifications. For the first three enzyme reactions, the enzymes were inactivated by
incubation for 10 minutes at 70°C. The resulting DNA fragments were isolated either by
phenol/chloroform extraction or by agarose gel separation.
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3.3.5. Polymerase chain reactions (PCR)
The PCR amplification was done according to Innis et al. (1992). In this study, two
polymerases (Vent- and Taq-) were used depend of the further uses of genes found by PCR.
Therefore, two PCR reactions were performed as follows:
(1) Vent polymerase buffer (10 ´) 10 ml
dNTP's 200 mM
DMSO 10 ml
MgSO4 (100 mM) 1 ml
Forward primer 50 pmol
Reverse primer 50 pmol
DNA template 10-100 ng
Vent-DNA polymerase 2.5 U
H2O to 100 ml
Mineral oil 50 ml
(2) Taq polymerase buffer (10 ´) 10 ml
dNTP's 200 mM
DMSO 5 ml
MgCl2 (50 mM) 3 ml
Forward primer 50 pmol
Reverse primer 50 pmol
DNA template 10-100 ng
Taq-DNA polymerase 2.5 U
H2O to 100 ml
Mineral oil 50 ml
The amplification profile was performed in two ways.
(1) Usually the amplification was done as follows. After an initial hot start at 98°C for 2
min, the polymerase was immediately added into the above mixture tubes. The mixture
was subjected to 30 cycles of amplification, each consisting of 1 min at 95°C, 40 s at an
annealing temperature (variable) and 1-2 min at 72°C. The thermal cycle was
(2) To detect the genes containing high GC contents from chromosomal DNA, 6 special
cycles were introduced before starting the 30 cycles of method (1). The first cycle was
1 min at 95°C, 40 s at an annealing temperature of T°C, and 1-2 min at 72°C. In every
subsequent cycle the annealing temperature was decreased by 1°C until the sixth cycle
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at (T-5)°C. Then the annealing temperature was returned to T°C, performing
amplication as (1).
The PCR products were analysed and purified by agarose gels or using the NucleoSpin
Extract kit. 
3.3.6. Separation of DNA fragment
Agarose gel electrophoresis was performed essentially as described by Sambrook et al.,
1989. DNA fragments were separated on horizontal 0.7-1.5% agrose gels containing 0.1
mg/ml ethidium bromide. One tenth volume of 10 ´ loading buffer was added to the DNA
solution. The agarose was dissolved in 1 ´ TAE buffer and electrophoresis was carried out
at 5-10 V/cm. DNA was visualized by illumination with long wavelength UV-light (366
nm).
The separation of DNA fragments for sequencing was carried out on a vertical denaturing
PAA gel. The gel contained 5.5% polyacrylamide (the FMC Long-Ranger Solution,
Biozym, Hameln), 7 M urea in 1 ´ TBE buffer. Then 350 ml APS (10%) and 42 ml TEMED
were added into 80 ml above solution to start the polymerization. The gel solution was
sandwiched between the glass plates (50 ´ 50 ´ 0.05 cm) and polymerized for 2 h. The gel
was run with 1 ´ TBE buffer at 45°C at 1500-2000 V in an A.L.F. DNA Sequencer
(Amersham).
Sucrose gradients were used for the size fractionation of DNA fragments for the cosmid
genomic library (see Section 3.4.1.2).
3.3.7. Radioactive labelling of DNA fragments
Double strand DNA fragments were labelled with [32P] using the Rediprime DNA labelling
system (Amersham) according to the manufacturer's specifications. In general, 5 ml of a-
[32P]-dCTP with a specific activity of 3000 Ci/mmol were used in the labelling reaction.
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3.3.8. DNA-DNA hybridization
The DNA fragments were separated on 0.8-1.0% agarose gels and transferred by capillary
stock onto a Hybond N+ membrane (Amersham) using 0.4 M NaOH for 12 h (Reed &
Mann, 1985). The membranes were shortly washed with 2 ´ SSC, air-dried and fixed at
80°C for 10 min or at UV light (360 nm) for 3 min. Membranes were prehybridized in 200-
400 ml prehybridization solution in a shaking water bath at 68°C for 3-4 h. The [32P]
labelled DNA probe was denatured by boiling for 10 min and immediately placed on ice.
Membranes were transferred to 100 ml hybridization solution and the denatured radioactive
probe was then added. The hybridization was carried out at 68°C for 12 h. A series of
washing steps followed. Membranes were washed twice with 6 ´ SSC / 0.1% SDS, each for
15 min. Stringency washes were carried out with 0.5-2 ´ SSC / 0.1% SDS at 68°C for 10
min with gentle shaking.
The cosmid colony hybridization for screening the gene library was performed as described
in Section 3.4.3.3.
3.3.9. DNA sequencing
Sequencing of double-stranded DNA was performed using the dideoxy nucleotide chain
termination method (Sanger et al., 1977). 6-8 mg of pUC18-derived plasmid DNA, mp13
(universal) and pUC18 (reverse) primers labelled with fluorescent dye, and the
Thermosequenase Cycle-Sequencing Kit  were used in a sequencing reaction according to
the manufacturer's specifications in an A.L.F. DNA sequencer.
3.3.10. Determination of DNA concentration
The concentration of double-stranded DNA was photometrically quantified at a wavelength
of 260 nm as described by Sambrook et al. (1989). An OD260 of 1.0 is equivalent to
approximately 50 mg/ml of double-stranded DNA. The value of OD in the DNA solution
was also measured at 280 nm to examine the contamination with phenol or proteins. The
ratio of OD260 to OD280 in pure DNA solution should be in a range of 1.8-2.0.
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3.3.11. Transformation of E. coli and S. lividans
Competent cells of E. coli strains were prepared as described by Hanahan (1983). The
transformation of E. coli cells was followed according to the protocol of Sambrook et al.
(1989). In general, 0.01-1 mg DNA was added to 100 ml competent cells, SOC or LB
medium was used to regenerate the cells.
Protoplasting and transformation of Streptomyces were carried out based on the method of
Babcock and Kendrick (1988). TSB-PEG 8000 medium was used to cultivate the cells.
PEG 1000 was used to mediate the transformation.
3.3.12. Heterologous gene expression in E. coli BL21 (DE3) pLysS
The method used  was based on the description of Studier et al. (1990). A single colony of
E. coli BL21 (DE3) pLysS harboring a pET-derived plasmid was inoculated in 3 ml of LB
medium containing 50 mg/ml ampicillin and 25 mg/ml chloramphenicol and the cells were
grown overnight at 37°C. The overnight culture (0.5 ml) was re-inoculated in 50 ml of LB
medium (or LB supplemented with 1M sorbitol and 2.5 mM betaine) with the same
antibiotics, and the cells were grown at 28°C in a rotary shaker (100 r.p.m.) to an OD600nm
of 0.5-0.7. Then the final concentration of  0.4 mM IPTG was added to the culture to
induce the T7-RNA polymerase production. In LB culture, the other 4 h cultivation was
done after induction, and 12 h was required in the culture of LB containing sorbitol and
betaine. Samples (1 ml) were taken prior to induction and at intervals after induction. The
cells were harvested by centrifugation and re-suspended in 50–100 ml of the loading buffer.
The proteins were subjected to electrophoresis by SDS-PAGE gel (see Section 3.5.3). The
remaining cultivated cells were extracted as described in Section 3.5.1.
3.3.13. Heterologous gene expression in S. lividans 1326
The expression of the specific genes inserted in pIJ4123 in S. lividans 1326 was followed
as the method of Takano et al. (1995) but using SGYEME medium. A single colony was
METHODS 47
inoculated into 10 ml of SGYEME medium with 50 mg/ml kanamycin and the cells was
grown at 28°C for 2 d as pre-culture. The pre-culture (0.5 ml) was then inoculated in 50 ml
of SGYEME medium containing the same antibiotic. After 12 h of cultivation, 10 mg/ml
thiostrepton was added to induce tipAp promoter. The cultivation was continued for another
24-36 h. The cells were harvested and extracted as described in section 3.5.1.
3.4. Manipulation of the cosmid genomic library of S. mycarofaciens
3.4.1. Construction of the cosmid genomic library
The genomic library of S. mycarofaciens UC189B (ATCC 21454) was constructed in this
work by using the pKU206 vector (Omura, personal communication; Kakinuma et al.,
1991) (Fig. 3.1) and S. mycarofaciens chromosomal DNA. The following manipulation was
based on Weis et al. (1987) with modifications.
Fig. 3.1. The bifunctional cosmid vector pKU206.
3.4.1.1. Partial digestion of S. mycarofaciens genomic DNA
The chromosomal DNA from S. mycarofaciens was prepared as described in Section 3.3.1.
0.3% agarose gel (using 0.5 cm depth of 1% agarose gel as a supporter under the bottom of
the gel lid) was used to examine the size of DNA (Little, 1987). The molecular length of
DNA must be larger than l DNA.
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Partial digestion of the genomic DNA with Sau3AI was done in a Eppendorf tube,
including 215 ml of DNA (~20 mg), 25 ml of 10 ´ React 4 buffer (Gibco BRL) and 10 ml
diluted Sau3AI (1U) and mixed carefully. The digestion was preformed at 37°C, and a 50
ml aliquot was removed at 5 min, 10 min, 15 min, 20 min, and 25 min and inactivated at
68°C for 10 min. Samples were combined when they showed the DNA in the size range of
25-45 kb by electrophoresis through 0.5% agarose gel.
3.4.1.2. Size fractionation of DNA fragments
Sucrose gradients were used for size fractionation of DNA molecules (Hadfield, 1987). The
new SW-41 ultracentrifuge tubes (Beckman, München) were filled with 10 ml of sucrose
gradient solution (see Section 2.2.3), sealed with Parafilm and frozen overnight at -20°C.
The frozen tubes were thawed at room temperature for 4-5 h. The freeze-thaw process was
repeated once to form the gradient.
The combined partially digested DNA was heated at 65°C for 5 min in order to dissociate
any DNA aggregates. 166 ml of the DNA solution was carefully layered on the top of the
sucrose gradient. The tubes were then centrifuged in an SW-28 rotor (Beckman) at 20°C,
25,000 r.p.m., for 18 h. After centrifugation, the bottom of the tubes were gently cleaned
with ethanol. The gradients were fractionated by carefully piercing the bottom of the tube
with a sterile needle. The small hole was rapidly blocked with the thumb and drops of the
gradient solution were allowed by slightly moving the thumb. Samples (each 0.2-0.3 ml)
were dropped into the new Eppendorf tubes and around 50 aliquots were collected from 10
ml of the sucrose gradient. Samples (15 ml) from every fifth aliquot were taken and
checked by electrophoresis on 0.5% gels, using the DNA marker diluted by the sucrose
gradient solution because of the high salt concentration in the solution affects DNA
mobility.
The correctly sized DNA (25-35 kb) was precipitated by adding two volumes of ethanol.
To avoid precipitation of sucrose, a further 1.5 ml of  70% ethanol was added and mixed
thoroughly and placed at –20°C overnight. The DNA was pelleted by centrifugation, and
the pellets were washed twice with 70% ethanol and re-suspended in an appropriate TE
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buffer. The aliquots of the DNA solution were combined to give a final concentration of
0.3-0.5 mg/ml.
3.4.1.3. Digestion of the cosmid vector pKU206
The cosmid vector pKU206 contains a BamHI site cloning site, (Kakinuma et al., 1991).
Hydrolysis of the vector was performed including 200 ml of pKU206 DNA (~20 mg), 1 ´
React 3 buffer (Life Technologie), 100 U of BamHI enzyme and distilled water in a 400 ml
volume. The incubation was carried out at 37°C for 3-4 h. An aliquot (3 ml) was removed
and analyzed by electrophoresis through a 0.6% agarose gel and compared to undigested
pKU206. The completely hydrolised sample was then extracted with phenol/chloroform
and the DNA was precipitated with ethanol. The DNA was re-suspended in 200 ml of TE
buffer. A 5 ml aliquot was taken and stored at –20°C.
The remainder of the sample was treated with 50 units (ATP hydrolysis units) of calf
intestinal phosphatase by an incubation at 37°C for 30 min. The dephosphorylation was
terminated by adding 1 ml of 0.5 M EDTA. The DNA was extracted twice with phenol and
once with chloroform and precipitated with ethanol. The pellet DNA was re-suspended in
TE buffer to give a final concentration of 0.3-0.5 mg/ml. A test re-ligation was carried out to
determine the effectiveness of the phosphatase treatment of the linearized vector. The
reaction was set up in a 10 ml volume including BamHI-cleaved pKU206 either
phosphatase-treated DNA or untreated (i.e. the above aliquot stored at –20°C) and using a
standard ligation buffer and conditions (see below). The test ligations were examined using
agarose gels. The phosphatase-treated sample should not be re-ligated.
3.4.1.4. Ligation of insert DNA to vector DNA
The following reaction mixture was set up in a 20 ml volume:
25-35 kb fragments of S. mycarofaciens 5 ml (~2.5 mg)
phosphatase-treated pKU206 10 ml (~5 mg)
10 ´ ligation buffer* (Roche) 2 ml
H2O 3 ml
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* the ligation buffer should be PEG-free quality.
An aliquot (1 ml ) was removed and stored at 4°C. Then 1 ml  (5 Weiss units) of T4 DNA
ligase (Roche) was added to the remainder of the mixture. The reaction was incubated
overnight at 12°C. At the end of the ligation, another 1 ml aliquot was taken and analyzed
by electrophoresis using 0.5% agarose gel together with the above aliquot stored at 4°C. If
the ligation was successful, the S. mycarofaciens DNA should have been converted to high-
molecular-weight concatemers.
3.4.1.5. Packaging of  ligated DNA
The ligated DNA was packaged in vitro  into bacteriophage l particles following the
protocol of DNA Packaging Kit (Roche). 4 ml of the ligation mixture was used, and the rest
of the ligation was stored at –20°C. After packaging was complete, 0.5 ml of SM buffer
was added to the reaction, and this packaging reaction was then mixed with 20 ml of
chloroform  and stored at 4°C for two weeks.
3.4.1.6. Adsorption of packaged recombinant cosmids to E. coli
The host strain E. coli JM108 was prepared as recommended by the protocol of DNA
Packaging Kit (Roche). 10 ml aliquot of the packaging reaction was mixed with 0.1 ml of
SM buffer and 0.2 ml of the host strain. The mixture was incubated for 30 min at 30°C to
allow the adsorption of the bacteriophage particles to the E. coli cells. Then 1 ml of SOC
medium was added and the incubation was continued for a further 60 min.
3.4.1.7. Plating of packaged recombinant cosmids
Samples (0.1 ml and 0.5 ml) of the bacterial culture were spread onto LB agar plates
containing 50 mg/ml of ampicillin. After incubating the plates at 30°C for 14-16 h, the
number of bacterial colonies was counted. Usually each microgram of ligated DNA should
yield at least 5 ´ 104 bacterial colonies.
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A number of individual colonies were picked and grown in 4 ml of overnight LB culture at
37°C. The plasmid DNA was isolated by using the alkaline lysis method (Birnboim &
Doly, 1979). The plasmid DNA was digested with BamHI or other restriction enzyme(s)
and the size of the resulting fragments was analysed by gel electrophoresis.
3.4.2. Plating out, amplification and maintenance of the cosmid genomic library
This work was done with  reference to Sambrook et al. (1989) and Weis et al. (1987).
3.4.2.1. Plating on agar for the library amplification
200 ml of the cells prepared as in Section 3.4.1.7 was spread on a LB plate containing 50
mg/ml ampicillin. The plates were incubated overnight at 30°C and usually over 2000
colonies were produced on a plate. Then 2 ml of LB liquid containing 15% glycerol was
added to the grown-colony plates. The colony suspension was carefully mixed, scraped,
pooled and stored at –70°C.
3.4.2.2. Picking and streaking colonies for screening and maintenance of the library
100 ml of the cells prepared as in Section 3.4.1.7 was spread on a LB plate containing 50
mg/ml ampicillin. The plates were incubated overnight at 30°C and usually over 1000
colonies were produced on a plate. In order to absolutely ensure the authentic result of
screening the library, ten thousand colonies were picked and streaked one by one onto new
LB plates containing 50 mg/ml ampicillin, in a matrix of 47 numbered points (each point
size ca. 2 mm). Each colony was picked and streaked onto two plates in the same position,
which one plate was used for screening the library and the other for maintenance of the
library.
Microtiter plates were used to store the cosmid colony cultures. A 96-well microtiter plate
was labelled and divided into two parts which were used for transferring two plates of
colonies. 300 ml of LB liquid containing 15% glycerol were first titred into each well.  A
plate containing 47 colonies grown overnight was gently duplicated using a sterile stainless
steel stamp containing 47 feet which is exactly the same as the matrix mentioned above.
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The stamp with the adhering bacteria was then dipped into the LB and glycerol medium at
the correct position in the microtiter plate and gently shaked for 1 min. The plates were
incubated overnight at 30°C and stored at –20°C.
3.4.3. Screening of the cosmid genomic library
The following experiments were based on the protocols described as Hanahan & Meselson
(1983) and Weis et al. (1987) with modifications.
3.4.3.1. Preparing duplicate membranes of cosmid colonies
Bacterial plates each containing 47 colonies grown overnight were first stored at 9°C for 1
h. Numbered disc membranes were then placed on the surface of the colony plates for 1
min, peeled off and air-dried for 10 min. The master plates were incubated for 3-4 h and
stored at 4°C.
3.4.3.2. Cosmid DNA binding to the membranes
A Whatman 3MM filter paper in a tray was soaked in 0.5 M sodium hydroxide. The disc
membranes, colony side uppermost , were placed onto this wet filter and lysed for 5 min to
denature the DNA. This step was repeated with a new 3MM paper with 0.5 M NaOH. The
membranes were then transferred onto a 3MM paper soaked with a solution of 1 M
Tris/HCl, pH 7.5 for neutralization. After 3 min the membranes were neutralized once
again by placing them onto a new 3 MM paper with the same solution. The membranes
were then washed with 2 ´ SSC solution for 5 min and air-dried. The dried membranes
were baked at 80°C for 90 min.
3.4.3.3. Screening the cosmid membranes
The baked membranes were placed in a plastic box with 300 ml of prehybridization. The
box was shaked slowly in a water bath at 65°C. After 1.5 h, the bacterial debris on the
membranes were wiped using soft tissues and the new prehybridization solution was added
into the box. The process was continued for another 1.5 h. The probe DNA was labelled as
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described in Section 3.3.7. The conditions of hybridization for the disc membranes were the
same as described in Section 3.3.8. After hybridization, the membranes were washed at
65°C twice with 2 ´ SSC/0.5% SDS, each time for 10 min, twice with 0.5 ´ SSC/0.5%
SDS, each time for 15 min, and once with 0.1 ´ SSC/0.5% SDS for 15 min. The
autoradiography of the membranes was followed by the standard method (Sambrook et al.,
1989). The positive spots were identified by comparing precisely the same position on the
membranes and the master plates. Finally the positive cosmid clones were picked from the
master plates and the plasmid DNA was prepared for further genetical analysis.
3.5. Biochemical methods
3.5.1. Cell-free extracts of E. coli and Streptomyces
The E. coli  or Streptomyces cells containing the expression-plasmids were harvested by
centrifugation and washed twice with a cold buffer of 25 mM Tris/HCl, pH 7.5 or 25 mM
potassium phosphate buffer, pH 7.2. The pellet was suspended with an appropriate
sonification buffer (see Section 2.2.3) according to the further use of the extracts in a ratio
of 1.0 ml buffer/0.2 g for E. coli cells and 1.5 ml /g for Streptomyces. The cells were
disrupted by treating 2 times for E. coli and 4 times for Streptomyces (each time for 20 sec
following 20 sec break) with the French-Press under a pressure of 1300 psi. The cell
suspension was centrifuged for 30 min at 30 000 g and the crude cell-free extracts were
stored at –80°C for 1-2 weeks.
3.5.2. Determination of protein concentration
The protein concentration of the cell-free extracts was measured according to Bradford
(1976) using Bio-Rad Protein Assay Kit (Bio-Rad) and BSA as a standard at a wavelength
of 595 nm.
3.5.3. SDS polyacrylamide gel electrophoresis (PAGE)
SDS-PAGE was performed according to Laemmli (1970) using 10-12% of polyacrylamide
in vertical slab gels. The protein standard VII-L (Sigma), BSA (Mr = 66 kDa), ovalbumin
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(Mr = 45 kDa), glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle (Mr = 36
kDa), carbonic anhydrase from bovine erythrocytes (Mr = 29 kDa), trypsinogen from
bovine pancreas (Mr = 24 kDa), trypsin inhibitor from soybean (Mr = 20 kDa) and a-
lactalbumin (Mr = 14 kDa), was applied to the gels in order to determine the Mr of the
proteins.
3.5.4. Western blotting and immuno-detection of proteins
The proteins produced in E. coli and Streptomyces were separated by SDS-PAGE. When
the expected protein was not detected on the gels, Western blotting was used for the
detection. The protein gels were transferred onto PVDF membrane ('Hybond P',
Amersham) using the Semi-Dry Transfer Cell (Bio-Rad). The Western blotting was
followed by a standard protocol (Winston et al., 1987) and the method of immuno-
detection of proteins was adapted here as recommended by Qiagen's protocol using an
Anti-His-tag antibody.
3.5.5. Analysis of the activity of dTDP-D-glucose 4, 6-dehydratase by RmlB
The activity of dTDP-D-glucose 4,6-dehydratase was determined according to Wang &
Gabriel (1969) and Okazaki et al. (1962) with minor modifications. The rmlB gene
(formerly called as rfbB) from Salmonella enterica B was cloned on the plasmid pSVW701
by Verseck (1997) and overexpressed in E. coli BL21(DE3). The reaction for analysis of
RlmB protein was performed as follows.
Potassium phosphate buffer, pH 7.2 50 mM
dTDP-D-glucose 4 mM
RlmB crude extract 0.1-0.2 mg/ml
Final volume 200 ml
The mixture was incubated at 37°C for 1 h. The formation of dTDP-4-keto-6-deoxy-
glucose was determined by taking 40 ml of the reaction sample and adding 960 ml of 0.1 N
NaOH and the mixture was re-incubated at 37°C for 20 min. The absorption was measured
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at 320 nm (e320nm = 4800 l/mol ´ cm). Blank experiments were carried out in the same way
but omitting the substrate.
3.5.6. Analysis of the activity of enzymes participating in dTDP-D-mycaminose
biosynthesis via a coupling reaction of RmlB, MidH and MidC
The genes encoded in the biosynthetic pathway of dTDP-D-mycaminose in macrolide
antibiotics were proposed as described as Gandecha et al. (1997). In this study, the
determination of the activities of the 3,4-isomerase (MidH) and the aminotransferase
(MidC) was performed with reference to the methods of Walker & Walker (1969). The
conversion of dTDP-glucose to dTDP-D-mycaninose by the coupling reaction of RlmB,
MidH and MidC was carried out as follows.
Potassium phosphate buffer, pH 7.2 50 mM
dTDP-glucose 4 mM
MgCl2 10 mM
L-Alanine or L-Glutamic acid 2.5 mM
PLP 1 mM
RlmB crude extract 0.1-0.2 mg/ml
MidH crude extract 0.2-0.3 mg/ml
MidC crude extract 0.2-0.3 mg/ml
The mixture was incubated at 37°C for 1 h and the reaction was terminated by heating at
95°C for 2 min. The mixture was centrifuged at 4°C for 20 min to remove the debris and
the supernatant was stored at –20°C for the product assay.
3.6. Chromatography methods
3.6.1. Thin-layer chromatography (TLC)
Antibiotic metabolites from cultures of Streptomyces were preliminarily identified by TLC
as described by Salah-Bey et al. (1998). The supernatants of cultures were adjusted to pH
9.0-10.0 with sodium hydroxide and extracted with ethyl acetate. Chromatogarphy was
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performed using dichloromethane-methanol (90/10, v/v). The compounds were visualized
by spraying the TLC plates with p-anisaldehyde/sulphuric acid/ethanol (1/1/9, v/v) with
subsequent heating for a few minutes at 80°C.
3.6.2. High pressure liquid chromatography (HPLC)
Analysis of nucleotide-activated sugars from the enzymatic reaction was performed by
HPLC according to Payne & Ames (1982) with modifications.  A reversed phase
chromatography was used as separation system equipped with a Eurospher 100 C18 ( corn:
5 m, 250 ´ 4.6 mm) (Knauer, Berlin). The mobile phase and operation of this system were
recommended by Verseck (1997).
3.6.3. HPLC coupled to mass spectrometry (LC-MS)
HPLC coupled to mass spectrometry (LC-MS) was carried out on a chromatography
system (Waters) equipped with a Finnigan TSQ 7000 mass spectrometer to identify the
novel products. This assay was performed at the University of Bochum by Dr. Blüggel.
3.7. Computer programs
DNA sequences were analysed using the program DNA-Strider 1.1 (Mark, 1988). The
programs Brugene II and MacFrame 1.3 were used to determine open reading frames and
G+C contents. Multiple sequence alignments were performed using the Clustal V 3.0
program (Higgins, 1991). Comparisons of DNA- and protein-sequences to GenBank were
done using FASTA (Pearson & Lipman, 1988) and BLAST (Altschul, 1990). Phylogenetic
trees were construcetd via the neighbor joining method (Saitou & Nei, 1987) using the
PAUP 3.1 program (D.L. Swofford, Center of Biodiversity, Champaign, III., USA).
Amplification temperatures for primers were calculated by the PrimFind V3.0 program
(Fröbel Labor-Geräte, Lindau).
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4. Results
4.1. Detection of pathway-specific genes from S. mycarofaciens by PCR
As mentioned in the introduction, most of the 6-deoxysugar biosynthetic genes are
clustered on both sides of a large portion of polyketide synthases (PKSs) in the macrolide
antibiotic biosynthesis, such as erythromycin (Gaisser et al., 1997; 1998; Salah-Bey et al.,
1998), oleandomycin (Olano et al., 1998), tylosin (Merson-Davies et al., 1994; Gandecha
et al., 1997; Fouces et al., 1999) and so on. Experimental evidence has suggested that
dTDP-4-keto-6-deoxyglucose is the precusor of most of the deoxysugars, for instance,
found from macrolide-producing strains (Liu & Thorson, 1994; Piepersberg, 1994) as well
as from anthracycline-producing strains (Thompson et al., 1992). Thus, because of the
similarity to tylosin, the detection of the gene encoding dTDP-glucose 4,6-dehydratase
was hoped to be the first and rational choice in order to probe the midecamycin
biosynthetic (mid) gene cluster from S. mycarofaciens. Based on mechanisms and
pathways from deoxysugar biosynthesis research, a glycosyltransferase is responsible for
transferring the sugar to the antibiotic aglycone when a D- or L-6-deoxysugar is formed
(Otten et al., 1995; Liu et al., 1993). Since midecamycin is structurally closely related to
tylosin, the organisation of the gene cluster of tylosin biosnythesis (acc. no. U08223;
Merson-Davies et al., 1994; acc. no. X81885; Gandecha et al., 1997) gives a hint that at
least some of the glycosyltransferase genes are located in the gene cluster on the side
opposite to the dTDP-glucose 4,6-dehydratase gene. Therefore, as a prediction, the
detection of a glycosyltransferase gene is the second choice in order to probe the gene
cluster of midecamycin biosynthesis in S. mycarofaciens.
In this study, PCR amplifications were applied to directly detect the genes encoding the
biosynthetic pathway of midecamycin from S. mycarofaciens UC189B (ATCC21454).
The identified genes were then used as homologous probes to hybridize the cosmid library
of S. mycarofaciens in order to identify the mid gene cluster.
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4.1.1. Identification and isolation of a gene, midB, encoding a dTDP-glucose 4, 6-
dehydratase from S. mycarofaciens
To identify the specific gene in midecamycin biosynthesis, the genomic DNA of S.
mycarofaciens was amplified by PCR using two oligodeoxynucleotide primers, AS2 and
AS5 (Stratmann, 1997), which were derived from the strE gene, encoding dTDP-glucose
4,6-dehydratase in the gene cluster of streptomycin biosynthesis from S. griseus
(Pissowotzki et al., 1991) and  showed the highly conserved sequences in the other dTDP-
glucose 4,6-dehydratase genes, such as tylAII from S. fradiae (Merson-Davies et al., 1994)
and rfbB from Salmonella typhimurium LT2 (Jiang et al., 1991). As a result of  PCR
amplification, a 303 bp DNA fragment from S. mycarofaciens genome was detected, and
the gel-purified DNA fragment was cloned into the SmaI site of pUC18 (Arnold, 1996).
This recombinant plasmid was named pLCW1, and the gene in the corresponding insert
DNA was designated midB. Sequencing analysis indicated that midB encodes a dTDP-
glucose 4,6-dehydratase and the product of midB in a 101 amino acid (aa) overlap is 58%
identical to the products of strE and tylAII, respectively, and 44% identical to the product
of rfbB. The sequence comparison between these proteins is shown in Fig. 4.1.
4.1.2. Identification and isolation of a gene, midI, encoding a glycosyltransferase from
S. mycarofaciens
The oligodeoxynucleotide primers, EryCIII/H, EryCIII/I and LC6, were derived from the
highly conserved sequence regions of macrolide glycosyltransferse genes, eryCIII and
tylMII in the gene clusters of erythromycin and tylosin biosynthesis (Salah-Bey et al.,
1998; Gandecha et al., 1997). The genomic DNA of S. mycarofaciens was first amplified
using primers EryCIII/H and EryCIII/I by PCR method 2 (see Section 3.3.5). The reaction
was carried out at an annealing temperature of 63°C and for an enlongation time of 60 sec.
An expected DNA fragment (500 bp) was observed in the PCR products by the use of
1.5% agarose gel. However, there existed unspecific bands mixed with or close to this
expected band, which caused difficulties for purification and cloning. Therefore, a pair of
internal primers, LC6 and EryCIII/I, were used to re-amplify the above product mixture by
using PCR method 1 (see Section 3.3.5) at an annealing temperature of 65°C and for an
enlongation time of 45 sec. As expected, a 420 bp DNA fragment was detected, and the
resulting fragment was cloned into the HincII site of pUC18. This recombinant plasmid
was named pLCW17, and the gene in the corresponding insert DNA was designated midI.
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Sequencing analysis confirmed that midI encodes a glycosyltransferase. The comparison
of the midI  product to other known glycosyltransferases revealed that MidI in a 142
amino acid overlap is 56% identical to TylMII and 53% identical to EryCIII, respectively
(for sequence alignment see Section 4.15).
TylAII          ----MRVLVTGGAGFIGSHFTGQLLT-GAYPDLGATRTVVLDKLTYAGNPANLEVA-GHP
StrE            MALTTHLLVTGAAGFIGSQYVRTLLGPGGPPDVVVT---ALDALTYAGNPDNLAAVRGHP
RfbB            ----VKILITGGAGFIGSAVVRHIIK--NTQDTVVN----IDKLTYAGNLESLSDISESN
MidB
                                                AS2
TylAII          DLEFVRGDIADHGWWRRLMEGVGL--VVHFAAESHVDRSIESSEAFVRTNVEGTRVLLQA
StrE            RYRFERGDICDAPG-RRVMAGQDQ--VVHLAAESHVDRSLLDASVFVRTNVHGTQTLLDA
RfbB            RYNFEHADICDSAEITRIFEQYQPDAVMHLAAESHVDRSITGPAAFIETNIVGTYALLEV
MidB                                          AAESHVDRSIDDADAFVRTNYLGTHVLLTE
                                              *********      *  **  **  **
TylAII          AVDAG-VG--------RFVHISTDEVYGSIAE----------GSWPEDHPVAPNSPYAAT
StrE            ATRHG-VA--------SFVQVSTDEVYGSLEH----------GSWTEDEPLRPNSPYSAS
RfbB            ARKYWSALGEDKKNNFRFHHISTDEVYGDLPHPDEVENSVTLPLFTETTAYAPSSPYSAS
MidB            ALAVRRPG--------RFVHVSTDEVYGSIPE----------GSWSEDHPLSPNSPYAAS
                *                *   *******                  *     * *** *
                AS5
TylAII          KAASDLLALAYHRTYGLDVRVTRCSNNYGPRQYPEKAVPLFTTNLLDGLPVPLYGDGGNT
StrE            KASGDLLALAHHVSHGLDVRVTRCSNNYGPRQFPEKLIPRFITLLMDGHRVPLYGDGLNV
RfbB            KASSDHLVRAWRRTYGLPTIVTNCSNNYGPYHFPEKLIPLVILNALEGKPLPIYGKGDQI
MidB            KAASDQLALAFHRTHGLPVCVTRCSNNYG
                **  * *  *     **   ** ******
TylAII          REWLHVDDHCRGVALVGAGGRPGVIYNIGGG-------TELTNAELTDRILELCGADRSA
StrE            REWLHVDDHVRGIEAVRTRGRAGRVYNIGGG-------ATLSNKELVGLLLEAAGADWGS
RfbB            RDWLYVEDHARALHMVVTEGKAGETYNIGGHNEKKNLDVVFTICDLLDEIVPKATSYREQ
MidB
TylAII          LRRVADRPGHDRRYSVDTTKIREELGYAPRTGITEGLAGTVAWYRDNRAWWEPLKRSPGG
StrE            VEYVEDRKGHDRRYAVDSTRIQRELGFAPAVDLADGLAATVAWYHKHRSWWEPLVPAGSL
RfbB            ITYVADRPGHDRRYAIDAGKISRELGWKPLETFESGIRKTVEWYLANTQWVNNVKSGAYQ
MidB
TylAII          RELERA-----
StrE            PA---------
RfbB            SWIEQNYEGRQ
MidB
Fig. 4.1. Amino acid sequence comparison of MidB with other dTDP-glucose dehydratases
from different bacteria. The proteins TylAII from S. fradiae, StrE from S. griseus and RfbB from
Salmonella typhimurium LT2 are aligned with MidB. The highly conserved sequence regions used
for designing the primers, AS2 and AS5, are marked and indicated by arrows. Sequence identities
between these proteins are indicated by asterisks.
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4.2. Construction and screening of a genomic library from S. mycarofaciens
A genomic library of S. mycarofaciens UC189B (ATCC 21454) was constructed during
this work by using the cosmid vector pKU206 and S. mycarofaciens chromosomal DNA.
The DNA fragments of midB and midI obtained by heterologous PCR (see Section 4.1.1-
2) were used as probes to sequentially screen the cosmid library.
4.2.1. Construction of the genomic cosmid library
To clone large DNA fragments (20-35 kb) in E. coli strains, and to be able at the same
time to directly introduce recombinant plasmids into Streptomyces strains, a Sreptomyces-
E. coli bifunctional cosmid vector pKU206 (15.5 kb) was used (Omura, personal
communication) (see Fig. 3.1). The shuttle cosmid pKU206 was derived from pKU205
(Kakinuma et al., 1991), containing the replication regions SCP2* and pMB1 and the
lambda cos region, by introduction of the 5 kb SCP2* stability region. Therefore, it was
expected that the vector and its recombinant derivatives should be relatively stable in S.
lividans. The steps taken to construct the cosmid library from the genomic DNA of S.
mycarofaciens are shown in Fig. 4.2.
4.2.1.1. Selection of 20-35 kb DNA fragments in S. mycarofaciens partial digestion
The genomic DNA of S. mycarofaciens was prepared as described in Section 3.3.1. Since
maximally non-sheared DNA fragments (usually in the size of 200-500 kb) are required
for obtaining a statistically useful cosmid library, the chromosomal DNA was tested for its
size before digestion. It is shown in Fig. 4.3 that the prepared S. mycarofaciens DNA
(track 3) was much larger than the l DNA (48 kb) (track 1).
The partial digestion of the genomic DNA of S. mycarofaciens was tested first in two trial
digestions in order to establish the optimal conditions to employ (see Section 3.4.1.1).
About 20 mg of the genomic DNA was used for partial digestion and for the subsequent
size fractionation. The digestion was controlled by  time limitation during an incubation at
RESULTS 61
Fig. 4.2. Construction of the genomic library of S. mycarofaciens in the cosmid pKU206. 20-
35 kb fragments of S. mycarofaciens genomic DNA generated by partial digestion with Sau3AI
were ligated  to DNA of the cosmid pKU206 digested with BamHI and dephosphorylated with
alkaline phosphatase. The resultant concatemers served as substrates for in vitro packaging of
bacteriophage l particles. Following introduction into E. coli, the cosmid DNA re-circularized and
replicated in the form of a large plasmid. The plasmid contains a b-lactamase gene that confers
resistance to ampicillin on the host bacterium.
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37°C. and the samples were removed at 5 min intervals, up to 25 min (Fig. 4.3). In this
experiment, samples from 5 min to 20 min digestions were combined for further use since
they seem to be the most suitable for providing high molecular weight genomic fragments
(³ 20 kb).
       1      2       3     4       5      6              7      8
Fig. 4.3. Analysis of Sau3AI partial
digestion of genomic DNA by agarose-
gel electrophoresis. A 0.5% gel was
used. Tracks (1) l DNA; (2) l DNA
digested with HindIII as size markers.
Tracks containing identical samples of
genomic DNA digested with equal unit
amounts of Sau3AI for different time
periods (as described in Section 3.4.1.1)
(3) 0 min; (4) 5 min; (5) 10 min; (6) 15
min; (7) 20 min; (8) 25 min.
Sucrose gradients were used for size fractionation of DNA molecules (see Section 3.4.1.2).
The fractionated DNA solutions were analysed and the DNA samples were selected in a
range of 20-35 kb (Fig. 4.4). Since it turned out that the sucrose concentration affected
migration of DNA fragments, the size marker of DNA had to be diluted 1:2 with the 40%
sucrose solution. Finally, fractions 1-20 in Fig. 4.4 were combined for further use.
                              No. of Fractions
                          1     5   10  15   20   25   30   35
Fig. 4.4. Analysis of sucrose gradient
fractions by agarose gel electrophoresis.
The first three tracks on the left contain l
DNA digested with HindIII as size markers,
l DNA and S. mycarofaciens genomic
DNA. A 0.5% agarose gel was used. 15 ml
of every fifth sample was loaded.
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4.2.1.2. Ligation, packaging and plating the library
According to their relative sizes (Tab. 4.1), approximately 5 mg of cosmid DNA and 2.5
mg of genomic DNA fragments were used for ligation as described in Section 3.4.1.4. An
aliquot sample was used to examine the results of ligation, and it proved that the ligation
was successful (Fig. 4.5) .
          Tab. 4.1. Relative sizes of DNA molecules
          DNA molecule                       Size (kb)                 Relative size
      Cosmid pKU206 15.5   1.0
S. mycarofaciens 20-35 1.6-2.2
genomic fragment
           1       2        3        4
Fig. 4.5. Analysis of ligation reaction by agarose-gel
electrophoresis. A 0.5% gel was used. Tracks (1) l
DNA digested with HindIII as size markers; (2) S.
mycarofaciens 20-35 kb fragments; (3) pKU206
digested with BamHI and treated with phosphatase; (4)
ligation of DNA fragments from (2) and (3) (1 ml
ligation mixture).
The adsorption of packaged recombinant cosmids to E. coli and the plating of packaged
recombinant cosmids were followed as in Section 3.4.1.6-7. The result was that around 5 C
104 to 5 C 105  transfected bacterial colonies per microgram of ligated DNA were counted.
About 5 C 103 ampicillin-resistant colonies were collected and used as the cosmid genomic
library for screening.
Twenty of the cosmid clones from the library were picked at random and the plasmid
DNA was isolated as described in Section 3.4.1.7. The DNA of plasmids was digested by
BamHI to examine the inserted DNA size of the recombinant cosmid clones. As a result,
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eighteen of the cosmid plasmids were observed to contain the insert DNA, the size being
in a range of 20-35 kb (data not shown).
4.2.2. Screening of the cosmid genomic library probed by the midB and midI DNA
fragments
As described in Section 4.1.1-2, the midB DNA fragment (303 bp) from pLCW1 and midI
DNA fragment (420 bp) from pLCW17 were identified as dTDP-glucose 4,6-dehydratase
and gylcosyltransferase, respectively. They were used as probes to hybridize the above-
established S. mycarofaciens genomic library. The probe fragments were purified twice by
agarose gel electrophoresis before radiolabelling in order to avoid non-specific
hybridization with vector DNA. Resulting from  hybridization experiments, 2  out of  3000
colonies on the disc membranes showed significant signals against the midB probe (Fig.
4.6). The cosmid DNA was isolated from these two putative positive clones and digested
with BamHI and BglII. The resulting DNA was transferred onto nylon filters and
hybridized with the midB probe again. As expected, the DNA of these two clones showed
signal bands in which the location was the same as the positive control from S.
mycarofaciens genomic DNA (data not shown). Also, both cosmids were used as
templates and amplified by primers AS2 and AS5, which could produce the midB DNA
fragment as described in Section 4.1.1. These two positive recombinant cosmids were
designated as Smyc-LC1 and Smyc-LC2.
One significant signal from 2000 colonies was obtained by the midI probe when screening
the same genomic library for a second time (data not shown). This putative positive
cosmid was further examined again by DNA hybridization and PCR amplification (data
not shown). All results supported that the insert DNA of this cosmid contained the midI
DNA fragment. This recombinant cosmid was designated as Smyc-LC3.
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                                       A                                                              B
Fig. 4. 6. Autoradiographic analysis of screening the cosmid genomic library probed
by the midB DNA fragment through Southern hybridization. Sets of each 47 single
cosmid colonies were blotted on Hybond N+ disc membranes. Screening colonies against
the probe was carried out as described in Section 3.4.3.3. Two strong signals from discs A
and B hybridized with the radiolabelled midB DNA fragment are visible (see arrows).
4.3. Restriction analysis and sequencing of partial regions of the recombinant
       cosmids
In order to analyse the insert DNA in the three recombinant cosmids, Smyc-LC1, Smyc-
LC2 and Smyc-LC3 were digested with BamHI, BglII and BamHI/BglII. The calculated
results showed that the insert DNA of Smyc-LC1, Smyc-LC2 and Smyc-LC3 were ca.
30.2 kb, 22.6 kb and 26.3 kb, respectively. The DNA fragments of Smyc-LC1 and Smyc-
LC2 overlap each other in a region of ca. 14.7 kb. This overlap was also confirmed
through hybridization of Smyc-LCl DNA with the DNA fragment probes  from both
terminal sides of Smyc-LC2. Therefore, Smyc-LC1 and Smyc-LC3 were used for further
restriction enzyme analysis. A set of single or double enzymes were applied in the
digestion reactions. From the results of the restriction enzyme analysis, restriction maps of
Smyc-LC1, Smyc-LC2 and Smyc-LC3 were constructed (Fig. 4.7 and Fig.4.8).
To quickly localize pathway-specific genes in Smyc-LC1 and Smyc-LC3, a set of
subclones in E. coli cloning vectors were also made as given in Fig. 4.7 and Fig. 4.8. The
insert DNA fragments of all subclones were sequenced at least at their ends. The regions
of Smyc-LC1 and Smyc-LC3 surrounding the already identified genes midB and midI,
were fully sequenced in about 10 kb and 6 kb, respectively.
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Fig. 4.7. Restriction map of Smyc-LC1 and Smyc-LC2 and sequencing strategy. The plasmids for sequencing were designated as pLC1-
and pLC2- with a number. The region of ca.15 kb BglII fragment is shown in greater detail.
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       Fig. 4.8. Restriction map of Smyc-LC3 and sequencing strategy. Plasmids for sequencing were named as pLC3- with a number.
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4.4. Chromosomal walking by using a 2.3 kb DNA fragment close to one end of Smyc-
       LC1 as a  probe to screen the S. mycarofaciens genomic library
To extend the existing gene sub-cluster region covered by Smyc-LC1, a 2.3 kb BamHI
fragment was isolated from pLC1-3 (see Fig. 4.7). This DNA fragment, when used as a
probe to again screen the cosmid genomic library, resulted in isolation of a positively
hybridizing cosmid, which was designated Smyc-LC4. The restriction analysis of this
recombinant cosmid with BamHI and BamHI/BglII showed the size of the inserted DNA
to be ca. 29.3 kb. The DNA fragment of Smyc-LC4 overlaps with Smyc-LC1 in a region
of ca. 11.3 kb and extends away from Smyc-LC1 in a region of ca. 18 kb, containing a
unique BamHI fragment. The summary of the suggested map location of the four cosmids,
Smyc-LC1, Smyc-LC2, Smyc-LC3 and Smyc-LC4, is shown in Fig. 4.9.
4.5. Open reading frames found in the gene sub-cluster analysed from Smyc-LC1
The sequence of a ca. 14 kb BglII fragment (site 1-15) of Smyc-LC1 which includes the
midB region was determined from the respective segments subcloned, in which some
regions were completely sequenced (ca. 10 kb) and others were partially sequenced (ca. 4
kb) (Fig. 4.10). The arrangement of the identified open reading frames and their encoded
proteins, e.g., midC encodes a TylB-related aminotransferase, was very similar to the
tylosin gene cluster of S. fradiae (see below). Therefore, the previous proposal was
confirmed that the sub-cluster covered by Smyc-LC1 is part of the gene cluster in
midecamycin biosynthesis and that these genes are essential for the 6-deoxysugar
biosynthetic pathway.
Upstream of midC there was a 500 bp non-coding sequence gap. Adjacent to this region,
one open reading frame was found to be orf1 (midM), showing the same reading direction
as midC. Downstream of midC,  five further complete open  reading frames,  orf3  (midA),
orf4 (midB), orf5 (midD), orf6 (midE) and orf8 (midL) were identified. The locations and
the reading directions are given in Fig. 4.10. An uncomplete reading frame, orf7, identified
as midF from the sequence of two small segments, was also found downstream of midE.
All of the reading frames display a typical Streptomyces codon bias (Bibb et al., 1984).
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Fig. 4.9. Schematic representation of cosmid clone location in the mid gene cluster. The black bars represent the region of S.
mycarofaciens chromosomal DNA found in existing cosmids. The white bar indicates the unresearched region of the chromosome with
a break shown as a double slant.
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Fig. 4.10.  Organisation of  the midecamycin  biosynthe tic  ge ne
cluste r  from  Smyc-LC1 and  Smyc-LC3  in S.  mycarofaciens.
The  regions midM-midF  and midG-midJ  are shown  in  greater detail.
The restriction sites are numbered. Orfs and the direction of transcription
are  shown  by  arrows.  The  open bars indicate the sequences obtained
only from small segments (see the details in the text).
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The further analysis of some pathway-specific genes postulated to be involved in
midecamycin sugar biosynthesis will be described in the following sections.
4.6. Open reading frames found in the gene sub-cluster analysed from Smyc-LC3
The complete sequence of a 4.3 kb BamHI fragment (sites 42-47) of Smyc-LC3 which
includes the midI region was determined from the suitable plasmids of the pLC3- series.
Adjacent to this region, a 1.38 kb BamHI fragment (sites 41-42) was also completely
sequenced, and another ca. 1.0 kb SstI-BamHI fragment (sites 40-41) was partially
sequenced. As a result, five open reading frames (orf11-15) were found in the region
between sites 40 and 47, four of which represented the complete reading frames, and all
read in the same direction (Fig. 4.10). Although the first open reading frame, orf11
(midG), had no complete sequence, it was found  to encode PKS at the 3´ end. Orf12
(midK) is located immediately downstream of midG. Orf13 (midH) was found to share the
sequence with the 3´ end of the midK gene in a region of 31 base pairs. Orf14 (midI) is
located downstream of the midH gene, and following the midI gene comes orf15 (midJ).
The detail analysis of the first four genes will be done in the following sections.
The sequence of an approximately 9.2 kb DNA fragment (sites 47-54 in Fig. 4.10) was
partially performed using respective plasmids from the pLC3- series. In this region, only
orf19 (mirA) was identified to be a complete open reading frame. The organization of the
partially sequenced orf16 (mdmB), orf17 (midN), orf18 (mirB), orf20 (midR) and
orf21(mdmC) is shown in Fig. 4.10.
 4.7. The PKS genes (midG)
Although finding the midecamycin PKS genes was not the target of this study, they could
facilitate the identification of the overall organisation and orientation of the gene cluster
and the genes encoding 6-deoxysugar biosynthetic enzymes. A little information about the
PKS genes was obtained from two adjacently sequenced fragments in Smyc-LC3. The first
sequence (404 bp) derived from plasmid pLC3-6, named as orf11 (midG), is located
immediately upstream of the 5´ end of orf12 (midK) in the BamHI fragment (site 41-42)
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(see Fig. 4.10). The deduced 133 aa sequence encoded by midG was found to be the 3´
end sequence of the midecamycin PKS, since the product of midG shows 60% identity to
PKS module 7, NidA5, in 16-membered niddamycin biosynthesis from S. caelestis (acc.
no. AF016585; Stephan et al., 1997), and 48% identity to tylactone PKS module 7,
TylGV, in tylosin biosynthesis (acc. no. U78289). The high sequence identity between the
deduced C-terminal amino acids derived from MidG and NidA5 has revealed that the
current found sequence is possibly encoded as a thioesterase (TE) which is responsible for
the release and cyclization of the macrolide ring, identifying the end of the PKS sub-
cluster (Donadio & Katz, 1992) (for sequence see Appendices 7.5). Another DNA
sequence of about 1.0 kb was obtained from part of the insert fragment of the plasmid
pLC3-22 extending from the BamHI (site 41) to the SstI (site 40) at the end of the Smyc-
LC3 insert. Although this fragment was not completely sequenced, information obtained
from partial sequencing has strongly supported that it is encoded as a PKS near the C-
terminus. The deduced 264 aa sequence derived from pLC3-22 shows end-to-end
similarity to niddamycin PKS module 7, NidA5 (58% identity) in which the nucleotide
sequence in this region is encoded as an acyl carrier protein (ACP) and a TE.
4.8. Regulation genes (midF and midR)
Sequencing two DNA segments, from pLC1-11 and pLC1-13 in Smyc-LC1, revealed that
the deduced product encoded by the nucleotide sequence is similar to the SrmR protein.
Therefore, this gene was identified as orf7 (midF) (see Fig. 4.10). The deduced 228 aa
sequence close to the N-terminus of MidF was found to have 49% identity to the product
of srmR (acc. no. X63451). SrmR has been identified as a transcriptional activator of the
expression of the PKS genes in the spiramycin biosynthetic gene cluster from S.
ambofaciens (Geistlich et al., 1992).
A second putative regulator gene, orf20 (midR) was found on Smyc-LC3 cloned in pLC3-
26, which is located downstream of orf19 (see Fig. 4.10). This partial sequence revealed
that the encoded 140 aa sequence, close to the N-terminus of MidR, was similar to OrfY
(36% identity), a regulator of antibiotic transport complexes in the rapamycin producing
strain S.  hygroscopicus (acc. no. X86780; Schwecke et al., 1995), and SC7H1.21 (34%
identity), a putative transcriptional regulator in S. coelicolor (acc. no. AL021411).
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4.9. Resistance genes (mdmA and mirB)
The 813 bp nucleotide sequence of orf19 located in Smyc-LC3 was found to be identical
to the previously identified gene, mdmA, whose sequence had been published elsewhere
(acc. no. A60725; Hara & Hutchinson, 1990). The deduced product of orf19 (271 aa)
exhibits 54% sequence identity to that of TlrD from S. fradiae (acc. no. X97721), which
confers ribosomal resistance to macrolides, lincosamides and streptogramin B type (MLS)
antibiotics, and methylates 23S rRNA (Gandecha & Cundliffe, 1996). So Orf19 (MdmA)
is identified as a putative midecamycin-resistance protein.
The second resistance gene, orf 18 (mirB), was found to be located upstream of mdmA (see
Fig. 4.10). Only a small segment encoding the N-terminal region  (135 aa) of mirB was
sequenced from the plasmid pLC3-2. This showed strikingly high sequence similarity to
three resistance proteins from the products of other 16-membered macrolides: CarA (67%
identity) from S. thermotolerans, a carbomycin producer (Schoner et al., 1992), SrmB
(63% identity) from S. ambofaciens in the spiramycin gene cluster (Geistlich et al., 1992),
and TlrC (54% identity) from S. fradiae in the tylosin gene cluster (Rosteck et al., 1991).
These proteins possess significant sequence similarity to ABC-transporters. The sequence
alignment (Fig. 4.11) demonstrates that all these proteins contain highly conserved regions
in the cytoplasmic ATP-binding domains typically present within this superfamily of
transport proteins.
MirB    ---MLTAQLALHDITKRYNDRVVLDRVGFTIKPGEKVGIIGHNGSGKSTLLKLIAGREQA
CarA    ---MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQP
SrmB    ---MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEP
TlrC    MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERP
               *  **  **** * ***      * **** * ** ** *****    **
MirB    DNGAVTMVAPGGTGYLAQTLELAPEATVQDAVDLAMVELREIEAGVRRAEAELGRTAL
CarA    DNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAER--
SrmB    DNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGES--
TlrC    DAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAA-
        * *  *  **** *** *** *   ****** ***   **  *   *  ** *
Fig. 4.11. Comparison of the N-terminal amino acid sequence of MirB with those of other
ABC-transporters from products of 16-membered macroildes. The following resistance
proteins are compared: CarA protein from S. thermotolerans (M80346); SrmB protein from S.
ambofaciens (X63451); TlrC protein from S. fradiae (M57437). GenBank accession numbers are
given in parentheses. A consensus ATP-binding motif is marked. Sequence identities between
these proteins are indicated by asterisks.
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4.10. Identification of midE, mdmB and mdmC
In the sequence of a complete open reading frame, orf6 (midE), located in Smyc-LC1, it
was found that the deduced product (388 aa) encoded by midE shows 51% sequence
identity to that of acyB1 from S. thermotolerans (acc. no. D31821; Arisawa et al., 1993).
AcyB1 is identified as 4''-O-isovaleryl transferase to convert the isovaleryl group to the
C4-OH of mycarose in carbomycin biosynthesis. Therefore, MidE is deduced as a 4''-O-
propionyl transferase to convert the propionyl group to the C4-OH of mycarose in
midecamycin biosynthesis (see the structures in Fig. 1.1; for sequence see Appendices
7.4).
Two adjacent genes, orf16 and orf21, are located downstream of midGKHIJ in Smyc-LC3
and both read in the opposite direction to midGKHIJ (see Fig. 4.10). Based on the
nucleotide sequences from small segments, orf16 and orf21 were found to be identical to
the genes, mdmB and mdmC, whose sequences have earlier been published by Hara and
Hutchinson (1992; acc. no. M93958). The mdmB gene encodes a 3-O-acyltransferase
which has the ability to catalyse the addition of a propional group to C3-OH of the lactone
ring in midecamycin biosynthesis. The mdmC gene encoding a O-methyltransferase is
located immediately downstream of mdmB, and the deduced product catalyzes the addition
of a methyl group to C4-OH of the lactone ring in the production of midecamycin.
4.11. The midC gene
Orf2 (midC), was identified in Smyc-LC1, encoding a polypeptide of 398 aa with an
estimated Mr of 42 323 and an average G+C content of 72.8%. At the stage of sequence
analysis, orf2 shows three putative start codons: an ATG codon which contains no
satisfied potential ribosomal binding site, a GTG codon located 12 base pairs downstream
of the first putative start codon, and another GTG codon appeared 6 base pairs
downstream of the second putative start codon, of which the first GTG codon is preceded
by a sequence (GGAGC) that possibly represents a ribosomal binding site, since it shows a
degree of complementarity to a region close to the 3' end of the 16S rRNA of S. lividans
(Bibb & Cohen, 1982) (Fig. 4.12). The definitive start codon will be determined through
gene expression by cloning these possible start codons into the expression vectors and
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examining the expression patterns (see Section 4.19.2). The orf2 ends in a TGA codon
which is one nucleotide before starting orf3 (midA) (for sequence see Appendices 7.2).
CAC ATT CCT GCG CGA CGC ATG GAG CAT AAA GTG AAC GTG CCC TTT CCT
H   I   P   A   R   R   M   E   H   K   V   N   V   P   F   P
Fig. 4.12. The sequence around the starting region of midC. Three
putative start codons of midC are printed in bold. A possible ribosomal
binding site is underlined.
The deduced product of midC shows significant sequence similarity with putative
aminotransferases from several deduced gene products in different antibiotic biosynthetic
pathways. The highest identity scores were found to OleN2 in the oleandomycin-
producing strain, S. antibioticus (49% identity); TylB in S. fradiae (47% identity); EryCI
in Sac. erythraea (47% identity; Dhillon et al., 1989); DesV in S. venezuelae (45%
identity), which is notable for its ability to produce two distinct groups of macrolide
antibiotics, 12-membered methymycin and neomethymycin, and 14-membered
narbomycin and pikromycin (Xue et al., 1998). The tylB product might catalyse the
conversion of dTDP-3-keto-6-deoxyglucose to dTDP-3-amino-6-deoxyglucose during
dTDP-D-mycaminose biosynthesis in the tylosin biosynthetic gene cluster. The EryCI,
OleN2 and DesV proteins might be involved in transamination during dTDP-D-
desosamine biosynthesis in the biosynthetic gene clusters of erythromycin, oleandomycin
and macrolides, respectively. The aminotransferase enzyme is thought to be dependent on
pyridoxal phosphate as a cofactor (Thorson et al., 1993;  Piepersberg, 1994; Pascarella  &
Bossa, 1994). The sequence similarities between these proteins are most covered in a
region of the protein that contains the conserved lysine residue which is supposed to be the
attachment site for pyridoxal phosphate and the conserved aspartate residue which makes a
hydrogen bond with N1 of the pyridoxal ring (Fig. 4.13).
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MidC     PVHLYGHPADLDPLLAIAERHGLAVVEDAGSAR-RPLPGRRIGS
TylB     PVHLYGHPVDLDPVGAFAEPHGLAVVEDAAQAT-ARYRGRRIGS
OleN2    PVHLYGHPADLAALSEVAERHGVRILEDAAQAHGAQAYGRRVGA
EryCI    PVHLYGHPADLDALRAIADRHGLALVEDVAQAVGARHRGHRVGA
DesV     PVHLYGHPADMDALRELADRHGLHIVEDAAQAHGARYRGRRIGA
         ******** *       *  **    **   *      * * *
MidC     GH-VVAFSFYPGKNLGAMGDGGAVVTGDAALADRIRLLRKCG
TylB     GH-RTAFSFYPGKNLGALGDGGAVVTSDPELADRLRLLRNYG
OleN2    WS-TTAFSFYPGKNLGGFGDGGAVVTDDAELAERVRLLRNYG
EryCI    GSNAAAFSFYPGKNLGALGDGGAVVTTDPALAERIRLLRNYG
DesV     GSSVAAFSFYPGKNLGCFGDGGAVVTGDPELAERLRMLRNYG
           ***********  ******** *  ** * * **  *
Fig. 4.13.  Partial sequence alignment of MidC with other macrolide aminotransferases.
TylB from S. fradiae (U08223), OleN2 from S. antibioticus (AF055579), EryCI from Sac.
erythraea (X155541) and DesV from S. venezuelae (AF079762).  GenBank accession numbers
are given in parentheses. The marked letters indicate the proposed consensus sequence for
putative pyridoxal phosphate-binding site (Piepersberg, 1994).
4.12. The midA and midB genes
Two complete open reading frames, orf3 and orf4, designated as midA and midB, were
found in Smyc-LC1, respectively. Orf3 is translationally coupled to orf2 (midC)  using  an
ATG start codon by overlapping one nucleotide with the 3' end of orf2, and terminates in a
TGA codon. Orf4 overlaps the 5' end of orf8 (midL) by two nucleotides, but reads away
from orf8. It starts with an ATG and ends six nucleotides upstream of orf5 (midD) in a
TGA codon (see Fig. 4.10; for sequence see Appendics 7.2 and 7.3).
The deduced product of midA (a protein of 303 aa residues) shows significant sequence
identity to putative dTDP-glucose syntheses from several Streptomycetes. These proteins
include DesIII from S. venezuelae (62% identity; acc. no. AF079762), TylAI from S.
fradiae (61% identity; acc. no. U08223), AveBIII from the avermectin-producing strain, S.
avermitilis (61% identity; acc. no. AB032523; Ikeda et al., 1999), SnogJ from the
nogalamycin-producing strain, S. nogalater (56% identity; acc. no. AF187532; Torkkell,
et al., 1997), and StrD from S. griseus (54% identity; acc. no. AF128273; Pissowotzki et
al., 1991). They all share a highly conserved motif close to the N-terminus (data not
shown).
The deduced product of midB (a protein of 326 aa residues) is highly similar in sequence
to dTDP-glucose-4,6-dehydratases from several deduced gene products in macrolide
antibiotics. These proteins include TylAII from S. fardiae (64% identity; acc. no.
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U08223), AveBII from S. avermitilis (64% identity; acc. no. AB032523), Gdh from Sac.
erythraea (60% identity; acc. no. L37354; Vara & Hutchinson, 1988), and DesIV from S.
venezuelae (60% identity; acc. no. AF079762). The dTDP-glucose-4,6-dehydratase
purified from Sac. erythraea showed that the enzyme required NAD+ as a cofactor (Vara
& Hutchinson, 1988). There is a putative binding site for the cofactor NAD+ located
within the N-terminus 30 aa residues of these proteins (data not shown) (Wierenga et al.,
1985; Scrutton et al., 1990). The enzyme activity of dTDP-glucose-4,6-dehydratase from
S. griseus in the gene cluster of streptomycin biosynthesis was also stimulated by addition
of NAD+ (Verseck, 1997).
4.13. The midK gene
Orf12 (midK) located in Smyc-LC3 encodes a polypeptide of 249 aa (Mr = 28 899 and
average G+C = 69%). Orf12 is immediately dowmstream of and reads in the same
direction as the genes encoding PKS, with an ATG start condon. Analysis of the open
reading frame showed that  orf12 ends with a TGA codon and overlaps the 5' end of orf13
(midH) by 31 base pairs (Fig. 4. 14(a), (b); for sequence see Appendices 7.5).
(a)
                 PKS
     T   L   L   T   G   G   K   H   *
    CAC CCT GCT CAC CGG AGG AAA ACA CTG ATG TAC GCC AAC GAC ATC GCG
                                        M   Y   A   N   D   I   A
                                        Orf12
  (b)
          Orf13
          M   P   I   P   A   T   A   P   A   P   V   N   A   G
    AAC CCA TGC CAA TCC CTG CCA CGG CGC CGG CGC CCG TGA ACG CCG GC
    N   P   C   Q   S   L   P   R   R   R   R   P   *
                                                Orf12
Fig. 4. 14 (a), (b). The location of start and stop sequences of orf12 (midK).
The deduced product of midK shows significant sequence similarity to a family of
enzymes which has recently been proposed to function as S-adenosylmethionine (SAM)-
dependent methyltransferases (Gandecha et al., 1997). Members of this family include
TylMI from S. fradiae (60% identity), which acts on the amino group of dTDP-3-amino-6-
deoxyglucose during mycaminose biosynthesis, perhaps by introducing two methyl groups
at that site (Gandecha et al., 1997); OleM1 from S. antibioticus (57% identity), which is
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involved in oleandomycin biosynthesis (Olano et al., 1998), DesVI from S. venezuelae
(53% identity), which is deduced as a N, N-dimethyltransferase involved in macrolide
biosynthesis (Xue et al., 1998), and EryCVI from Sac. erythraea (51% identity), which
participates in erythromycin biosynthesis (Gaisser et al., 1997). A sequence alignment of
these proteins shows that they each possess all three of the consensus sequence motifs
typical of methyltransferases that use SAM as co-substrate (Kagan & Clarke, 1994) (Fig.
4.15). Motif I, near their N-terminus in these proteins, containing the consensus sequence
LLDVACGTG, is thought to be a variant of canonical methyltransferase motif G´G´G
(Ingrosso et al., 1989; Haydock et al., 1991) which is found  in  glycine   N-
methyltransferases, and  forms  part  of  the SAM-binding pocket according to
crystallographic data relating to the HhaI DNA m5C methyltransferase (Cheng et al.,
1993).
MidK     YDLVHEGKGKDYRQEAEEIAQLVRAHRPATRSLLDVACGTGQHLRHLDGLFDHVEGLE
TylMI    YDLVHQGKGKDYHREAADLAALVRRHSPKAASLLDVACGTGMHLRHLADSFGTVEGLE
OleM1    YDAVYRGRGKDYAGEAKDVADLVRDRVPDASSLLDVACGTGAHLRHFATLFDDARGLE
DesVI    YDLFYLGRGKDYAAEASDIADLVRSRTPEASSLLDVACGTGTHLEHFTKEFGDTAGLE
EryCVI   YDRFYRGRGKDYAAEAAQVARLVRDRLPSASSLLDVACGTGTHLRRFADLFDDVTGLE
         **    * ****  **   * ***   *   *ooooooooo **      *    **o
                                          motif I
MidK     LSQDMLAIAIGRNPDVTLHEGDMRSFALGRRFDAVICMFSSIGHLRTTDELDSTLRCF
TylMI    LSADMLAIPRRRNPDAVLHHGDMRDFSLGRRFSAVTCMFSSIGHLAGQAELDAALERF
OleM1    LSASMLDIARSRMPGVPLHQGDMRSFDLGPRVSAVTCMFSSVGHLATTAELDATLRCF
DesVI    LSEDMLTHARKRLPDATLHQGDMRDFRLGRKFSAVVSMFSSVGYLKTTEELGAAVASF
EryCVI   LSAAMIEVARPQLGGIPVLQGDMRDFALDREFDAVTCMFSSIGHMRDGAELDQALASF
         **  *               **** * * oooooooo*****       **      *
                                      motif II
MidK     AGHLEPGGAIVIEPWWFPDSFTPGYVGATSPRRANGTICRVSDSVREGDATRIEVH
TylMI    AAHVLPDGVVVVEPWWFPENFTPGYVAAGTVEAGGTTVTRVSHSSREGEATRIEVH
OleM1    ARHTRPGGVAVIEPWWFPETFTDGYVAGDIVRVDGRTISRVSHSVRDGGATRMEIH
DesVI    AEHLEPGGVVVVEPWWFPETFADGWVSADVVRRDGRTVARVSHSVREGNATRMEVH
EryCVI   ARHLAPGGVVVVEPWWFPEDFLDGYVAGDVVRDGDLTISRVSHSVRAGGATRMEIH
         * *ooooooooo******  *  * *          *  ***** * *** * * *
            motif III
Fig. 4.15. Partial comparison of the amino acid sequence of MidK with other macrolide
methyltransferases. The following proteins are compared: TylMI from S. fradiae (X81885);
OleM1 from S. antibioticus (AJ002638); DesVI from S. venezuelae (AF079762); EryCVI protein
from Sac. erythraea (U77459). GenBank accession  numbers are given in parentheses. Sequence
identities between these proteins are indicated by asterisks. Motifs I to III are marked and shown
by circles.
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4.14. The midH gene
Orf13 (midH) found in Smyc-LC3 encodes a 414 aa polypeptide (Mr = 44 275 and
average G+C = 75.7%). Based on sequence alignment and open reading frame analysis,
orf13 is translationally coupled to orf12, since the putative ATG start codon of orf13
begins 31 base pairs upstream of the TGA stop codon of orf12 (see Fig. 4. 14(b)). The
overlapping genes, like orf12 and orf13, which are involved in the same metabolic
process, are quite common in bacteria (Normark et al., 1983). Orf13 ends 42 base pairs
upstream of orf14 with a TGA codon (for sequence see Appedix 7.5) .
The deduced product of midH shows sequence similarity to TylMIII from the tylosin
biosynthetic gene cluster of S. fardiae (35% identity; acc. no. X81885), which was recently
identified as a hypothetical NDP-hexose 3,4-isomerase and may be involved in mycaminose
biosynthesis, and to DnrQ from the daunorubicin biosynthetic gene cluster of S. peucetius
(32% identity; acc. no. L47164; Otten et al., 1995), which might participate in daunosamine
biosynthesis. The midH gene product also shows a moderate overall sequence similarity (28-
30%) to OleP1 from S. antibioticus (acc. no. AJ002638), DesVIII from S. venezuelae (acc.
no. AF079762), SnogN from S. nogalater (acc. no. AF187532), and EryCII from Sac.
erythraea (acc. no. Y14332). All these proteins also show end-to-end sequence similarity to
cytochrome P450 enzymes from a variety of sources, but none of them have the
characteristic P450 motif (Bairoch, 1992) which contains the highly-conserved heme binding
site and includes the cysteine residue that serves as the heme iron ligand (Nelson et al.,
1993). In the case of the EryCII protein, experimental evidence demonstrated that it possibly
acts as a 3,4-isomerase to form dTDP-3-keto-6-deoxy-hexose during dTDP-D-desosamine
biosynthesis (Summers et al., 1997; Salah-Bey et al., 1998).
4.15. The midI gene
Orf14 (midI) found in Smyc-LC3 encodes a 421 aa polypeptide (Mr = 45 993 and average
G+C = 80%). Orf14 starts 42 base pairs downstream of orf13 (midH) using a GTG codon
with a putative ribosomal binding site (GGAGT) and ends 31 base pairs upstream of orf15
(midJ) using a TGA codon (for sequence see Appendices 7.5).
RESULTS 80
The deduced product of midI shows convincing end-to-end sequence similarity to several
macrolide antibiotics. The highest identity scores were found to TylMII from S. fradiae
(59% identity), which encodes a glycosyltransferase that adds mycaminose to the 5-OH of
tylactone, the polyketide aglycone of tylosin (Gandecha et al., 1997), DesVII from S.
venezuelae (55% identity), which has the ability to catalyze glycosylation of both the 12-
membered and 14-membered ring macrolactones in macrolide biosynthesis (Xue, et al.,
1998), OleG2 from S. antibioticus (54% identity), which catalyses glycosylation of
oleandolide in the oleandomycin biosynthetic pathway (Olano et al., 1998), and EryCIII
from Sac. erythraea (51% identity) (Summers et al., 1997; Salah-Bey et al., 1998), which
encodes the desosaminyl glycosyltransferase that adds dTDP-D-desosamine to the 5-OH of
3-a-mycarosyl erythronolide B, an intermediate after the first sugar, mycarose, is attached
to erythronolide B that is catalysed by another glycosyltransferase, EryBV (46% sequence
identity to MidI) (Gaisser et al., 1997; Summers et al., 1997). A sequence alignment of
these proteins is shown in Fig. 4.16. All these glycosyltransferases retain a characteristic
motif, P-NVR-VDFVPL-ALLP-C---VHHGG-GT--TA--HG-P, present in UDP-glycosyl
transferases(Jenkins & Cundliffe, 1991), which is localised close to the C-terminus of
these enzymes.
4.16. Identification of genes encoding dTDP-D-mycaminose biosynthetic pathway
As described in the introduction, various 6-deoxyhexoses, present in a range of antibiotic
molecules, are made from D-glucose-1-phosphate via dTDP-glucose and dTDP-4-keto-6-
deoxy-glucose before the pathways diverge (Liu & Thorson, 1994; Piepersberg, 1994).
Based on the above sequence analysis and comparison, the midA and midB genes are
supposed to be responsible for the early steps in the midecamycin biosynthetic gene
cluster. Three genes, midC, midH and midK, might participate in the synthesis route to
dTDP-D-mycaminose, and the midI gene is believed to be responsible for attachment of
mycaminose to midecamycin lactone. The detail discussion about these genes and their
deduced functions involved in the mycaminose biosynthetic pathway and transfer will be
commented and concluded in Section 5.
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      MidI         --------------------VRVLLTSLAHNTHYYSLVPLAWALRAAGHEVRVASPPSLT
      TylMII       MRRALDDRRRGPHGPEGKPPMRVLLTCIAHNTHYYNLVPVAWALRAAGHEVRVAAQPALT
DesVII       --------------------MRVLLTSFAHHTHYYGLVPLAWALLAAGHEVRVASQPALT
OleG2        --------------------MRVLLTCFANDTHFHGLVPLAWALRAAGHEVRVASQPALS
EryCIII      --------------------MRVVFSSMASKSHLFGLVPLAWAFRAAGHEVRVVASPALT
                                  **     *   *   *** ***  ********   * *
MidI         DVITSTGLPAVPVGDDQPAAELLAEMGGDLVPYQRGFEFAEVEPAQETTWEHLLGQQSMM
TylMII       DTITASGLTAVPVGGNESVLEFVTEIGGDPGPYQRGMDFAETC-GEPLSYEHALGQQTAM
DesVII       DTITGSGLAAVPVGTDHLIHEYRVRMAGEPRPNHPAIAFDEAR-PEPLDWDHALGIEAIL
OleG2        DTITQAGLTAVPVGRDTAFLELMGEIGADVQKYSTGIDLGVR--AELTSWEYLLGMHTTL
EryCIII      EDITAAGLTAVPVGTDVDLVDFMTHAGHDIIDYVRSLDFSERD-PATLTWEHLLGMQTVL
               **  ** *****                                       **
                             EryCIII/H
MidI         SALWFAPFSGAATMDDIGRLRRDWRPDLVVWEPWTYAGPIAARACGAAHARILWGPDAIG
TylMII       SALCFAPFNCDSTIDDMVALARSWRPDLVLWEPFTYAGPIAAHACGAAHARLLWGPDVIL
DesVII       APYFHLLANNDSMVDDLVDFARSWQPDLVLWEPTTYAGAVAAQVTGAAHARVLWGPDVMG
OleG2        VPTFYSLVNDEPFVDGLVALTRAWRPDLILWEHFSFAGALAARATGTPHARVLWGSDLIV
EryCIII      TPTFYALMSPDTLIEGMVSFCRKWRPDLVIWEPLTFAAPIAAAVTGTPHARLLWGPDITT
                                  * * ***  **    *   **   *  *** *** *
                              LC6
MidI         RSRRRFLEALERVPEELREDPIAEWLGWTLDRYGCAFD----ERDVLGHWVIDPGPRSTR
TylMII       NARAQFRRLAPDSPEEPREDPVAEWLGWTLERHGLTAERETVEELIGGQWTLDPTAESLR
DesVII       SARRKFVALRDRQPPEHREDPTAEWLTWTLDRYGASFE----EELLTGQFTIDPTPPSLR
OleG2        RFRRDFLAERANRPAEHREDPMAEWLGWAAERLG-STFD---EELVTGQWTIDPLPRSMR
EryCIII      RARQNFLGLLPDQPEEHREDPLAEWLTWTLEKYGGPAFD---EEVVVGQWTIDPAPAAIR
               *  *       * * **** **** *     *        *    *    **     *
MidI         LDLGQTTVPMCYVPYNGRAVIEPWLAEKPERPRVCLTLGISARETYGRDAVSYSELFQAL
TylMII       CPR-PAVVPFRFVPYNGRSVLPDWLLRKPGRPRVCFTLGVSARETYGRDAVPFHELLAGL
DesVII       LDTGLPTVGMRYVPYNGTSVVPDWLSEPPARPRVCLTLGVSAREVLGGDGVSQGDILEAL
OleG2        LPTGTTTVPMRYVPYNGRAVVPAWVRQRARRPRICLTLGVSARQTL-GDGVSLAEVLAAL
EryCIII      LDTGLKTVGMRYVDYNGPSVVPEWLHDEPERRRVCLTLGISSRENS-IGQVSIEELLGAV
                    *    * ***  *   *      * * * *** * *       *
                                           EryCIII/I
MidI         GRMEIEVVATLDASQQKRLGSLPDNVVPVDFVPLDALLPSCAAIIHHGGAGTWSTALLHG
TylMII       GDLDAEIVATLDPGQLSGAGEVPRNVRAVDFVPMDALLPTCSAVVHHGGAGTCFTATLNG
DesVII       ADLDIELVATLDASQRAEIRNYPKHTRFTDFVPMHALLPSCSAIIHHGGAGTYATAVINA
OleG2        GDVDAEIVATLDASQRKLLGPVPDNVRLVDFVPLHALMPTCSAIVHHGGAGTWLTAAVHG
EryCIII      GDVDAEIIATFDAQQLEGVANIPDNVRTVGFVPMHALLPTCAATVHHGGPGSWHTAAIHG
                  *  ** *  *       *       ***  ** * * *  **** *   **
MidI         VPQILLPALWDAPLKAQQLQRLSAGLNLPAATLTARRLADAVHTAVHDP-AIRAGARRLR
TylMII       LPQIVVAALWDAPLKGAQLAEAGAGVSIAPEKLDAATLRAGVVRALEDEGHSRRSAGLLR
DesVII       VPQVMLAELWDAPVKARAVAEQGAGFFLPPAELTPQAVRDAVVRILDDP-SVATAAHRLR
OleG2        VPQIVLGDLWDNLLRARQTQAAGAGLFIHPSEVTAAGLGEGVRRVLTDP-SIRAAAQRVR
EryCIII      VPQVILPDGWDTGVRAQRTQEFGAGIALPVPELTPDQLRESVKRVLDDP-AHRAGAARMR
              **      **            **                *     *       *   *
MidI         EEMLADPTPAAIVPTLERLTALHRAA--------
TylMII       AEMLAEPTPAGLVPQLERLTALHRNGRSRSAPER
DesVII       EETFGDPTPAGIVPELERLAAQHRRPPADARH--
OleG2        DEMNAEPTPGEVVTVLERLAASGGRGRGGGNHAG
EryCIII      DDMLAEPSPAEVVGICEELAAGRREPR-------
                   * *   *   * * *
Fig. 4.16. Comparison of amino acid sequence of MidI with other macrolide
glycosyltransferases. The following proteins are compared: TylMII from S. fradiae
(X81885); DesVII from S. venezuelae (AF079762); OleG2 from S. antibioticus (AJ002638);
EryCIII protein from Sac. erythraea (Y14332). GenBank accession numbers are given in
parentheses. Sequence similarity between these proteins are indicated by asterisks. The
highly conserved sequence regions used for designing the primers, EryCIII/H, EryCIII/I and
LC6, are marked and indicated by arrows (see Section 4.1.2).
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4.17. About strains of S. mycarofaciens UC189B (ATCC 21454) and S. mycarofaciens
         ATCC 21454
During the course of examining the production pattern of S. mycarofaciens UC189B
(ATCC 21454), it was proved that it is a non-producing strain. In order to re-evaluate the
two currently identified gene sub-clusters, a series of PCR experiments to compare S.
mycarofaciens UC189B (ATCC 21454) with S. mycarofaciens ATCC 21454, which is a
midecamycin-producing strain,  were carried out by using primers designed from the
identified genes, midB, midC, midK and midI, as previously described. As a result, it is
confirmed that the two existed sub-clusters encoding deoxysugar genes do contain the
same pattern in S. mycarofaciens UC189B (ATCC 21454) and ATCC 21454 (data not
shown). Further sequence analysis found that downstream of the midG (PKS) starting
region is a large segment gap (about 4 kb) of unknown coding sequence, that is unusual
when compared to those of other macrolide PKS genes, e.g., tylactone PKS tylG from S.
fradiae (acc. no. U78289) and platenolide PKS SrmG from S. ambofaciens (acc. no.
Z46913), which are themselves clustered. Therefore, it is concluded that a mutation in the
early steps of midecamycin lactone biosynthesis pre-existed in S. mycarofaciens UC189B
(ATCC 21454).
4.18. Heterologous complementation of midK and midI into Sac. erythraea mutants
To characterise some pathway-specific genes involved in the mycaminose biosynthetic
pathway and for the sugar  attachment  to  the  midecamycin lactone,  plasmids  containing
either midK, or midI  or  both genes were constructed  to transform  Sac. erythrea  mutants
CIII68 and CIV89 (Fig. 4.17). The mutants CIII68 and CIV89 were generated by Salah-
Bey et al. (1998) and identified as the deficient of desosamine biosynthesis and its
attachment to macrolactone in the erythromycin gene cluster. When cell supernatants were
analysed by TLC from individual transformants of CIII68/pLCW1-29, CIII68/pLC1-31
and CIII68/pLCW1-21, there were some new spots available compared to several control
samples. However, none of them showed antibiotic activities via bioassay (data not
shown).
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Fig. 4.17. Plasmids used to transform into Sac. erythraea mutants strains CIII68 and CIV89
4.19. Heterologous expression of the MidH, MidC, MidK and MidI proteins
In order to characterise enzyme proteins encoded by the proposed genes for the pathway of
mycaminose biosynthesis and transfer of the sugar to the midecamycin lactone, the over-
expression of individual genes in suitable hosts was investigated. The genes, midH, midC,
midK and midI, were amplified by PCR from the cosmid DNA of Smyc-LC1 and Smyc-
LC3. The forward primers were designed for introduction of an NdeI site, changing the
sequence at the natural start codon for the ability to create start codon fusion of these
genes into the promoter/ribosome-binding-site cassettes of expression vectors. The reverse
primers were designed for introduction of a BamHI or BglII site located immediately
downstream of the stop codon of the gene. The amplified DNA fragments were cloned
into (i) two expression vectors of E. coli, pET11a, and pET16b (a His-tag fusion protein),
under the control of the T7 promoter; (ii) a E. coli-Stretomyces shuttle vector, pUWL201
under the control of ermE up promoter; (iii) a S. lividans vector, pIJ4213 (a His-tag fusion
protein) under the control of tipAp promoter (Tab. 4.2). The expression conditions and the
host strains used will be given in detail in the following sections.
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Tab. 4.2. The structure of recombinant plasmids for the heterologous
expression of proteins MidH, MidC, MidK and MidI in E. coli and S. lividans
Protein Recombinant Vector            Mr. of recombinant
                             Plasmid          proteins (kDa)
MidH pLCW4-2 pET11a 44.3
His-tag-MidH pLCW4-3 pET16b 46.3
MidH pLCW4-6 pUWL201 44.3
His-tag-MidH pLCW4-7 pUWL201 46.3
His-tag-MidH pLCW4-10 pIJ4123 45.1
His-tag-MidC pLCW2-20 pET16b 43.5
His-tag-MidC pLCW2-21 pET16b 44.3
MidC pLCW2-23 pET11a 42.3
MidK pLCW3-2 pET11a 28.9
His-tag-MidK pLCW3-3 pET16b 30.9
MidK pLCW3-8 pUWL201 28.9
His-tag-MidK pLCW3-9 pUWL201 30.9
His-tag-MidK pLCW3-12  pIJ4123  29.7
MidI pLCW1-33 pET11a 46.0
His-tag-MidI pLCW1-23 pET16b 48.0
MidI pLCW1-41b pUWL201 46.0
His-tag-MidI pLCW1-51b pUWL201 48.0
His-tag-MidI pLCW1-61 pIJ4123 46.8
For the plasmid construction see Section 2.3.3. The amplification was performed by
using PCR method 2 as described in Section 3.3.5.
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4.19.1. Over-expression of the MidH protein
Two recombinant expression-plasmids, pLCW4-2 and pLCW4-3 were constructed to
introduce the midH gene and transformed into E. coli BL21(DE3)pLysS. When the
respective transformants were cultivated  in  LB  liquid  medium at  28°C  or 37°C  at  220
r.p.m. in a rotary shaker, the over-expressing MidH proteins in both expression-clones
were visible on SDS-PAGE gels, but they formed insoluble inclusion bodies. However,
when the shaking rate was decreased from 200 r.p.m. to 100 r.p.m., surprisingly, a
production of soluble native MidH protein was obtained in large quantities (Fig. 4.18A). A
further effort to produce soluble MidH protein was made by using LB liquid supplemented
with 1 M sorbitol and 2.5 mM betaine. Because of enhanced osmotic stress of the medium,
the  culture  grew   much   more  slowly  (see  Section  3.3.12).  The  resulting expression
pattern of E. coli /pLCW4-2 or /pLCW4-3 (Fig. 4.18B) showed that the proteins of MidH
and its His-tag derivative were produced in large quantities in soluble form. The attempt to
express the midH gene in S. lividans TK23 using the recombinant plasmids pLCW4-6 and
pLCW4-7 failed, since neither the SDS-PAGE gels nor Western blotting could observe
any visible expected bands.
                            A                                                                      B
Fig. 4.18. Expression of MidH in E. coli BL21 (DE3) pLysS. The cultivation of transformants was
performed by (A) agitation at 100 r.p.m, or (B) using LB medium supplemented with sorbitol and betaine.
For the other expression conditions see text. Electorphoresis was run in 10% SDS-PAGE gel. About 5 mg
of protein was loaded in each lane. Extracts were obtained from E. coli transformants containing the
following plasmids: pET11a, from the intact cells (lanes 1 and 5) and the cell-interrupted supernatants
(lanes 3 and 6); pLCW4-2, from the intact cells (lanes 2 and 9) and the cell-interrupted supernatants
(lanes 4 and 10); pLCW4-3, from the intact cells (lane 7) and the cell-interrupted supernatants (lane 8),
respectively. The molecular masses (kDa) of the marker proteins (lane M) are given. The overproduction
of the MidH protein is indicated by arrows.
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4.19.2. Overexpression of the MidC protein
As described in Section 4.11, the sequence analysis of midC shows three putative start
codons: the first is an ATG codon, the second is a GTG codon located 12 bp downstream
of the first putative start codon, and the third is another GTG codon, which is located 6 bp
downstream of the second putative start codon (see Fig. 4.12). In order to be able to
express an active protein, three recombinant expression-plasmids were constructed in E.
coli expression vectors (see Tab. 4.2). In pLCW2-21 and pLCW2-23  the first start codon
(ATG) regions, and in pLCW2-20 the second start codon (GTG) region, were replaced by
an NdeI site. When transformed into E. coli BL21 (DE3)pLysS, the expression of MidC
proteins was tested in LB liquid medium at 100 r.p.m., 28°C. From the results of SDS-
PAGE separation of the respective cell extracts (Fig. 4.19), the overproduction of large
amounts of the soluble MidC protein was achieved from the cell-free extracts of the
transformants E. coli/pLCW2-21 or /pLCW2-23. However, E. coli/pLCW2-20 didn't show
the expected expression band. The expression could not even be detected by Western
blotting analysis (data not shown). Based on this experimental evidence, it is concluded
that the translation of midC starts with the first ATG codon.
Fig. 4.19. Expression of MidC in E. coli BL21 (DE3) pLysS. For the expression
conditions see text. Electrophoresis was run in 10% SDS-PAGE gel. About 5 mg of protein
was loaded in each lane. Extracts were obtained from E. coli containing the following
plasmids: pET11a, from the intact cells and the cell-interrupted supernatants (lanes 1 and
5); pLCW2-21 from the intact cells and the cell-interrupted supernatants (lanes 2 and 6);
pLCW2-23 from the intact cells and the cell-interrupted supernatants (lanes 3 and 7);
pLCW2-20 from the intact cells and the cell-interrupted supernatants (lanes 4 and 8),
respectively. The molecular masses (kDa) of the marker proteins (lane M) are given. The
overproduction of soluble MidC protein is indicated by arrows.
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4.19.3. Expression and detection of the MidK protein
An attempt was made to express the MidK protein from two recombinant plasmids,
pLCW3-2 and pLCW3-3. These were again transformed into E. coli BL21 (DE3)pLysS.
The expression of both corresponding clones resulted in the overproduction of large
amounts of the MidK protein. However, the protein was formed as insoluble inclusion
bodies although various experimental conditions, such as cultivating in LB medium with
or without sorbitol and betaine, or in mineral medium; also, different incubation
temperatures at 37°C, 28°C or 20°C with high or slow shaking rates, were tried, but to no
avail (data not shown).
Attempts were made to clone the midK gene into the E. coli-S. lividans shuttle expression
vector, pUWL201. The respective plasmids, pLCW3-8 and pLC3-9, were transformed into
S. lividans TK23. Unfortunately, no visible specific-expression bands were visible either
on SDS-PAGE gels from the extracts of both expressing clones or by Western blotting
detection from the extracts of TK23/pLCW3-9 (data not shown). Next, the midK gene was
cloned into the S. lividans expression vector, pIJ4123, and the resulting recombinant
plasmid pLCW3-12 was transformed into S. lividans 1326. Expression of MidK was tested
in SGYEME liquid medium at 220 r.p.m., 28°C by thiostrepton induction (see Section
3.3.13). These transformants didn’t express the MidK protein in a visible form on SDS-
PAGE gels. Therefore, Western blotting and immuno-detection were used to detect the
His-tag MidK protein. The result of the expression (Fig. 4.20) showed that soluble His-
tag-MidK protein was indeed produced by the recombinant clone, but in low quantities.
Fig. 4.20. Analysis of the expression of MidK in S.
lividans 1326 by Western blotting. For the
expression conditions see text. Western blotting and
immuno-detection see Section 3.5.4. Cell-free
extracts were obtained from S. lividans containing the
following plasmids: pIJ6021 (lane 1) and pLCW3-12
(lanes 2 and 3). The expression of MidK is indicated
by arrows.
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4.19.4. Expression and detection of the MidI protein
For the expression of the putative glycosyltransferase, MidI, two recombinant expression-
plasmids, pLCW1-23 and pLCW1-33 were constructed. These were transformed into E.
coli BL21 (DE3) pLysS and E. coli JM109 (DE3). Overproduction of the MidI protein was
observed in the intact cell extracts of both expression-clones in both E. coli host strains.
However, the products were not visible in the cell-disrupted supernatant (cell-free extracts)
(data not shown). By using Western blotting and immuno-detection, the soluble His-tag-
MidI protein was detected from the clone E. coli BL21 (DE3) pLysS/pLCW1-23 (Fig.
4.21).
Other efforts were made in order to produce the soluble MidI protein, such as testing
different media and temperatures, but all failed. The midI gene was also cloned into
pUWL201, resulting in the plasmids pLCW1-41b and pLCW1-51b, and into pIJ4123,
producing the respective plasmid pLCW1-61. These were transformed into S. lividans
TK23 and S. lividans 1326, respectively. Unfortunately, the expression of MidI was not
visible on SDS-PAGE gels in any of the recombinant clones. Further analysis by Western
blotting revealed that small quantities of the soluble MidI protein were obtained from the
cell-free extracts of S. lividans 1326/pLCW1-61, however, the expression band was much
weaker than the expression shown in lane 2 of Fig. 4.21 (data not shown).
Fig. 4.21. Analysis of the expression of MidI in E.
coli BL21 (DE3) pLysS by Western blotting. The
expression strain contains the following plasmids:
pET16b from the cell-disrupted supernatants (lane
1) and the intact cell extracts (lane 3); pLCW1-23
from the cell-disrupted supernatants (lane 2) and the
intact cell extracts (lane 4). The expression of MidI
is indicated by arrows.
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4.20. Assay for activity of a coupling reaction of the RlmB, MidH and MidC proteins
The proposed mycaminose biosynthetic pathway starts from D-glucose-1-phosphate, via
dTDP-glucose and dTDP-4-keto-6-deoxy-glucose. In course of their further conversion to
dTDP-D-mycaminose, the following two intermediates, dTDP-3-keto-6-deoxy-D-glucose
and dTDP-3-amino-6-deoxy-D-glucose, are postulated (see Fig. 1.6). In order to confirm
this hypothesis by experimental data, the over-expressed proteins, MidH and MidC,
putatively involved in the biosynthesis of mycaminose, were tested by coupled enzyme
reactions in vitro.
4.20.1. Activity assay of dTDP-D-glucose 4,6-dehydratase by RmlB
To prepare the first intermediate, dTDP-4-keto-6-deoxy-D-glucose (II), the expressed
RmlB protein (Verseck, 1997) was used to catalyse the following reaction using dTDP-D-
glucose (I) as a substrate.
The crude extract of soluble RmlB protein was obtained from the expression-clone E. coli
BL21(DE3)/pSVW701, thereby the enzymatic reaction doesn’t need NAD+ as a cofactor
since NAD+ is present in tightly bound dehydratases in E. coli (Wang & Gabriel, 1969).
The analysis of this enzyme reaction (see Section 3.5.5) was performed by HPLC. A
typical  wide  peak  appeared  at   33.37 min,   which   was  identified   as   the    converted
prodcut II, compared to a peak at 34.49 min for the substrate I (Fig. 4.22A, B). Some
small peaks came out at the early stage in Fig. 4.22B because the RmlB was extracted
directly from the expression culture without further purification.
4,6-dehydratase
    (NAD+)
dTDP-D-glucose dTDP-4-keto-6-deoxy-D-glucose
H2O(I) (II)
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Fig. 4.22. HPLC analysis of the RmlB reaction product.  (A) a peak at 34.49 min is dTDP-D-
glucose (I) as a control. (B) a peak at 33.37 min is dTDP-4-keto-6-deoxy-D-glucose (II) converted
by the crude RmlB extracts.
4.20.2. Reaction products from combined catalysis by RmlB, MidH and MidC
Two enzymes are postulated to be involved in the following reactions in the pathway of
mycaminose biosynthesis. Based on the above study, the over-expressed MidH and MidC
proteins were used to test their deduced functions as an isomerase and an
aminotransferase, respectively.
     (II)                                                            (III)                                                         (IV)
Since the intermediates II and III were produced as an unstable form, a coupling
enzymatic reaction to combine RmlB, MidH and MidC was done to detect the conversion
of the substrate I to the product IV, by using L-alanine or L-glutamic acid as an amino acid
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donor and PLP as a cofactor. The crude extracts of MidH and MidC were obtained from
the expression clones E. coli BL21(DE3)/pLCW4-2 and /pLCW2-23, respectively. The
result of HPLC assay showed that there was a specific peak at 4.6 min when compared to
all other controls. Unfortunately, because all used enzymes, RmlB, MidH and MidC, were
not purified, the high background appeared at the beginning of retention time on HPLC
(data not shown). Therefore, LC-MS was used to further analyse this new peak. It showed
a peak at m/z = 546 (M-H+) which is the expected dTDP-amino-6-deoxy-D-glucose
product, compared to a peak at m/z = 545 (M-H+)  which is the compound II and a peak at
m/z = 547 (M-H+) which is dTDP-L-rhamnose that was  produced as a by-product due to
the crude enzymes used. ESI-MS/MS spectra by single ion monitoring confirmed this
result to compare a peak at m/z = 562.8 (M-H+)  which is the substrate I (Fig. 4.23).
    Fig. 4. 23. ESI-MS/MS spectra of dTDP-D-glucose and dTDP-amino-6-deoxy-D-glucose.
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5. Discussion
Midecamycin biosynthesis proceeds via the production of a 16-atom polyketide lactone, to
which two deoxyhexose moieties are subsequently added (see Fig. 1.1). For a better
understanding and application of this process, cloning of the midecamycin biosynthetic
(mid) gene cluster was suggested as a useful tool to step-wise analyse the functions
encoded by these genes in the production of midecamycin. The individual tools delivered
by the mid gene cluster could also be used as  part of a system for combinatorial
biosynthesis, which involves the genetic manipulation of mutistep biosynthetic pathways to
create molecular diversity in natural products for use in drug discovery. The main goals of
this work, therefore, were to identify the sub-clusters for 6-deoxyhexose formation and
transfer as well as the expression and enzymological analysis of the dTDP-D-mycaminose
pathway.
5.1. The S. mycarofaciens cosmid genomic library
To quickly isolate the mid gene cluster and identify the sugar sub-clusters in it, a cosmid
genomic library was first constructed using the S. mycarofaciens chromosomal DNA and
the cosmid vector pKU206. This turned out to be a straightforward process for the
following reasons. (1) Large and expected DNA fragments were cloned in a range of 20-35
kb. (2) The recombinant cosmid clones can directly replicate both in E. coli and in S.
lividans, which could facilate gene function analysis in Streptomyces. (3) It is more stable
when the positive recombinant cosmid clones are kept in S. lividans for maintenance.
There were two major problems encountered during the manipulation of this gene library.
First, how to maintain all cosmid clones as long as possible? Three alternative methods for
storing different stages of the gene library were used in this study. They were (i) as ligation
stored at -20°C for an indefinite period; (ii) as frozen transformed E. coli  clone  mixture  at
-70°C for a few years; (iii) as frozen transformed E. coli single clones in microtiter plates
stored at -70°C for a few years (see Section 3.4.1.5 and 3.4.2.1-2). We had used the two-
year-old ligation for packaging and plating a new gene library. The efficiency of producing
DISCUSSION 93
cosmid clones turned out to be almost the same as the first gene library. The second method
was easier to handle but it implicated the amplification of the whole library during repeated
uses. The third method can keep an authentic gene library, but it requires some skill to
handle the process of storing. Secondly, cosmid clones have been noted to have a problem
of instability (Weis et al., 1987). Deletions arose if the cloned DNA contained larger
repeated sequences, especially PKS genes (Omura & Ikeda, personal communication). In
this study, E. coli JM108 was chosen as the host strain, which is recA deficient, and
transductions and transformations were performed at 30°C to minimize the potential
problems. It was also suggested that plating and screening the gene library be done
immediately, because a proportion of E. coli cells containing cosmids lose viability.
5.2. Architecture of the mid gene cluster in S. mycarofaciens
DNA sequencing of two cosmid plasmids, Smyc-LC1 and Smyc-LC3, allowed the
identification of PKS genes, lactone and sugar modification genes, resistant and regulatory
genes, and sugar biosynthetic genes, which are all necessary for midecamycin biosynthesis
(Tab. 5.1 and Tab. 5.2). Up to now, the mid gene cluster has been obtained from about 74
kb in the genome of S. mycarofaciens. The gene organisation in the midecamycin producer,
S. mycarofaciens, at the beginning seemed to be quite similar to that of the tylosin-
producing S. fradiae in the large central region. Both gene clusters demonstrate that the
large PKS genes (midG or tylG) are flanked by two regions containing genes encoding
enzymes for the biosynthetic deoxysugars, as well as resistance and regulatory enzymes
(for midecamycin biosynthesis: Hara & Hutchinson, 1990; 1992; this study; for tylosin
biosynthesis: Baltz & Seno, 1988; Birmingham et al., 1989; Zalacain & Cundliffe, 1991;
Merson-Davies et al., 1994; Gandecha et al., 1997; Bate et al., 1999; Buter et al., 1999). As
shown in Fig. 5.1, the gene order for the mycaminose biosynthetic genes and some others
for lactone ring modification and regulation was found to be conserved between both
clusters, but the transcription patterns were different in part.
However, the location of genes involved in the mycarose biosynthetic pathway turned out
to be different between the mid and tyl  (tylosin biosynthetic) gene clusters. The five genes
(tylCII,  tylCIII,  tylCIV, tylCV  and  tylCVII)  are located  downstream of  tylG.  In contrast,
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       Tab. 5.1. Summary of the genes found in Smyc-LC1
                                                                                Coding capacity
 Orf
     in Gene                   aa    Putative  Proteins with
     Fig. 4.10    function  identity score3
orf1 midM1 {388} cytochrome P450 TylI: 57%; PicK: 32%
orf2 midC 398 aminotransferase OleN2: 49%; TylB: 47%;
EryCI: 47%; DesV: 45%
orf3 midA 303 dTDP-glucose DesIII: 62%; TylAI: 61%;
synthase AveBIII: 61%; SnogJ: 56%
orf4 midB 326 dTDP-glucose TylAII: 64%; AveBII: 62%;
4,6-dehydratase Gdh: 60%; DesIV: 60%
orf5 midD 264 thioesterase TylO: 44%; PikAV: 39%;
Rif-ORF12: 43%
orf6 midE 388 4''-O-propionyl AcyB1: 51%
transferase
orf7 midF2 {228} regulator SrmR: 49%
orf8 midL1 {372} 2,3-dehydratase TylCVI: 50%; OleV: 48%;
EryBVI: 42%
                                                            Coding capacity
  Location      Temporary
 at site No.     gene name        DNA length      Putative function              Proteins with
in Fig. 4.10                            (kb)             of deduced aa seq.             identity score
1-3 mid1-4 1.8 unknown
15-16 midO 0.6 4-ketoreductase TylCIV: 50% {in 54 aa}
17-18 mid1-6rp 0.55 dehydratase OleN2: 72%; EryCIV: 67%
{in 132 aa}
17-18 mid1-6up 0.55 acyl-CoA SCI30A.22c: 44%
dehydrogenase {in 95 aa}
18-19 mid1-3up 0.6 pyruvate PdhA: 41% {in 175 aa}
dehydrogenase
18-19 mid1-3rp 0.8 unknown
(1) Partial sequence of orfs, incomplete at the 3' end.  (2) Partial sequence of orf. (3) AcyB1 from S.
thermotolerans (D31821); AveBII and AveBIII from S. avermitilis (AB032523); DesIII, DesIV and DesV
(AF079762), and PicK (AF087022) from S. venezuelae; EryCI (X155541), EryBVI (Y11199) and Gdh
(L37354) from Sac. erythraea; OleN2 and OleV from S. antibioticus (AF055579); PdhA (L31844) from
Thiobacillus ferrooxidans; Rif-ORF12 (AF040571) from Amycolatopsis mediterranei; SCI30A.22c
(AL096811) from S. coelicolor; SnogJ from S. nogalater (AF187532); SrmR from S. ambofaciens (X63451);
TylI, TylAI, TylAII, TylB and TylO (U08223), TylCIV (U77459) and TylCVI (AF210634) from S. fradiae.
Acc. no. are given in parentheses. The aa numbers in partial protein sequence are indicated in braces.
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         Tab. 5.2. Summary of the genes found in Smyc-LC3
                                                                                           Coding capacity
 Orf
  in Gene aa Putative Proteins with
Fig. 4.10 function identity score3
orf11 midG1 {133} PKS module 7?(3'-end) NidA5: 60%; TylGV: 48%
orf12 midK 249 N-methyltransferase TylMI: 60%; OleM1: 57%
DesVI: 53%; EryCVI; 51%
orf13 midH 414 3,4-isomerase TylMIII: 35%; DnrQ: 32%;
orf14 midI 421 glycosyltransferase TylMII: 59%; DesVII: 55%;
OleG2: 54%; EryCIII: 51%
orf15 midJ 448 crotonyl-CoA Ccr: 75%; SC9C7.09c: 75%
reductase
orf16 mdmB2 387 3-O-acyltransferase AcyA: 59%
orf17 midN1 {109} cytochrome P450 Car-orfP450: 56%
orf18 mirB1 {135} ABC-transporter CarA: 67%; SrmB: 63%
orf19 mdmA2 271 resistance TlrD: 54%
orf20 midR1 {140} regulator OrfY:36%; SC7H1.21:34%
orf21 mdmC2 221 O-methyltransferase Car-orfB: 51%
                                                                                        Coding capacity
  Location         Temporary
 at site No.        gene name aa                 Putative     Proteins with
in Fig. 4.10                      function     identity score
40-41 midG1 {265} PKS module7? NidA5: 55%; TylGV: 43%
55-56 mid3-19B1 {243} 3-oxoadipate enol-lactone SC3A7.07: 61%
hydrolase/4-carboxymucono-
lactone decarboxylase
56-57 mid3-19A1 {246} hypothetical protein SC3A7.08: 72% {in 124 aa}
putative exonuclease SC3A7.09: 78% {in 101 aa}
57-58 mid3-71 {250} glutamate uptake system SC4H8. 16c (GluA): 73%
ATP-binding protein {in 147 aa}
(1) Partial sequence of orfs. (2) The genes, mdmA (A60725), mdmB and mdmC (M93958) were identified
elsewhere (see Section 4.9-10). (3) AcyA, Car-orfB and Car-orfP450 (D30759), and CarA (M80346) from S.
thermotolerans; DesVI and DesVII from S. venezuelae (AF079762); DnrQ from S. peucetius (L47164);
EryCIII (Y14332) and EryCVI (U77459) from Sac. erythraea; NidA from S. caelestis (U78289); OleG2 and
OleM1 from S. antibioticus (AJ002638); OrfY from S. hygroscopicus (X86780); SC3A7.07, SC3A7.08 and
SC3A7.09 (AL031155), SC4H8.16c (AL020958), and SC9C7.09c (AL035161) from S. coelicolor; TylG
(U78289), TylMI, TylMII, TylMIII and ccr (X81885), and TlrD (X97721) from S. fradiae. Acc. no. are given
in parentheses. The aa numbers in partial protein sequence are indicated in braces.
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Fig. 5.1. Comparison of part of the gene clusters of midecamycin and tylosin. (A) The region of
upstream of PKSs (midG and tylGI). (B) The region of downstream of PKSs (midG and tylGV).
Genes are not drawn to scale. Genes having the same function from the mid and tyl clusters are
drawn by arrow bars with the same dark colour or pattern, in which uc means uncoding sequences,
and the deduced gene functions from the mid cluster were listed in Tab. 5.1 and Tab. 5.2. The white
arrow bars indicate various genes which are specific in the mid or tyl clusters, in which tyl-orf9 and
metK are not published the sequence data, tylCII encodes a 2,3-enoyl reductase, tylCIII encodes a 3-
C-methyltransferase, tylCIV encodes a 4-ketoreductase, tylCV encodes a mycarosyl transferase and
tylCVII encodes a 3,5- (or 5-) epimerase (acc. no. AF147704), and the mid genes see Tab. 5.1 and
Tab. 5.2.
a partial sequence midO (tylCIV-like) was found on the cosmid Smyc-LC1, upstream of
midG (Fig. 5.1). Analogous to tylC-gene organisation, the further genes encoding mycarose
biosynthetic enzymes are expected to locate in the region of the 4.2 kb BamHI-BglII DNA
fragment (site16-17 in Fig. 4.10), next to the midO gene. Very recently, this fragment was
partially sequenced by a Cambridge group (Leadlay, personal communication), confirming
that it contains a set of genes for mycarose biosynthesis.
As seen in Tab. 5.1, a putative dehydratase gene,  temporarily named as mid1-6rp, was
found  in the Smyc-LC1 sub-cluster at the site 17-18 of Fig. 4.10. The deduced product of
this gene showed high identities with OleN2 and EryCIV, in which EryCIV might act as a
tylGItylItylBtylAItylAIItylOtylCVItylR
midGmidMmidCmidD midAmidBmidLmidEmidF
uc
uc
midG
tylGV tylMIII tylMII tylMI ccr tlrD
midK midH midI midJ mdmC mdmB mirB mdmA midR
tylCVII tylCV tylCIII tylCII tylCIV
midN
metK
A
B
midO
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pyridoxal phosphate-dependent dehydratase to catalyse the removal of a water molecule at
C3-C4 during the biosynthesis of desosamine in Sac. erythraea (Gaisser et al., 1997), and
OleN2 might be involved in the course of transamination for the biosynthesis of the
desosamine precursor of oleandomycin in S. antibioticus. However, since the structure of
mycaminose differs from that of desosamine in that no C-4 hydroxyl elimination has to
take place, therefore, the finding of mid1-6rp gene in the mid gene cluster is currently
beyond a useful explanation.
In the sub-cluster contained on Smyc-LC3, the region (4 kb or larger) downstream of midR
was found to host genes for which the deduced polypeptide products are highly similar in
both structure and order to those of so-called house-keeping genes from the S. coelicolor
genome (see Tab. 5.2). These genes in the vicinity of the mid gene cluster might play an
important role in the primary metabolism for the synthesis of the sugar or lactone precusors
before or during midecamycin biosynthesis. Another, more likely, explanation would be
that the whole mid-cluster has been inserted into a control region of the chromosome
containing essential genes and, therefore, might be more stable than the genes at the
chromosome ends (Lin & Chen, 1997; Volff et al., 1997).
The mid gene cluster was successfully probed by two homologous genes, midB (encoding a
dTDP-glucose 4,6-dehydratase) and midI (encoding a glycosyltransferase). These two
genes were first amplified by PCR and then chosen as probes to screen the cosmid library
of S. mycarofaciens. This basic strategy was considered mainly on the basis of the
published data of the tyl gene cluster, since the two genes, tylB (as midB) and tylMII (as
midI) are located at the two sides of the PKS sub-cluster. The data obtained have confirmed
that the midB and midI genes in the mid cluster have the same order as in the tyl cluster, and
this could be understood as both antibiotics are structurally closely-related 16-membered
macrolides. This study could suggest that the midB- or tylB-like genes, and the midI- and
tylMII-like genes can now be used as further hybridization probes with much higher safety
to quickly isolate other 16-membered macrolide biosynthetic clusters. Since the dTDP-
glucose 4,6-dehydratase is a common enzyme catalysing in the biosynthetic pathways of
mycaminose, mycarose and other 6-deoxysugars, and glycosyltransferase for the macrolide
aminosugar is necessary for sugar transfer to the aglycone directly, i.e., the specific
macrolactone ring.
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5.3. Hybrid antibiotic production by heterologous complementation
Recombinant DNA techniques now make it possible to produce new antibiotic structures
by engineering the biosnythetic pathways of antibiotics. This experimental approach is
called combinatorial biosynthesis and the substances thus produced are called hybrid
antibiotics. One of the methods to reach this goal is to transform the specific genes into
heterologous host strains, express and recombine them there in new combinations.
Although there were no antibiotic activities detected when the midK and midI genes were
transformed into the Sac. erythraea mutants CIII68 and CIV89 (see Section 4.18), it is a
preliminary trial towards hybrid antibiotic production. Moreover, the finding of the mid
gene cluster and the analysis of gene functions carried out in this study have opened several
opportunities for further efforts to produce novel antibiotics. (1) Three acylation genes,
mdmB, mdmC and midE, could be used to modify the activity of macrolide antibiotics by
acylating hydroxyl groups on both lactone and sugar moieties, as was demonstrated earlier
engineering of carE from  S. thermotolerans into S. thermotolerans and S. lividans (Epp et
al., 1989). For example, if mdmB (3-O-acyltransferase), or/and midE (4"-O-
propionyltransferase) could be introduced into the tylosin-producing strain,  S.  fradiae,
which does not acylate tylosin, it is expected that the recombinants would produce 3-O-
acetyltylosin, or 4"-O-propionyltylosin or 3-O-acetyl 4"-O-propionyltylosin, respectively.
(2) The midI gene encodes a glycosyltransferase possibly responsible for transfer of
mycaminose to the midecamycin aglycone. Recently, several experiments demonstrated
remarkably relaxed specificities of other glycosyltransferases towards both their sugar and
aglycone substrates. For instance, Xue et al. (1998) found that the desVII gene could accept
both 10-deoxymethynolide, the macrolactone of the 12-membered macrolides methymycin
and neomethymycin, and narbonolide, the macrolactone of the 14-membered macrolides
narbomycin and pikromycin, as substrates to add the desosamine moiety to their aglycones
in S. venezuelae. Moreover, Borisova et al. (1999) revealed that the glycosyltransferase
(DesVII) of the desosamine biosynthetic pathway is capable of recognizing the keto sugar
intermediate, the macrolide product produced by a des mutant, to attach it to the
macrolactone of methymycin. Therefore, it is conceivable that the MidI protein as a
component of the condensing machinery in macrolide biosynthesis could further explore its
application, including carrying sets of diverse nucleotide sugars, and attaching them to
different targets, such as 14- and 16-membered macrolide aglycones, or even an already
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glycosylated macrolide. Protein engineering even could widen the specificity of MidI, or
hybrids thereof, for the acceptance of completely different aglycones and/or NDP-sugars.
5.4. Heterologous enzyme expression and combined enzymatic analysis
In order to achieve the soluble proteins of MidH, MidC, MidK and MidI, each in their
active forms, different expression systems in E. coli and S. lividans were tested and the
interpreted results are summarised in Tab. 5.3. To optimize the expression conditions,
lower temperature (28°C), and slow shaking rate (100 r.p.m.) and different media were
compared for expression of MidH, MidC, MidK and MidI in E. coli BL21(DE3)pLysS. As
a successful example the native soluble protein of MidH could be obtained when the
shaking rate was decreased from 200 r.p.m. to 100 r.p.m. during expression cultivation (cf.
Fig. 4.18A). This possibly causes change in the cytoplasmic environment for expression
and especially could reduce the rate of protein synthesis and, therefore, could facilitate its
correct folding. When the medium of LB/sorbitol/betaine was used instead of LB medium
for expression of the four proteins, the production in all cases was significantly increased
(see Tab. 5.3). This osmotic stress culture system could decrease growth rates because of
reduction of the carbon  dioxide  level,  however,  it  can facilitate the  uptake of the
'compatible  solute', glycyl betaine, which is believed to cause thermodynamically
unfavourable 'preferential hydration' if excluded from the immediate domains of proteins
and, thus minimisation of solvent-protein contact and stabilisation of protein structure
could be the result (Arakawa & Timasheff, 1985; Blackwell & Horgan, 1991). However,
the expression of MidK and MidI in E. coli resulted in strong production of inclusion
bodies under various conditions of manipulation tested. Further efforts will have to be
made to recover the active proteins of MidK and MidI in E. coli, e.g., by applying other
expression strategies, including co-expression of molecular chaperones (Martin & Hartl,
1997), using thioredoxin-deficient host strains to maintain a favorable redox potential and
facilitate disulfide bond formation in the cytoplasmic environment, and/or using soluble
polypetide products of the host as fusion partners (Makrides, 1996; Hannig & Makrides,
1998). Expression of the four proteins failed by using the pUWL201 vector and insertion at
the 3' end of the ermE up promoter in S. lividans TK23. One of the possible reasons could
be the structure of the ribosomal binding sites (RBS) of these recombinant expression-
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plasmids which were taken from that of the pET-cassette. This RBS might not be suitable
for the translation of mRNA to protein in Streptomyces.
To characterise the postulated function of MidH as an isomerase and MidC as an
aminotransferase in the pathway of mycaminose biosynthesis, a coupling enzymatic
reaction of RmlB, MidH and MidC was analysed by HPLC and followed by LC-MS. It was
confirmed that: (i) RmlB as a 4,6-dehydratase is to convert the substrate dTDP-D-glucose
to the intermediate dTDP-4-keto-6-deoxy-D-glucose (Verseck, 1997); and (ii) MidC is
indeed responsible for transamination to form dTDP-amino-6-deoxy-D-glucose (see
Section 4.20.2). But it is not clear at this point whether this transamination occurs at C-3 or
C-4 since the function of MidH was not individually elucidated. To further characterise the
specific function of MidC in the future, it is suggested that all three enzymes have to be
purified to reduce non-specific products produced. For instance, dTDP-L-rhamnose was
detected as a by-product in the reaction catalysed by the mixture of the crude extracts
containing the above three enzymes. The MidK (N-methyltransferase) protein was also
combined with RmlB, MidH and MidC to assay the reaction products. However, there was
no measurable transfer of methyl groups to the products. The possible reasons were either
because the soluble MidK protein was produced at very low levels (see Fig. 4.20), or the
protein is inactived.
Protein
         Expression plasmids
pET11a                             pET16b       
MidH
MidC
MidK
MidI
pUWL201
pIJ4123
 
++/s +++/s +++/is ++++/s
++++/s +++/s
+++/is ++++/is +++/is ++++/is
+++/is +++/is++++/is ++++/is
w/+
w/+ w/+
(native) (His-tag)
w/+
M1 M2 M1 M2
-
-
-
-
-
-
-
-
w/-
w/-
w/-
w/-
-
-
w/+
w/+
Tab. 5.3. Summary of protein expression in different expression systems
++ = protein overexpression, the production level is increased with more plus; - = no protein expression 
on SDS-PAGE gels; ++/s  or  ++/is = soluble or insoluble proteins were observed  on  SDS-PAGE gels, 
respectively; w/+ = soluble proteins were detected by Western boltting; w/- = no expected proteins were 
detected by Western boltting. M1: LB liquid medium; M2: LB with sorbitol and betaine.
(His-tag)
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5.5. Phylogenetic analysis of some enzymes involved in midecamycin biosynthesis
A detailed analysis of the phylogenetic relationships of several of the mid-encoded proteins
within the same family of proteins was carried out in order to obtain further information
about how the secondary metabolic gene clusters, especially for macrolides, have been
evolved. In Fig. 5.2, seven phylograms are re-produced in which the MidD-tree deals with
thioesterases, affecting the product accumulation in the producing strains, and the other six
trees concern proteins which are involved in de novo mycaminose biosynthetic enzymes.
Fig. 5.2. Phylogenetic trees (non-rooted) of the proteins of MidD, MidA, MidB, MidC, MidH,
MidK and MidI aligned with the protein sequences of the corresponding family. The
phylograms were calculated by the program PAUP 3.1. The numbers denote the calculated lengths
of branches; The numbers in parentheses give the percent score of nodes found in bootstrapping
(500 times). For the amino acid sequence alignments see Appendices 7.6 to 7.12. The following
sequences were used and identified by their accession numbers in parentheses. MidD-tree:
ORF12Ame:  Amycolatopsis  mediterranei (AF040571); ThiESgr: S. griseus (M93058); PikAVSve:
S. venezuelae (AF079138); TylOSfr: S. fradiae (U08223); GrsTBbr: Bacillus brevis (M29703);
SC3F7.14Sco: S. coelicolor (AL021409); TesAMtu: Mycobacterium tuberculosis (Z74697);
MLCB12.04cMle: M. leprae (AL035480); Orf1Shy: S. hygroscopicus (M64783); PchCPae:
Pseudomonas aeruginosa (X82644); Ery3Ser: Sac. erythraea (X60379); SrfADBsu: Bacillus
subtilis (X70356). MidA-tree: StrDSgr: S. griseus (X62567); OleDSan1:  S. antibioticus
(AF055579); DnrLSpe: S. peucetius (L47163); GraDSvi: S. violaceoruber  Tü22 (AJ011500);
RmlAMle: M. leprae (L78815); TylAISfr: S. fradiae (U08223); AcbAAct: Actinoplanes sp.
(Y18523); YifGEco: E. coli (U00096); RmlAEco:  E. coli (AF125322); LmbOSli:  S. lincolnensis
(X79146). MidB-tree: SCF81.08c: S. coelicolor (AL133171); StrESgr: S. griseus (X62567);
StrESgl: S. glaucescens (AJ006985); OleESan:  S. antibioticus (AF055579); GraESvi: S.
violaceoruber Tü22 (AJ011500); TylAIISfr: S. fradiae (U08223); GdhSer: Sac. erythraea
(L37354); AcbBact: Actinoplanes sp. (Y18523); AcbDSgl: S. glaucescens (Fa. Hoechst. Dt.
Patentanmeldung Nr. 19622783 [1996]); RffEEco: E. coli (M87049); RmlBEco: E. cloi
(AF125322); LmbMSli: S. lincolnensis (X79146). MidH-tree: DnrQSpe: S. peucetius (L47164);
TylMIIISfr: S. fradiae (X81885); OleP1San: S. antibioticus (AJ002638); DesVIIISve: S. venezuelae
(AF079762); SnogNSno: S. nogalater (AF187532); Pra10Ahi: Actinomadura hibisca (D87924);
MidC-tree: StsASgr: S. griseus (Y08763); StsCSgr: S. griseus (Y08763); StrSSgr: S. griseus
(Y00459); DnrJSpe: S. peucetius (M80237); TylBSfr: S. fradiae (U08223); OleN2San: S.
antibioticus (AF055579); DesVSve: S. venezuelae (AF079762); EryCISer: Sac. erythraea
(X155541); EryCIVSer: Sac. erythraea (U77459); OleN1San: S. antibioticus (unpublished data);
PerSVch: Vibrio cholerae (X59554); LamSSli: S. lincolnensis (X79146). MidK-tree: OleM1San:
S. antibioticus (AJ002638); EryCVISer: Sac. erythraea (U77459); StsGSgr: S. griseus (Y08763);
GlyMRa: glycine methyltransferase from rat (X07833); LmbJSli: S. lincolnesis (X79146). MidI-
tree: OleG1San: S. antibioticus (AJ002638); OleG2San: S. antibioticus (AJ002638); EryCIIISer:
Sac. erythraea (Y14332); TylMIISfr: S. fradiae (X81885); EryBVSer: Sac. erythraea (U77459);
TylNSfr: S. fradiae (AJ005397).
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The second thioesterase (MidD): The polypeptide product of midD was shown to be
highly identical to the second thioesterase encoded by the tylO gene in tylosin biosynthesis
of S. fradiae (Merson-Davis et al., 1994) (see Tab. 5.1), and both genes are located shortly
upstream of midG and tylG, respectively. As with other type I PKS, the enzyme catalysing
the final enlongation step (TylGV) in S. fradiae contains an integral C-terminal thioesterase
domain that is believed to be responsible for chain termination and ring closure to produce
tylactone; also, the aa sequence is highly identical to the C-terminal segment of the
midecamycin PKS, MidG (see Section 4.7). The question then arises what is the function of
MidD or TylO, these second (or free) thioesterases in macrolide biosynthesis. Bulter et al.
(1999) recently demonstrated that this free thioesterase activity of TylO is necessary  for
bulk accumulation of tylosin in S. fradiae and that at least 85% of antibiotic production is
lost when TylO is inactivated. Therefore, they proposed that the TylO protein carries out an
editing function, whereby aberrant polyketide precusors blocking the synthase complex can
be removed to allow continued synthesis of normal products. Such free thioesterase genes
also have been found in the gene clusters of other macrolide biosynthesis, such as orf5 in
Sac. erythraea (Haydock et al., 1991), pikV in S. venezuelae (Xue et al., 1998), as well as
the free thioesterase gene in Bacillus subtilis during non-ribosomal peptide biosynthesis
(Schneider & Marahiel, 1998). However, suprisingly, the results of the phylogram showed
a close correlation between several sources of organisms (MidD-tree in Fig. 5.2). This
could be explained in that either, all of the genes have had a high rate of evolution, or, the
DNA fragments have horizontally been transferred between species which probably could
reduce the enzyme specificity. In part recent horizontal gene transfer and sometimes recent
gene duplication and divergence possibly resulted in two branches, GrsTBbr and
SC3F7.14Sco, and TesAMtu and MLCB12.04cMle, respectively.
The dTDP-D-glucose synthase (MidA): This enzyme has been studied in several cases
and catalyses the activation of nucleotidyl glucoside in the biosynthetic sequence for 6-
deoxysugars. In the comparison of the aa sequences of 12 proteins in this family, the MidA-
tree in Fig. 5.2 revealed that overall there are two principal subgroups, when LmbO, with
clearly having a different function, was used as an outgroup. It is indicated in the first
group that MidA and TylAI which are the enzymes for 16-membered macrolide sugar
biosynthesis in Streptomyces, and AcbA which is the enzyme for the biosynthesis of the a–
glucosidase inhibitor acarbose in Actinoplanes, are closer to three other proteins from E.
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coli and Mycobacteria. However, MidA and TylAI are distinct from the second group, i.e.,
enzymes for the same function in the biosynthesis of 14-membered macrolides (OleD),
aminoglycosides (StrE), and anthracyclines (DnrL) in Streptomyces species. This indicates
that all of these genes, though being of common ancestry, have undergone divergence in at
least the Actinomycetes after horizontal gene migration. Therefore, the relationships seem
to be distributed non-taxonomically. In contrast to all other proteins in the MidA-tree, the
LmbO protein was proposed to use dTDP-octose instead of dTDP-glucose as substrate for
lincomycin biosynthesis in S. lincolnensis (Peschke et al., 1995; Piepersberg, personal
communication). Thus, the changed function to accept different substrate probably led to
fast evolution of the gene in the producers of lincosamids.
The dTDP-glucose 4,6-dehydratase (MidB):  This enzyme is characterised as for
conversion of dTDP-D-glucose into dTDP-4-keto-6-deoxyglucose, a common intermediate
for most 6-deoxysugars. This is a catalytically NAD+-dependent redox reaction for water
elimination (Wierenga et al., 1985; Scrutton et al., 1990). As shown in MidB-tree of Fig.
5.2, it is obvious that the enzymes in the first large group including 10 members of
Actinomycetes sequences are distinct from the second group, two enzymes from E. coli.
Multiple branches in the first group may be of recent origin or the genes have recently
evolved at different rates. As a result, the MidB, TylAII and Gdh proteins are closely-
related to each other which are all likely to be involved in macrolide biosynthesis.
However, it is important to note, (1) the gdh gene was not found within the erythromycin
gene cluster of Sac. erythraea, which lacks the dTDP-glucose 4,6-dehydratase gene, (2) the
midB gene is separated by another gene, midD, from midA, which is in contrast to the
organisation of the equivalent genes in the tyl cluster (cf. Fig. 5.1; the midBD unit might
have been inverted later after branching off from a common ancestor in which the gene
order was as in the tyl cluster, tylAI,AII,O), (3) the OleE protein is more related to those
proteins in another branch of actinomycete members, though being used in an
erythromycin-like macrolide pathway. This allows the following general conclusions: (i)
the genes for the more frequently used first- and second-step enzymes (e.g., MidA, MidB)
in dTDP-6-deoxysugar pathways are not necessarily needed as inside components (strongly
co-regulated) of the gene clusters (as are more specific genes); (ii) these genes, when
present inside the biosynthetic clusters, do not necessarily co-evolve with the cluster.
Rather they can be easily gathered from various different sources, probably by horizontal
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gene transfer in most cases; (iii) their presence and conservation of these genes are kept
under selective pressure only by the end product(s) which are formed from the pathway(s).
The differently functioning LmbM protein was used as an outgroup again in the MidB-tree
and confirmed that in the lincomycin biosynthesis, a biosynthetic unit, a-
methylthiolincosaminide (MTL), utilized a starting sugar other than D-glucose.
The 3,4-isomerase (MidH): The aa sequence comparison of midH to other proteins in the
GenBank showed that the top scores of identities to TylMIII and DnrQ are only  35% and
32%, respectively. Although these proteins showed end-to-end sequence similarity to
cytochrome P450 enzymes from a variety of organismal sources, they all lack the critical
cysteine residue which provides the characteristic ligand to the heme iron in cytochrome
P450 (Bairoch, 1992; Nelson et al., 1993). This fact suggests that they represent a new
family of proteins with unknown enzymatic mechanism though they are likely to be derived
from cytochrome P450 proteins. The MidH-tree in Fig. 5.2 revealed that these proteins
from Actinomycetes seem not to need high sequence conservation. Therefore, rapid
divergence could cover to form a new family of enzymes, probably because very few or
none of the aa-motifs needed to be conserved for the mechanism. These genes may have
had a long period of evolution and during this period they have acquired their species
specificity by rapid horizontal gene exchanges to add up to the overall picture of a family
of proteins with the low conservation level and no heme-binding motif. It is clear from the
recently reported data (Gandecha et al., 1997; Salah-Bey et al., 1998; Madduri et al., 1998)
that these proteins are 6-deoxy-hexose 3,4-isomerases involved in 3-aminosugar
biosynthesis in several gene clusters. Therefore, the still unknown mechanism of action and
the high divergence rate will have to be further analysed in order to interpret this result.
The aminotransferase (MidC): The polypeptide product of midC highly resembles the
putative aminotransferases from several deduced gene products in antibiotic biosynthesis,
so-called secondary metabolic aminotransferases (SMAT). The phylogenetic tree of 13
members of proteins in the SMAT family (MidC-tree in Fig. 5.2) demonstrated the
following. (1) The proteins MidC, TylB, EryCI, OleN2 and DesV for transamination in
macrolide biosynthesis are more closely-related than the proteins from other Streptomyces
species. In addition, the MidC and TylB proteins of 16-membered macrolides are much
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closer than the proteins of 12- or 14-membered macrolides. (2) The StsA, StsC and StsS
proteins are more similar to one another, where StsC acts as the L-glutamine:scyllo-inosose
aminotransferase to catalyse the first amino transfer in the biosynthesis of the streptidine
subunit of streptomycin, and StsA might catalyse the second step of the cyclitol
transamination reaction in S. griseus (Ahlert et al., 1997). The EryCIV and OleN1 proteins
are distinct from the proteins of the above macrolide group because they might act as
pyridoxal-phosphate-dependent dehydratases during desosamine biosynthesis in the
macrolide production as explained in Section 5.2. (3) The branch of the LmbS protein in
this phylogram was again used as an outgroup because it is a putative ketooctose
aminotransferase (Peschke et al., 1995; Piepersberg, personal communication). Taken
together, the macrolide sugar aminotransferases here behave as would be expected from a
common brand of PKS and sugar genes (in contrast to the other trees above).
The methyltransferase (MidK): The MidK protein shows significant sequence similarity
to a family of SMA-dependent N-methyltransferases from several Streptomces species. A
mini-phylogram (MidK-tree in Fig. 5.2) showed that there are two subgroups, a macrolide
group and the other group in addition to one outgroup (LmbJ). In the first group, the
relationship between MidK and OleM1 is surprisingly closer than that between EryCVI and
OleM1. The StsG protein from S. griseus is close to GlyM, a glycine methyltransferase
from rat (Ogawa et al., 1987). This reflects the common ancestry on one hand, but also the
random and non-predictable horizontal gene transfer between various organisms.
The glycosyltransferase (MidI): The MidI protein highly resembles various
glycosyltransferases that are involved in the transfer of various deoxysugars to different
aglycones during antibiotic biosynthesis. The MidI-tree (see Fig. 5.2) revealed that, as is
expected, the relationship between MidI and TylMII, which are the putative
mycaminosyltransferases, is closer than that between EryCIII and OleG2, which are
desosaminyltransferases. It is understood that the EryBV protein is distinct from the above
four proteins because it is a putative mycarosyltransferase. The OleG1 protein is
responsible for oleandrose transfer in the biosynthesis of oleandomycin in S. antibioticus
(Olano et al., 1998). However, OleG1 is closer to OleG2 and EryCIII in the MidI-tree. This
could be explained in that the oleG1 and oleG2 genes are adjacent in the oleandomycin
gene cluster of S. antibioticus, and one gene was derived from the other via recent gene
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duplication and subsequent functional divergence. The TylN protein is responsible for 6-
deoxyallose transfer in tylosin biosynthesis of S. fradiae (Wilson & Cundliffe, 1998),
therefore, it is less-closely related to the TylMII and MidI proteins.
Based on analysis of the deduced functions of the above proteins and mechanistic
considerations, the biosynthetic route to dTDP-D-mycaminose, a precursor of midecamycin
in S. mycarofaciens is proposed as given in Fig. 5.3, in which the proposed action of the
MidH protein (3,4-isomerase) is still hypothetical, since it is the only remaining essential
gene product for aminosugar biosynthesis, which could have that function.
Fig. 5.3. The proposed biosynthetic route to mycaminose and the mid-encoding proteins
deduced to catalyse the various steps.
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7. Appendices
7.1 The nucleotide and encoded amino acid sequences of the midM  region of
      Smyc-LC1
1                                       31
TTT CTC CGT GCA TCC CTC TCG CAC GTG AAC AGT GAA GTG TTC AGC ACC GGG ACG GCG AGG
61                                      91
ACA ACC GGC GAG CGG TGA ATG TGT CAG GGT GCC GGG GGC GCT GCG GCA GCC CCG GCG GTT
121                                     151
TCC CGT CCG CGG GGG CGG ACG GGG AGG TCA TTG TGT CAG GAC TCC CTT GCT GGC GAT CTT
181                                     211
GAG CGA TTC ATA GGC TCA CCG GCG TCG AGA GAC CGA AGT GCC CGC GTC GCG TGC TCG GTC
241                                     271
CGC CGT ACC ACT TCC CAA GGA GAA TGG CCG ATG TCC GAG GCT CCG ACA GTG CCA CTC GAA
                                        M   S   E   A   P   T   V   P   L   E
     MidM
301                                     331
CTC AGC AAG GAG GCG AAC GCC CAG GAA CTC CTG GGA CTG GGT TCG CCT TCA ACC GGG ACC
L   S   K   E   A   N   A   Q   E   L   L   G   L   G   S   P   S   T   G   T
361                                     391
CAT CAC CCG GTC TTC TGG GAC GAG AAT TGG GCA TGC CTG GGC AAG GTC TTC CGT TAC GAC
H   H   P   V   F   W   D   E   N   W   A   C   L   G   K   V   F   R   Y   D
421                                     451
GAC TAC CTG ACG GTC TCC AAC AAT CCG CAG TTC TTC TCC TCC GAC TTC AAC GAG GTC ATG
D   Y   L   T   V   S   N   N   P   Q   F   F   S   S   D   F   N   E   V   M
481                                     511
CCG ACC CCG CCC GAG CTG GAG AtG GTC ATC GGG CCG GGG ACC ATC GGC GCC CTC GAC CCG
P   T   P   P   E   L   E   M   V   I   G   P   G   T   I   G   A   L   D   P
541                                     571
CCC GCC CAC GGC CCG ATG CGC AAG CTG GTC AGC CAG GCC CTC ACC CCG CGG CGG ATG GCC
P   A   H   G   P   M   R   K   L   V   S   Q   A   L   T   P   R   R   M   A
601                                     631
CGT CTG GGA CCC CGC ATC CGG GCC GTC ACT CAG GGG CTC CTC GAT GCG GTG CGC GGC CAG
R   L   G   P   R   I   R   A   V   T   Q   G   L   L   D   A   V   R   G   Q
661                                     691
GAG ACC ATC GAC GTC GTC GGC GAC CTC TCC TAC GCC CTG CCC GTG ATC GTC ATC GCC GAG
E   T   I   D   V   V   G   D   L   S   Y   A   L   P   V   I   V   I   A   E
721                                     751
CTG CTG GGC ATA CCG TCC GGT GAC CGC GAT GTG TTC CGC GGG TGG GTC GAC ACC CTG CTC
L   L   G   I   P   S   G   D   R   D   V   F   R   G   W   V   D   T   L   L
781                                     811
ACC AAC GAG GGC CTG GGG TAC CCG AGC CTC CCG GAC AAC TTC AGC GAG ACG ATC GCC CCC
T   N   E   G   L   G   Y   P   S   L   P   D   N   F   S   E   T   I   A   P
841                                     871
GCC CTC AAG GAG ATG ACC GAC TAT CTC CTG CAC CAG ATT CAC GCC AAG CGC GAG GCC CCG
A   L   K   E   M   T   D   Y   L   L   H   Q   I   H   A   K   R   E   A   P
901                                     931
GTC GAC GAC CTG ATC TGC GGC CTG GTC CAG GCC GAG CAG GAC GGC CGC AAG CTC ACC GAC
V   D   D   L   I   C   G   L   V   Q   A   E   Q   D   G   R   K   L   T   D
961                                     991
GTG GAG ATC GTC AAC ATC GTG GCC CTG CTG CTC ACC GCC GGG CAC GTC TCG TCA AGC ACG
V   E   I   V   N   I   V   A   L   L   L   T   A   G   H   V   S   S   S   T
1021                                    1051
CTG CTC AGC AAC CTC TCC CTG GTA CTG GAG GAG AAC CCG CAG GCG CTG GCG GAC CTG CGC
L   L   S   N   L   S   L   V   L   E   E   N   P   Q   A   L   A   D   L   R
1081                                    1111
GCC GAC CGC GAG CTG GTG ACC GGT GCG GTG GAG GAG ACA CTG CGC TAC CGC AGC CCC TTC
A   D   R   E   L   V   T   G   A   V   E   E   T   L   R   Y   R   S   P   F
1141                                    1171
AAC AAC ATC TTC CGC TTC CTC AAG GAG GAC ACC GAC ATC CTC GGC CCG GAA ATG AAG AAG
N   N   I   F   R   F   L   K   E   D   T   D   I   L   G   P   E   M   K   K
1201                                    1231
GGC CAG ATG GTC ATC GCC TGG AGC CAG TCG GCC AAC CGC GAC CCC GAA CAC TTC CCG GAG
G   Q   M   V   I   A   W   S   Q   S   A   N   R   D   P   E   H   F   P   E
1261                                    1291
CCC GAC ACC TTC GAC ATC CGA CGC TCA AGC AGC TCC CGC CAT ATG GCG TTC GGC ATC GGT
P   D   T   F   D   I   R   R   S   S   S   S   R   H   M   A   F   G   I   G
1321                                    1351
ATT CAC CAC TGC CTG GGC GCC TTC CTG GCA CGT CAG GAA GGC AAG GTG GTA CTG GAA CTG
I   H   H   C   L   G   A   F   L   A   R   Q   E   G   K   V   V   L   E   L
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1381                                    1411
ATG CTG GAT CAG GTC AGG GAA TTC GAG CTC GGT ACC CGG GAT CCT CTA GAG TCG AC*
M   L   D   Q   V   R   E   F   E   L   G   T   R   D   P   L   E   S
* The sequence is not complete at the 3´end.
7.2. The nucleotide and encoded amino acid sequences of the midCA  region
       of Smyc-LC1
1                                       31
GGC CCA ATG GTT TTG CCG AGT GCT CAA GGA ATT CGC ACC GGA ATC GTT CGC CCT TAG TCC
61                                      91
TTC GCT CGC GGC ATA CGA GGA GTC CGA TTA TTA CCG CGA CTA CGA CAC ATT CCT GCG CGA
121                                     151
CGC ATG GAG CAT AAA GTG AAC GTG CCC TTT CCT CGA CGC GGG TGC GGC TAT CGG GAG CTG
    M   E   H   K   V   N   V   P   F   P   R   R   G   C   G   Y   R   E   L
    MidC
181                                     211
CGG GCC GAC ATC GAC GGG GCC CTT CGG CGG GTG TCC GCC TCC GGA CGC TAT CTG CTG GGT
R   A   D   I   D   G   A   L   R   R   V   S   A   S   G   R   Y   L   L   G
241                                     271
GCG GAA CTG GCG GGG TTC GAG GCG GAA TTC GCC GCG TAC TGC GAC AAC GAC TGC GTG GCG
A   E   L   A   G   F   E   A   E   F   A   A   Y   C   D   N   D   C   V   A
301                                     331
GTC GGC AGC GGC TGC GAC GCC CTG GAG CTG GTG CGC GCG CTC GGC ATC GGC CCC GGT GAC
V   G   S   G   C   D   A   L   E   L   V   R   A   L   G   I   G   P   G   D
361                                     391
GAG GTG GTG GTG CCC GCG CAC ACC TTC ATC GGC ACC TGG CTG GCG GTG TCC GCC GCC GGG
E   V   V   V   P   A   H   T   F   I   G   T   W   L   A   V   S   A   A   G
421                                     451
GCC CGG CCG GTG GGT GTC GAC CCG ACG CCG GAC GGG CTG TCC ATG GAC CCG GCG CAG GTG
A   R   P   V   G   V   D   P   T   P   D   G   L   S   M   D   P   A   Q   V
481                                     511
GAG GCG GCG ATC ACT CCC CGG ACC AGG GCC GTG ATG CCG GTG CAT CTG TAC GGG CAT CCG
E   A   A   I   T   P   R   T   R   A   V   M   P   V   H   L   Y   G   H   P
541                                     571
GCC GAT CTG GAC CCG CTT CTG GCG ATC GCC GAA CGG CAC GGC CTG GCC GTG GTG GAG GAC
A   D   L   D   P   L   L   A   I   A   E   R   H   G   L   A   V   V   E   D
601                                     631
GCC GAG CAG GCG CAC GGC GCC CGC TAC CGG GGC CGC CGG ATC GGC TCG GGC CAT GTG GTC  MidC
A   E   Q   A   H   G   A   R   Y   R   G   R   R   I   G   S   G   H   V   V
661                                     691
GCG TTC AGC TTC TAC CCC GGC AAG AAC CTC GGC GCC ATG GGA GAC GGC GGG GCG GTG GTC
A   F   S   F   Y   P   G   K   N   L   G   A   M   G   D   G   G   A   V   V
721                                     751
ACC GGC GAC GCC GCC CTG GCC GAC CGG ATC CGG CTG CTG CGC AAA TGC GGC TCC CGT GAG
T   G   D   A   A   L   A   D   R   I   R   L   L   R   K   C   G   S   R   E
781                                     811
AAG TAC CGG CAC GAG GTA CAG GCC ACC AAC TCG CGG CTC GAC GAG TTC CAG GCC GCC GTG
K   Y   R   H   E   V   Q   A   T   N   S   R   L   D   E   F   Q   A   A   V
841                                     871
CTG CGC GCC AAG CTG CCA CGG GTG CCG GCC TGG AAC GCC CTC CGA GTG CGC ACG GCC GAG
L   R   A   K   L   P   R   V   P   A   W   N   A   L   R   V   R   T   A   E
901                                     931
CGC TAC AGC CAG GTC TTG GGT GCC CTC CCG CAG ATT GCC GTC CCC GCC GCC GCC CCC TGG
R   Y   S   Q   V   L   G   A   L   P   Q   I   A   V   P   A   A   A   P   W
961                                     991
GCC GAT CCG GTG TGG CAC CTT TAT GTG ATC CTG CGC GCG AAC CGC GAC GAA CTG CGC CGC
A   D   P   V   W   H   L   Y   V   I   L   R   A   N   R   D   E   L   R   R
1021                                    1051
CGA ATC GAA CGG GCC GGG GTG GAG ACC CTG ATC CAC TAC CCC GTA CCG CCC CAC CGG ACC
R   I   E   R   A   G   V   E   T   L   I   H   Y   P   V   P   P   H   R   T
1081                                    1111
CCG GCC TAC GCC GAC GAT TCC GGC CGG CGC TCC GGC CGC ACC CAC CCG CTC AGC GAA CGC
P   A   Y   A   D   D   S   G   R   R   S   G   R   T   H   P   L   S   E   R
1141                                    1171
CGT GCG GCG GAG AGC CTC AGC CTT CCC TCG GGC CCC CAC CTC GGG GAC GAC GCG TTC CAG
R   A   A   E   S   L   S   L   P   S   G   P   H   L   G   D   D   A   F   Q
1201                                    1231
ACC GTC GTA GCG GCG GTC CGC GCG GCG GCC GTA GGA CTG CCG GCG TAT CCG GCG CCG GAC
T   V   V   A   A   V   R   A   A   A   V   G   L   P   A   Y   P   A   P   D
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1261                                    1291
GAC ACG GAG CGC GCG ACG CCG GGC GGC CAC CGT CTT CCT CTA TCG ACG GAG ATA CGA TGA
D   T   E   R   A   T   P   G   G   H   R   L   P   L   S   T   E   I   R   *
                                                                          M   T
                                                                          MidA
1321                                    1351
CCG AGA CCA TAT CGG GGT GTC CCG GAA TGA AGG GAA TCA TCC TCG CCG GTG GCG GTG GCA
  E   T   I   S   G   C   P   G   M   K   G   I   I   L   A   G   G   G   G   T
1381                                    1411
CCC GCC TGC GCC CCC TGA CCG GGA CGC TGT CCA AGC AGC TGC TCC CGG TCT ACA ACA AGC
  R   L   R   P   L   T   G   T   L   S   K   Q   L   L   P   V   Y   N   K   P
1441                                    1471
CGA TGA TCT ACT ACC CGC TGT CCG TGC TGA TGC TGG GCG GCA TCA ACG AGA TCC TCA TTA
  M   I   Y   Y   P   L   S   V   L   M   L   G   G   I   N   E   I   L   I   I
1501                                    1531
TCT CCA CGC CGG ACC ATA TCC TTG AGC AGT TCA GCG GCT GCT GGC GAC GGG TCC GGC TCG
  S   T   P   D   H   I   L   E   Q   F   S   G   C   W   R   R   V   R   L   G
1561                                    1591
GCC TCG ACA TCA CGT ACG CGG AGA GCC CGA GCC CCA GGG GCA TCG CCC AGG CCC TCA CCA
  L   D   I   T   Y   A   E   S   P   S   P   R   G   I   A   Q   A   L   T   I
1621                                    1651
TCG GCT CGG ACC ACA TCG GCA ACT CCC CGG TGG CGC TGA TCC TGG GCG ACA ACA TCT TCC
  G   S   D   H   I   G   N   S   P   V   A   L   I   L   G   D   N   I   F   H
1681                                    1711
ACG GCC CCG GGT TCT CCT CCG TGC TCC AGG GCA GCA TCC GCC ACC TTG ACG GCT GTG TGC  MidA
  G   P   G   F   S   S   V   L   Q   G   S   I   R   H   L   D   G   C   V   L
1741                                    1771
TGT TCG GCT ATC CGG TGA GCG ATC CAG GGC GCT ACG GCG TCG GGG AGA TCG ACC GGG ACG
  F   G   Y   P   V   S   D   P   G   R   Y   G   V   G   E   I   D   R   D   G
1801                                    1831
GGC TGC TGC TCT CCC TGG AGG AGA AGC CCG TTC GTC CCC GCT CCA ACC TGG CCG TCA CCG
  L   L   L   S   L   E   E   K   P   V   R   P   R   S   N   L   A   V   T   G
1861                                    1891
GGC TGT ACC TCT ACG ACA ACG ACG TCG TCG ACA TCG CCA AGA ACA TCA GGC CGT CCG CAC
  L   Y   L   Y   D   N   D   V   V   D   I   A   K   N   I   R   P   S   A   R
1921                                    1951
GCG GTG AGT TGG AGA TCA CCG ACG TCA ACA AGG TCT ATC TGG AGC AGC GAC GCG CCC GGT
  G   E   L   E   I   T   D   V   N   K   V   Y   L   E   Q   R   R   A   R   L
1981                                    2011
TGA TCG AGC TGG GTC ACG GCT TCG CCT GGC TGG ACA TGG GTA CCC ACG ACT CGC TGC TCC
  I   E   L   G   H   G   F   A   W   L   D   M   G   T   H   D   S   L   L   Q
2041                                    2071
AGG CCA GCC AGT ACG TCC AAC TGC TGG AGC AGC GCC AGG GGG TGC GGA TCG CCT GCG TCG
  A   S   Q   Y   V   Q   L   L   E   Q   R   Q   G   V   R   I   A   C   V   E
2101                                    2131
AGG AGA TCG CCC TGC GGA TGG GGT TCA TCA ACG CCG ACG AGC TGT ATC TGC TCG GCT GCG
  E   I   A   L   R   M   G   F   I   N   A   D   E   L   Y   L   L   G   C   E
2161                                    2191
AGC TGG GCA ACT CGG GCT ACG GCT CCT ACC TGA TGG AGG tGg CTT CCC ATG CCG GCG CTG
  L   G   N   S   G   Y   G   S   Y   L   M   E   V   A   S   H   A   G   A   A
2221                                    2251
CCT GAG ACG GAA CCG TGG ACC AAC ACC CGG GGC ATC ATC CGG GGA CCG CTG CGG ATT CCC
  *
2281                                    2311
GGT ACC GAT CTC CGG TAC CCG GGG ATC CTC CTA G
APPENDICES 125
7.3. The nucleotide and encoded amino acid sequences of the midDBL region
       of Smyc-LC1
1                                       31
CTG CAG GCG GTC GGC GTA GTC GGC CTC GGC GAC GGA CCC CGG TTC AGG CCG CAT GGC TCC
GAC GTC CGC CAG CCG CAT CAG CCG GAG CCG CTG CCT GGG GCC AAG TCC GGC GTA CCG AGG
                                                         *   A   A   H   S   G
61                                      91
CCC TGG CGC CCG CGG GGA GCA GCG GTG CGA GGG TGT CCA TGA GGG CCC CGC ACA CCT CTG
GGG ACC GCG GGC GCC CCT CGT CGC CAC GCT CCC ACA GGT ACT CCC GGG GCG TGT GGA GAC
 R   A   G   A   P   L   L   P   A   L   T   D   M   L   A   G   C   V   E   A
121                                     151
CGA CCT GCT GGT AGA GGA AGA AGT GGC CGC CGG GGA AGG TCC GCA CCT GGG CGC CGG CCT
GCT GGA CGA CCA TCT CCT TCT TCA CCG GCG GCC CCT TCC AGG CGT GGA CCC GCG GCC GGA
 V   Q   Q   Y   L   F   F   H   G   G   P   F   T   R   V   Q   A   G   A   E
181                                     211
CCG CGA CGG CCT GCC ATG CCG CTG CCT CGG TCG CCG TGA CGT TGG GGT CGT CGG CGC CGG
GGC GCT GCC GGA CGG TAC GGC GAC GGA GCC AGC GGC ACT GCA ACC CCA GCA GCC GCG GCC
 A   V   A   Q   W   A   A   A   E   T   A   T   V   N   P   D   D   A   G   T
241                                     271
TGA ACA CGG TGA GCG CGG AGG CCA GCG GCG CCC CGG GCG GGT GGG TGT AGG TCC CCA CGG
ACT TGT GCC ACT CGC GCC TCC GGT CGC CGC GGG GCC CGC CCA CCC ACA TCC AGG GGT GCC
 F   V   T   L   A   S   A   L   P   A   G   P   P   H   T   Y   T   G   V   A
301                                     331
CCC GGT AGT CGT TGC GGA TCG CGG GCA GCA CCA TCT GCA GCA GCT CGG GGT CGT TGA GCA
GGG CCA TCA GCA ACG CCT AGC GCC CGT CGT GGT AGA CGT CGT CGA GCC CCA GCA ACT CGT
 R   Y   D   N   R   I   A   P   L   V   M   Q   L   L   E   P   D   N   L   L
361                                     391
GAC TCT CGT CGG TGC CTT CGA GCG AGC GGA GCT CAG CCA GCA GCC GGT CGT CGT CAT AGA
CTG AGA GCA GCC ACG GAA GCT CGC TCG CCT CGA GTC GGT CGT CGG CCA GCA GCA GTA TCT
 S   E   D   T   G   E   L   S   R   L   E   A   L   L   R   D   D   D   Y   L
421                                     451
GGT GCA CGG TCA TCG GAC GGT TCA CGA TGG GGG CCC GGC GGC CGG AGA CCA CCA ATC CGG  MidD
CCA CGT GCC AGT AGC CTG CCA AGT GCT ACC CCC GGG CCG CCG GCC TCT GGT GGT TAG GCC
 H   V   T   M   P   R   N   V   I   P   A   R   R   G   S   V   V   L   G   A
481                                     511
CCG GCG CCG CCC CCC GCT GCT GGA GCA CGC GGG CGA CCT CGT AGG CCA CGG TGG CGC CCA
GGC CGC GGC GGG GGG CGA CGA CCT CGT GCG CCC GCT GGA GCA TCC GGT GCC ACC GCG GGT
 P   A   A   G   R   Q   Q   L   V   R   A   V   E   Y   A   V   T   A   G   M
541                                     571
TGC TGT GCC CGA AGA GCA CCA GGG GCC GGT CGG AGT GCG TCG CCA GCA CCT CGG CCA GGG
ACG ACA CGG GCT TCT CGT GGT CCC CGG CCA GCC TCA CGC AGC GGT CGT GGA GCC GGT CCC
 S   H   G   F   L   V   L   P   R   D   S   H   T   A   L   V   E   A   L   P
601                                     631
GCT CGA CCA GGC CCT CGA TGG TCC CGA TCA GCG GCT CGC CGC GGC GGT CCT GGC GGC CGG
CGA GCT GGT CCG GGA GCT ACC AGG GCT AGT CGC CGA GCG GCG CCG CCA GGA CCG CCG GCC
 E   V   L   G   E   I   T   G   I   L   P   E   G   R   R   D   Q   R   G   P
661                                     691
GGT ACT GGA CGG CCA GCA TCT CGA CCT GGT CGG GCA GCG TCT GGA CGA ACG GCA GGA AGG
CCA TGA CCT GCC GGT CGT AGA GCT GGA CCA GCC CGT CGC AGA CCT GCT TGC CGT CCT TCC
 Y   Q   V   A   L   M   E   V   Q   D   P   L   T   Q   V   F   P   L   F   S
721                                     751
ACG TGG CCG AGC CGC CGG CGT GCG GGA AGC AGA CCA GCC GCA CCG CAG GGG CCG GCC GGG
TGC ACC GGC TCG GCG GCC GCA CGC CCT TCG TCT GGT CGG CGT GGC GTC CCC GGC CGG CCC
 T   A   S   G   G   A   H   P   F   C   V   L   R   V   A   P   A   P   R   A
781                                     811
CCG GTA ACC GGC GCA GCA CAA GGT CGC TCA GGA GGC GCG GAT CTG TCG ATG CGG ACA CGA
GGC CAT TGG CCG CGT CGT GTT CCA GCG AGT CCT CCG CGC CTA GAC AGC TAC GCC TGT GCT
 P   L   R   R   L   V   L   D   S   L   L   R   P   D   T   S   A   S   M
                                                                      MidD   
841                                     871
AGG TTC ATC GTC CTT TCT TGA GGG GCT TCC ACC ACG CGC GGT TCT CGC GAT ACC AGC GCA
TCC AAG TAG CAG GAA AGA ACT CCC CGA AGG TGG TGC GCG CCA AGA GCG CTA TGG TCG CGT
 T   *   R   G   K   K   L   P   K   W   W   A   R   N   E   R   Y   W   R   V
901                                     931
CGG TCT CCG CCA GTC CCT CGT CGA TAC CGA TCC GCG GCG CAT AGC CCA GCT CAT TGG CGA
GCC AGA GGC GGT CAG GGA GCA GCT ATG GCT AGG CGC CGC GTA TCG GGT CGA GTA ACC GCT
 T   E   A   L   G   E   D   I   G   I   R   P   A   Y   G   L   E   N   A   I   MidB
961                                     991
TCT TGG CGT AGT CGA CGG AGT AGC GGC GGT CGT GGC CCT TGC GGT CCG GTA CCT CCC GCA
AGA ACC GCA TCA GCT GCC TCA TCG CCG CCA GCA CCG GGA ACG CCA GGC CAT GGA GGG CGT
 K   A   Y   D   V   S   Y   R   R   D   H   G   K   R   D   P   V   E   R   V
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1021                                    1051
CCG CCG ACC AGT CGG TTC GCA CAG CTT CAG CAG GGC GTT CGG TGA GCT CGG TGT TGG TCA
GGC GGC TGG TCA GCC AAG CGT GTC GAA GTC GTC CCG CAA GCC ACT CGA GCC ACA ACC AGT
 A   S   W   D   T   R   V   A   E   A   P   R   E   T   L   E   T   N   T   L
1081                                    1111
GTT CGG TGC CGC CGC CGA TGT TGT AGA CCT TCG CCG GGC GGC CGC CCC GGG CCA CCA GGG
CAA GCC ACG GCG GCG GCT ACA ACA TCT GGA AGC GGC CCG CCG GCG GGG CCC GGT GGT CCC
 E   T   G   G   G   I   N   Y   V   K   A   P   R   G   G   R   A   V   L   A
1141                                    1171
CGA TGC CCC GGC AGT GGT CGT CCA CGT GCA GCC AGT CGC GCC GGT TGC CGC CGT CGC CGT
GCT ACG GGG CCG TCA CCA GCA GGT GCA CGT CGG TCA GCG CGG CCA ACG GCG GCA GCG GCA
 I   G   R   C   H   D   D   V   H   L   W   D   R   R   N   G   G   D   G   Y
1201                                    1231
AGA GCG GGA CGG CCG CCC CGT CAA GCA GAT TGC TGA CGA ACA GCG GAA TGA TCT TCT CCG
TCT CGC CCT GCC GGC GGG GCA GTT CGT CTA ACG ACT GCT TGT CGC CTT ACT AGA AGA GGC
 L   P   V   A   A   G   D   L   L   N   S   V   F   L   P   I   I   K   E   P
1261                                    1291
GGT ACT GGT ACG GGC CGT AGT TGT TGG AGC AGC GGG TGA CGC ACA CCG GCA GCC CGT GTG
CCA TGA CCA TGC CCG GCA TCA ACA ACC TCG TCG CCC ACT GCG TGT GGC CGT CGG GCA CAC
 Y   Q   Y   P   G   Y   N   N   S   C   R   T   V   C   V   P   L   G   H   T
1321                                    1351
TCC GGT GGA AGG CCA GCG CCA GCT GGT CGG AGG CCG CCT TGG AGG CGG CGT AGG GGG AGT
AGG CCA CCT TCC GGT CGC GGT CGA CCA GCC TCC GGC GGA ACC TCC GCC GCA TCC CCC TCA
 R   H   F   A   L   A   L   Q   D   S   A   A   K   S   A   A   Y   P   S   N
1381                                    1411
TGG GGC TCA GCG GGT GGT CCT CAG ACC ACG ACC CTT CCG GAA TCG AGC CGT ACA CCT CGT  MidB
ACC CCG AGT CGC CCA CCA GGA GTC TGG TGC TGG GAA GGC CTT AGC TCG GCA TGT GGA GCA
 P   S   L   P   H   D   E   S   W   S   G   E   P   I   S   G   Y   V   E   D
1441                                    1471
CCG TGG AGA CAT GCA CGA ACC GGC CCG GGC GCA CGG CCA GCG CCT CCC GGA GGA GGA CGT
GGC ACC TCT GTA CGT GCT TGG CCG GGC CCG CGT GCC GGT CGC GGA GGG CCT CCT CCT GCA
 T   S   V   H   V   F   R   G   P   R   V   A   L   A   E   R   L   L   V   H
1501                                    1531
GGG TGC CCA GCA CAT TGG TGC GCA CGA AGG CGT CCG CGT CGT CGA TCG ACC GGT CCA CAT
CCC ACG GGT CGT GTA ACC ACG CGT GCT TCC GCA GGC GCA GCA GCT AGC TGG CCA GGT GTA
 T   G   L   V   N   T   R   V   F   A   D   A   D   D   I   S   R   D   V   H
1561                                    1591
GCG ACT CGG CCG CGA AGT GCA CCA CCA GAT CGG CGC CCG CCA TGG CAA GGG CGA CGG TGC
CGC TGA GCC GGC GCT TCA CGT GGT GGT CTA GCC GCG GGC GGT ACC GTT CCC GCT GCC ACG
 S   E   A   A   F   H   V   V   L   D   A   G   A   M   A   L   A   V   T   S
1621                                    1651
TGC GGT CGC AGA TGT CCC ACG CAA CGA CCC TCA GCC CCC CAC AGT CGC CCA CCG GCG CCA
ACG CCA GCG TCT ACA GGG TGC GTT GCT GGG AGT CGG GGG GTG TCA GCG GGT GGC CGC GGT
 R   D   C   I   D   W   A   V   V   R   L   G   G   C   D   G   V   P   A   L
1681                                    1711
GAT TGG CCA GGT TGC CCG CGT AGG TAA GCG CGT CCA GCA CCA CCA CCT CGG GCT TGC CGA
CTA ACC GGT CCA ACG GGC GCA TCC ATT CGC GCA GGT CGT GGT GGT GGA GCC CGA ACG GCT
 N   A   L   N   G   A   Y   T   L   A   D   L   V   V   V   E   P   K   G   F
1741                                    1771
ACT CCG GCA GCG AGC CGT TCA GCA GGG CGT TCA CAA AGC GTG AGC CGA TGA AGC CGG CCC
TGA GGC CGT CGC TCG GCA AGT CGT CCC GCA AGT GTT TCG CAC TCG GCT ACT TCG GCC GGG
 E   P   L   S   G   N   L   L   A   N   V   F   R   S   G   I   F   G   A   G
                              MidL
1801                          M   P   A   G   G   G   P   C   E   D   G   T   G
CTC CGG TGA CCA GGA TCC TCT GCA TGC CTG CAG GCG GTG GTC CTT GCG AAG ACG GCA CCG
GAG GCC ACT GGT CCT AGG AGA CGT ACG GAC GTC CGC CAC CAG GAA CGC TTC TGC CGT GGC
 G   T   V   L   I   R   Q   M
                          MidB
1861                                    1891
  N   L   R   H   E   T   G   R   F   F   S   V   E   G   L   R   T   S   S   D
GCA ATC TGC GCC ACG AGA CGG GTC GCT TCT TCT CCG TCG AAG GTC TGC GTA CCA GCT CCG
CGT TAG ACG CGG TGC TCT GCC CAG CGA AGA AGA GGC AGC TTC CAG ACG CAT GGT CGA GGC
1921                                    1951
  L   D   P   V   D   R   I   Q   P   I   I   V   Q   P   E   V   G   L   L   G
ACC TCG ACC CCG TCG ACC GCA TCC AGC CGA TCA TCG TGC AGC CCG AAG TGG GGC TGC TGG     MidL
TGG AGC TGG GGC AGC TGG CGT AGG TCG GCT AGT AGC ACG TCG GGC TTC ACC CCG ACG ACC
1981                                    2011
  I   L   A   R   E   F   D   G   V   L   H   F   L   M   Q   A   K   P   E   P
GCA TCC TGG CGC GCG AGT TCG ACG GGG TGT TGC ACT TTC TGA TGC AGG CGA AGC CGG AAC
CGT AGG ACC GCG CGC TCA AGC TGC CCC ACA ACG TGA AAG ACT ACG TCC GCT TCG GCC TTG
2041                                    2071
  G   N   V   N   G   L   Q   L   S   P   T   V   Q   A   T   R   S   N   F   D
CCG GCA ACG TCA ACG GGC TCC AGC TCT CCC CTA CGG TGC AGG CCA CCC GCA GCA ACT TCG
GGC CGT TGC AGT TGC CCG AGG TCG AGA GGG GAT GCC ACG TCC GGT GGG CGT CGT TGA AGC
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2101                                    2131
  E   V   H   R   G   R   S   T   P   F   L   D   R   F   I   Q   R   P   G   R
ACG AGG TGC ATC GCG GCC GCT CGA CGC CGT TCC TGG ACC GCT TCA TCC AGC GAC CGG GGC
TGC TCC ACG TAG CGC CGG CGA GCT GCG GCA AGG ACC TGG CGA AGT AGG TCG CTG GCC CCG
2161                                    2191
  R   V   L   V   D   A   I   Q   S   E   Q   A   D   W   F   L   H   K   R   N
GCC GGG TGC TGG TCG ATG CCA TTC AGT CGG AGC AAG CCG ACT GGT TCC TGC ACA AAC GCA
CGG CCC ACG ACC AGC TAC GGT AAG TCA GCC TCG TTC GGC TGA CCA AGG ACG TGT TTG CGT
2221                                    2251
  R   N   M   V   V   E   I   D   S   G   V   A   E   H   C   S   F   R   W   L
ACC GCA ACA TGG TCG TCG AGA TCG ACT CGG GCG TGG CGG AGC ACT GCT CGT TCC GCT GGC
TGG CGT TGT ACC AGC AGC TCT AGC TGA GCC CGC ACC GCC TCG TGA CGA GCA AGG CGA CCG
2281                                    2311
  T   L   G   Q   I   R   R   L   L   L   R   D   D   L   V   N   M   D   T   R
TGA CGC TCG GCC AGA TCC GTC GCC TGC TGC TCC GGG ACG ACC TCG TCA ATA TGG ACA CCC
ACT GCG AGC CGG TCT AGG CAG CGG ACG ACG AGG CCC TGC TGG AGC AGT TAT ACC TGT GGG
2341                                    2371
  S   V   L   A   C   L   P   N   C   A   R   R   T   R   R   R   R   R   R   F
GCA GCG TGC TGG CCT GCC TGC CGA ACT GCG CAC GGC GCA CCC GGC GAC GAC GAC GAA GGT
CGT CGC ACG ACC GGA CGG ACG GCT TGA CGC GTG CCG CGT GGG CCG CTG CTG CTG CTT CCA
2401                                    2431
  P   A   A   L   R   R   S   F   Y   G   E   T   E   L   N   A   I   T   G   C
TCC CGG CGG CGC TGA GGC GCT CCT TCT ACG GGG AGA CCG AGC TCA ACG CGA TCA CCG GCT
AGG GCC GCC GCG ACT CCG CGA GGA AGA TGC CCC TCT GGC TCG AGT TGC GCT AGT GGC CGA
2461                                    2491
  L   I   D   V   Q   A   L   R   V   L   R   Q   Q   K   V   P   L   N   Q   V
GTC TCA TCG ACG TCC AGG CGC TGC GTG TGC TGC GCC AGC AGA AGG TCC CGC TCA ACC AGG
CAG AGT AGC TGC AGG TCC GCG ACG CAC ACG ACG CGG TCG TCT TCC AGG GCG AGT TGG TCC  MidL
2521                                    2551
  Y   E   D   G   W   Q   R   I   G   A   T   I   R   H   R   S   G   E   G   L
TGT ACG AGG ACG GCT GGC AAC GGA TCG GGG CCA CCA TCC GGC ACC GCA GCG GCG AGG GCT
ACA TGC TCC TGC CGA CCG TTG CCT AGC CCC GGT GGT AGG CCG TGG CGT CGC CGC TCC CGA
2581                                    2611
  P   I   M   A   V   E   V   T   A   E   Q   R   E   V   A   S   W   T   Q   P
TGC CCA TCA TGG CGG TCG AGG TCA CCG CGG AGC AGC GCG AGG TGG CGT CCT GGA CCC AGC
ACG GGT AGT ACC GCC AGC TCC AGT GGC GCC TCG TCG CGC TCC ACC GCA GGA CCT GGG TCG
2641                                    2671
  L   L   A   P   V   S   Q   G   L   M   A   L   V   V   R   R   I   N   G   A
CGC TGC TGG CGC CCG TGT CCC AGG GGC TGA TGG CCC TGG TCG TCC GGC GGA TCA ACG GGG
GCG ACG ACC GCG GGC ACA GGG TCC CCG ACT ACC GGG ACC AGC AGG CCG CCT AGT TGC CCC
2701                                    2731
  L   H   A   L   V   A   A   R   S   D   V   G   T   L   N   F   A   E   F   G
CGT TGC ACG CCC TGG TGG CGG CCC GGT CGG ACG TGG GCA CGC TGA ACT TCG CCG AGT TCG
GCA ACG TGC GGG ACC ACC GCC GGG CCA GCC TGC ACC CGT GCG ACT TGA AGC GGC TCA AGC
2761                                    2791
  P   T   V   Q   L   R   S   A   W   P   R   G   K   G   N   P   P   P   Y   L
GCC CCA CCG TGC AGC TCA GGT CGG CGT GGC CGC GCG GCA AGG GCA ACC CGC CGC CGT ATC
CGG GGT GGC ACG TCG AGT CCA GCC GCA CCG GCG CGC CGT TCC CGT TGG GCG GCG GCA TAG
2821                                    2851
  E   Y   V   Q   S   A   A   P   G   R   V   R   Y   D   A   V   A   L   V   R
TAG AGT ACG TGC AGT CCG CTG CTC CGG GCC GCG TAC GGT ACG ACG CGG TGG CTC TCG TAA
ATC TCA TGC ACG TCA GGC GAC GAG GCC CGG CGC ATG CCA TGC TGC GCC ACC GAG AGC ATT
2881                                    2911
  G   W   A   L   L   S   T   R   A   T   G   S   Q   V   V   E   A   G   P   *
GAG GGT GGG CGC TTC TAT CCA CGC GCG CAA CCG GGT CAC AGG TCG TCG AGG CCG GCC CTT
CTC CCA CCC GCG AAG ATA GGT GCG CGC GTT GGC CCA GTG TCC AGC AGC TCC GGC CGG GAA
2941
  L   P   G   G   L   P   A   R   L
AAC TTC CCG GTG GAC TTC CCG CCC GGC TT*
TTG AAG GGC CAC CTG AAG GGC GGG CCG AA
     * The sequence of midL is not complete at the 3’ end.
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7.4. The nucleotide and encoded amino acid sequences of the midE  region
       of Smyc-LC1
1                                       31
GGC GGC CGG CAG CGC ACC CGT ACC TGA TGG CCA ACT CAC CTG TAC GGA CCG CTG GTT GGT
61                                      91
GTC GGG ACA CCT CAT CGA ATG GCG CTA CGG AAC GAC GCC GCT ACG TCC GGT GAT TGC GAA
121                                     151
ATC CAT TCT TCC TGA CGT TTT CCG GAC GCT GAC ACC ACT GTG TCA GCT GCC ACT TGC CGG
181                                     211
GCT CAG CGG CCA TGC CCT AGA AAT CCC CTC TCA TCC ACG CCC ATT TAC CTG CGA GGT ACT
241                                     271
GCT ATG CCC TTG CCG AAA CAC CTG CCG TCG CTC GGC GGC ATG CGG GCC ATC GCC GCA CTG
    M   P   L   P   K   H   L   P   S   L   G   G   M   R   A   I   A   A   L
    MidE
301                                     331
GTG GTG TTC TGC TCT CAT ATC GCT TCC CAG CCG TTT TTC CGC AAC GCC AAG ATA TAC TCC
V   V   F   C   S   H   I   A   S   Q   P   F   F   R   N   A   K   I   Y   S
361                                     391
ACC GCA CAG GTC CCG CTG GAC GTC CTG GGG CCG CTG GCG GTC TCG TTC TTC TTC ATG CTC
T   A   Q   V   P   L   D   V   L   G   P   L   A   V   S   F   F   F   M   L
421                                     451
AGC GGA TTC GTC CTC ACC TGG GCG GGC ATG CCC GAC CCG TCC AAG CCT GCC TTC TGG CGC
S   G   F   V   L   T   W   A   G   M   P   D   P   S   K   P   A   F   W   R
481                                     511
CGC CGT TGG GTT CGG GTC TAC TCG CTG CAC CTG CCG GTC CTG CTG CTC ACG CTG GCG ATC
R   R   W   V   R   V   Y   S   L   H   L   P   V   L   L   L   T   L   A   I
541                                     571
GTG CTG TGG CTG AAG GAA CCC AAT ATG GGC GGG TCG GTG TGG GAC GGC TTC CTC AGC AAC
V   L   W   L   K   E   P   N   M   G   G   S   V   W   D   G   F   L   S   N
601                                     631
CTG CTG CTC GTC CAG TCG TGG TGC CCC GAC TAC CAC CAG TAC GGC AGC ATG AAC CCG GTG
L   L   L   V   Q   S   W   C   P   D   Y   H   Q   Y   G   S   M   N   P   V
661                                     691
GCG TGG TCC CTC TCC TGC GAG ATG CTG TTC TAC GCC GCC TTC CCG TTC CTG TTC GCC TTC
A   W   S   L   S   C   E   M   L   F   Y   A   A   F   P   F   L   F   A   F
721                                     751
TTC TCC AAG ATG CGT GCC GAG CGG CTG TGG TCC TGG GTC CTG GGC ATC TCC GTC GTC GCC
F   S   K   M   R   A   E   R   L   W   S   W   V   L   G   I   S   V   V   A
781                                     811
GCG GCC GTG CCC GCC CTC GCC CTG CTG CTC CCC TCG GCC CCC ACG CTG CCC TGG GAC CCG
A   A   V   P   A   L   A   L   L   L   P   S   A   P   T   L   P   W   D   P
841                                     871
AAC ATG CCG GAG CTC CAA TAC TGG TTC ATC TAC ATG CTT CGC GCG GTG CGG CTG CTG GAA
N   M   P   E   L   Q   Y   W   F   I   Y   M   L   R   A   V   R   L   L   E
901                                     931
TTC GCG CTC GGC GGC GTC CTG ATG GCG CAG ATC GTC AGG CGC GGC CGC TGG ATC GGC CCG
F   A   L   G   G   V   L   M   A   Q   I   V   R   R   G   R   W   I   G   P
961                                     991
ACC CCG GGG GTG TGC GCG CTG CTG TTC GCC GGC GCG TTC GCG CTG TCC TTC GCC CTG CCG
T   P   G   V   C   A   L   L   F   A   G   A   F   A   L   S   F   A   L   P
1021                                    1051
TCC TAT CTG GCT CGC GAT GCG CCG ACG GTC CCG CTG ATC GCG CTG CTG CTC GGC TCC CTG
S   Y   L   A   R   D   A   P   T   V   P   L   I   A   L   L   L   G   S   L
1081                                    1111
GCA GCT GGC GAC ATA CGC GGT ACC CGG TCG TGG CTG GGC ACC CGG ACG ATG GTG CTG CTG
A   A   G   D   I   R   G   T   R   S   W   L   G   T   R   T   M   V   L   L
1141                                    1171
GGT GAA CTC ACC TTC GCC TTC TAC GTC ATC CAC TAC CTC GTC ATC CAG TAC GGG CAC CGC
G   E   L   T   F   A   F   Y   V   I   H   Y   L   V   I   Q   Y   G   H   R
1201/401                                1231/411
TTC CTC GGC GGT GAG CTG AGC TAC TAC CGA CAG TGG GAC ACC CCG GCC GCG ATC GGC CTC
F   L   G   G   E   L   S   Y   Y   R   Q   W   D   T   P   A   A   I   G   L
1261                                    1291
ACC GTT CTC GCC CTC GGG CTC AGC GTG GGC CTC GCC GCG CTC CTC CAC TTC TTC GTG GAG
T   V   L   A   L   G   L   S   V   G   L   A   A   L   L   H   F   F   V   E
1321                                    1351
AAG CCG GTC GTC CGG GCC CTC GGC CGC TCC GGC AAG GCG TCC CGC GCG TCC AAG GCC CCG
K   P   V   V   R   A   L   G   R   S   G   K   A   S   R   A   S   K   A   P
1381                                    1411
CAG CCC GAG CCG CCG GCG CCC CTG CTG TCC TGA GCG GGT CCG GCG GCA CAA CAG TGT GCG
Q   P   E   P   P   A   P   L   L   S   *
1441
GGG CGC GCC ACA TG
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7.5. The nucleotide and encoded amino acid sequences of the midGKHIJ
       region of Smyc-LC3
1                                       31
GGA TCC CGG GTA CCG AGC TCG GTA CCG GGG ATC TCG GCG CGA TGG GCG TCT GGC GCG AAG
  I   P   G   T   E   L   G   T   G   D   L   G   A   M   G   V   W   R   E   D
  MidG (Module7?)
61                                      91
ACC TGC TGC GCT GGG CCC TCG ACC GCA GCA CCG TCA CCC TGG AGG ACC ACC GGC TCA CCG
  L   L   R   W   A   L   D   R   S   T   V   T   L   E   D   H   R   L   T   A
121                                     151
CCA TGG CCG GCT ACC ACC GGC TGC TGC TCG ACA CCA GGC TCA CCG CAC TAC GCG CCC CGG
  M   A   G   Y   H   R   L   L   L   D   T   R   L   T   A   L   R   A   P   V
181                                     211
TCC TGC TCG TCC GGG CGT CCG AGC CGC TGC GCG AGT GGC CCG CCG ACG CGG GCC GAG GCG
  L   L   V   R   A   S   E   P   L   R   E   W   P   A   D   A   G   R   G   D  MidG
241                                     271
ACT GGC GCT CCC AGG TTC CGT TCG CCC GGA CCG TCG CCG AGG TGC CCG GCA ATC ACT TCA
  W   R   S   Q   V   P   F   A   R   T   V   A   E   V   P   G   N   H   F   T
301                                     331
CCA TGC TCA CCG AAC ACG CGC GGC ACA CCG CGT CCG TCG TGC ACG ACT GGC TGG GTG CCG
  M   L   T   E   H   A   R   H   T   A   S   V   V   H   D   W   L   G   A   D
361                                     391
ACC CGC GGC CAG CCG AGC CCA CCC TGC TCA CCG GAG GAA AAC ACT GAT GTA CGC CAA CGA
  P   R   P   A   E   P   T   L   L   T   G   G   K   H   *
                                                             M   Y   A   N   D
                                                             MidK
421                                     451
CAT CGC GGC CCT CTA CGA CCT GGT CCA CGA AGG GAA GGG CAA GGA CTA CCG GCA GGA GGC
 I   A   A   L   Y   D   L   V   H   E   G   K   G   K   D   Y   R   Q   E   A
481                                     511
CGA GGA GAT CGC CCA GTT GGT GCG AGC CCA CCG CCC GGC CAC CCG GTC GCT GCT CGA CGT
 E   E   I   A   Q   L   V   R   A   H   R   P   A   T   R   S   L   L   D   V
541                                     571
CGC CTG CGG AAC CGG CCA GCA CCT GCG CCA CCT CGA CGG CCT CTT CGA CCA CGT CGA GGG
 A   C   G   T   G   Q   H   L   R   H   L   D   G   L   F   D   H   V   E   G
601                                     631
CTT GGA GCT CTC CCA GGA CAT GCT GGC CAT CGC CAT CGG CCG GAA CCC GGA TGT CAC CCT
 L   E   L   S   Q   D   M   L   A   I   A   I   G   R   N   P   D   V   T   L
661                                     691
CCA CGA GGG AGA TAT GCG CTC CTT CGC GCT GGG CCG CCG GTT CGA TGC GGT GAT CTG CAT
 H   E   G   D   M   R   S   F   A   L   G   R   R   F   D   A   V   I   C   M
721                                     751
GTT CAG CTC CAT CGG TCA TTT ACG GAC CAC CGA CGA ACT CGA CAG CAC CCT GCG GTG CTT
 F   S   S   I   G   H   L   R   T   T   D   E   L   D   S   T   L   R   C   F      MidK
781                                     811
CGC CGG CCA CCT TGA GCC CGG CGG CGC CAT CGT CAT CGA ACC CTG GTG GTT CCC CGA CTC
 A   G   H   L   E   P   G   G   A   I   V   I   E   P   W   W   F   P   D   S
841                                     871
CTT CAC CCC CGG CTA CGT CGG CGC CAC GTC ACC GAG GCG GGC GAA CGG CAC CAT CTG CCG
 F   T   P   G   Y   V   G   A   T   S   P   R   R   A   N   G   T   I   C   R
901                                     931
GGT CTC CGA CTC CGT GCG GGA GGG GGA CGC CAC ACG CAT TGA GGT GCA CTA CCT GGT CGC
 V   S   D   S   V   R   E   G   D   A   T   R   I   E   V   H   Y   L   V   A
961                                     991
CGA GCC AGG CGG CGG CAT TCG CCA CCT CAC CGA GGA CCA CAC CAT CAC CCT GTT CCC ACG
 E   P   G   G   G   I   R   H   L   T   E   D   H   T   I   T   L   F   P   R
1021                                    1051
CGC CGA CTA TGA GCG CGC CTT CGA GCG TGC CGG CTG CGA CGT GCG CTA CCA GGA GGG CGG
 A   D   Y   E   R   A   F   E   R   A   G   C   D   V   R   Y   Q   E   G   G
1081                                    1111
CTC CTC CGG CCG CGG ACT GTT CAT CGG CAG CCG GCT GAC GCG GAT TCC GCC CCG AGA CGA
 S   S   G   R   G   L   F   I   G   S   R   L   T   R   I   P   P   R   D   D
1141                                    1171
CGA GAG GAA CCC ATG CCA ATC CCT GCC ACG GCG CCG GCG CCC GTG AAC GCC GGC ACC CGG
 E   R   N   P   C   Q   S   L   P   R   R   R   R   P   *
                M   P   I   P   A   T   A   P   A   P   V   N   A   G   T   R
                MidH
1201                                    1231
GAG CTC GGC CGC CGG CTT CAA CTG ACC CGT GCC GCG CAG TGG TGC GCG GGT AAC CAG GGC
E   L   G   R   R   L   Q   L   T   R   A   A   Q   W   C   A   G   N   Q   G    MidH
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1261                                    1291
GAC CCG AAC GCG CTG ATC CTG CGC GCC ACC GCC GAC CCC GCC CCG CTC GAA CGG GAG ATC
D   P   N   A   L   I   L   R   A   T   A   D   P   A   P   L   E   R   E   I
1321                                    1351
CGC GCC CGC GGA CCA TGG TTC CGC AGC GAG TTG ACC GGC GCT TGG GTG ACC GCG GAT CCG
R   A   R   G   P   W   F   R   S   E   L   T   G   A   W   V   T   A   D   P
1381                                    1411
AGG TGG CGG CAG GCC GCG CTG GCC GAC CGC GCC TTT GCA CGC TCG ACC GCG CCG ACC GTC
R   W   R   Q   A   A   L   A   D   R   A   F   A   R   S   T   A   P   T   V
1441                                    1471
GTC CGG ACG CGG AAC TGC TGC CCC TCG CAG AGG CTT TCC CCT GCC ATG AGC GTG CAG AGC
V   R   T   R   N   C   C   P   S   Q   R   L   S   P   A   M   S   V   Q   S
1501                                    1531
TCG CCC GGC TAC GGG CTG GCC GCC CCG GTG CTG AGT CGC TGC GCC CCG GCC GAG GCG CCC
S   P   G   Y   G   L   A   A   P   V   L   S   R   C   A   P   A   E   A   P
1561                                    1591
TGC GAG GCG CGT ACC GCC GCT CGT CGG TTG CTC CGC CGT CTC CTT CCC TCC GAC GGC GCC
C   E   A   R   T   A   A   R   R   L   L   R   R   L   L   P   S   D   G   A
1621                                    1651
GGG TTC GAC CTC GTC ACC GAG GTC GCC CGG CCG TAC GCC GTC GGG CTG GTG CTC CGG CTT
G   F   D   L   V   T   E   V   A   R   P   Y   A   V   G   L   V   L   R   L
1681                                    1711
CTC GGC GTG CCG GAC TGC GAC CGC GAC ACC ATG GGG CGG GCG CTC GCC GGC TGC GCT CCC
L   G   V   P   D   C   D   R   D   T   M   G   R   A   L   A   G   C   A   P
1741                                    1771
AAC TTt GAC GCC CGG TTG GCC CGC AGA CCC TGG CTG TCG CTC GGG AGT CCA CCG ACG CCG
N   F   D   A   R   L   A   R   R   P   W   L   S   L   G   S   P   P   T   P    MidH
1801                                    1831
TCC AGA CCT TGG CCG ACC ATG TCC CGG AAC TCG TTG CTG AGA AGC AGC GGG CCG TCG AGA
S   R   P   W   P   T   M   S   R   N   S   L   L   R   S   S   G   P   S   R
1861                                    1891
GCG CCG AGC CCC GGC CCG ACG ATG TTC TCG CCC TCC TCC TGC GCG ACG GTG CCG CCC CGC
A   P   S   P   G   P   T   M   F   S   P   S   S   C   A   T   V   P   P   R
1921                                    1951
GAT GTC GAG CGG ATC GCG CTG CTC CTC GCC ATC GGC ACC CCC GAG CCC GCG GCC ACC GCC
D   V   E   R   I   A   L   L   L   A   I   G   T   P   E   P   A   A   T   A
1981                                    2011
GTC GCG AAC ACG GTG CAC CGG CTG CTG AAC CGG CCG GGG GAG TGG GGA CGT GTC CGC CGG
V   A   N   T   V   H   R   L   L   N   R   P   G   E   W   G   R   V   R   R
2041                                    2071
ACC CCG GCC GCC GCG CGG GCC GTC GAC CGG ACC CTG CGC GAC CGG CCC CCG GCC CGA CTG
T   P   A   A   A   R   A   V   D   R   T   L   R   D   R   P   P   A   R   L
2101                                    2131
GAG AGC AGG GTC GCC AGC ACC GAC CTT GAG TCG cGT GGT TGC CGG ATC GCC GCC GAC GAC
E   S   R   V   A   S   T   D   L   E   S   R   G   C   R   I   A   A   D   D
2161                                    2191
CAC GTC GTG GTG CTG GCC GCC GCG GGG CGG GAC GCT CCG GGG CCC GAG CCG CTC GGC GGC
H   V   V   V   L   A   A   A   G   R   D   A   P   G   P   E   P   L   G   G
2221                                    2251
CGG ACG CGA CCG CAC TTG GCC CTC GCC CTC CCG CTC ATC CGG CTG GCC GCC ACC ACC GCT
R   T   R   P   H   L   A   L   A   L   P   L   I   R   L   A   A   T   T   A
2281                                    2311
GTC CAG GTC ATG GCC GGA CGC CTG CCC GGA CTG AGG GTC GAG GAC GAG CCT CTG ACC CGG
V   Q   V   M   A   G   R   L   P   G   L   R   V   E   D   E   P   L   T   R
2341                                    2371
CCG CGC TCC CCG GTC GTA TGC GCC TGT GCC CGC TTC CGG GTC CAC CCG GGA TGA CCC TGC
P   R   S   P   V   V   C   A   C   A   R   F   R   V   H   P   G   *
2401                                    2431
CGC CCG TAC ACC CCG GCC CGA ACT GGA GTC ACC GTG CGC GTC CTG CTG ACC TCC CTA GCC
                                            M   R   V   L   L   T   S   L   A
                                            MidI
2461                                    2491
CAC AAC ACC CAC TAC TAC AGC CTG GTG CCC TTG GCG TGG GCC CTA CGC GCG GCC GGG CAC
H   N   T   H   Y   Y   S   L   V   P   L   A   W   A   L   R   A   A   G   H
2521                                    2551
GAG GTG CGG GTG GCG AGC CCG CCC TCG CTC ACC GAT GTC ATC ACC TCC ACC GGG CTG CCC
E   V   R   V   A   S   P   P   S   L   T   D   V   I   T   S   T   G   L   P
2581                                    2611                                     MidI
GCC GTC CCC GTC GGC GAC GAC CAG CCC GCC GCC GAA CTG CTC GCC GAG ATG GGC GGC GAC
A   V   P   V   G   D   D   Q   P   A   A   E   L   L   A   E   M   G   G   D
2641                                    2671
CTC GTC CCC TAT CAG CGG GGC TTT GAG TTC GCC GAG GTG GAG CCC GCC CAG GAG ACC ACC
L   V   P   Y   Q   R   G   F   E   F   A   E   V   E   P   A   Q   E   T   T
2701                                    2731
TGG GAG CAT CTG CTC GGC CAG CAG AGC ATG ATG TCC GCC TTG TGG TTC GCG CCG TTC AGC
W   E   H   L   L   G   Q   Q   S   M   M   S   A   L   W   F   A   P   F   S
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2761                                    2791
GGC GCC GCC ACG ATG GAC GAC ATC GTC GAC TTC GCC CGC GAC TGG CGT CCC GAC CTC GTC
G   A   A   T   M   D   D   I   V   D   F   A   R   D   W   R   P   D   L   V
2821                                    2851
GTA TGG GAA CCC TGG ACC TAC GCC GGG CCG ATC GCG GCT CGT GCC TGC GGC GCC GCC ACC
V   W   E   P   W   T   Y   A   G   P   I   A   A   R   A   C   G   A   A   T
2881                                    2911
GCG CGT ATC CTC TGG GGC CCC GAC GCC ATC GGA CGG TCC CGG CGG CGC TTC CTC GAA GCG
A   R   I   L   W   G   P   D   A   I   G   R   S   R   R   R   F   L   E   A
2941                                    2971
CTC GAA CGA GTG CCG GAG GAG CTG CGC GAG GAC CCC ATC GCC GAA TGG CTC GGC TGG ACG
L   E   R   V   P   E   E   L   R   E   D   P   I   A   E   W   L   G   W   T
3001                                    3031
CTG GAC CGG TAC GGG TGC GCC TTC GAC GAA CGC GAC GTG CTC GGC CAC TGG GTG ATC GAC
L   D   R   Y   G   C   A   F   D   E   R   D   V   L   G   H   W   V   I   D
3061                                    3091
CCG GGG CCC CGC AGT ACC CGA CTG GAC CTG GGA CAG ACC ACG GTC CCC ATG TGC TAC GTG
P   G   P   R   S   T   R   L   D   L   G   Q   T   T   V   P   M   C   Y   V
3121                                    3151
CCC TAT AAC GGG CGC GCC GTC ATC GAA CCC TGG CTT GCC GAG AAG CCC GAG CGC CCT CGC
P   Y   N   G   R   A   V   I   E   P   W   L   A   E   K   P   E   R   P   R
3181                                    3211
GTC TGC CTC ACT CTC GGG ATC TCC GCC CGC GAG ACC TAC GGC CGC GAC GCG GTC TCC TAC
V   C   L   T   L   G   I   S   A   R   E   T   Y   G   R   D   A   V   S   Y
3241                                    3271                                     MidI
TCC GAG TTG CTT CAG GCG CTG GGC CGC ATG GAG ATC GAG GTG GTG GCC ACC CTC GAT GCC
S   E   L   L   Q   A   L   G   R   M   E   I   E   V   V   A   T   L   D   A
3301                                    3331
TCG CAG CAG AAG CGC CTC GGC AGC CTT CCC GAC AAC GTC GTG CCG GTG GAC TTC GTG CCG
S   Q   Q   K   R   L   G   S   L   P   D   N   V   V   P   V   D   F   V   P
3361                                    3391
CTC GAC GCG CTG CTG CCG AGC TGT GCC GCG ATC ATC CAC CAC GGC GGC GCG GGC ACT TGG
L   D   A   L   L   P   S   C   A   A   I   I   H   H   G   G   A   G   T   W
3421                                    3451
TCC ACC GCC CTG CTC CAC GGC GTA CCG CAG ATC CTG CTG CCC GCG CTG TGG GAC GCG CCG
S   T   A   L   L   H   G   V   P   Q   I   L   L   P   A   L   W   D   A   P
3481                                    3511
CTC AAG GCC CAG CAG CTC CAG CGC CTG TCG GCC GGA CTC AAC CTG CCC GCC GCG ACC CTC
L   K   A   Q   Q   L   Q   R   L   S   A   G   L   N   L   P   A   A   T   L
3541                                    3571
ACG GCG CGC CGC TTG GCC GAC GCG GTG CAC ACG GCC GTA CAC GAT CCC GCG ATC CGG GCG
T   A   R   R   L   A   D   A   V   H   T   A   V   H   D   P   A   I   R   A
3601                                    3631
GGC GCG CGG CGG CTG CGC GAG GAG ATG CTC GCC GAC CCC ACG CCC GCG GCA ATC GTC CCC
G   A   R   R   L   R   E   E   M   L   A   D   P   T   P   A   A   I   V   P
3661                                    3691
ACG CTG GAG CGC CTC ACC GCC CTG CAC CGG GCG GCC TGA CGC AAC GTT CGA ACG GAG CCG
T   L   E   R   L   T   A   L   H   R   A   A   *
3721                                    3751
ATC CAC CAT GCC CGA CAG TCA TGC CCT GAG CGA GCT GCT CGC CGC GAG CCG CGC GCC CGA
         M   P   D   S   H   A   L   S   E   L   L   A   A   S   R   A   P   D
         MidJ
3781                                    3811
CCA CAC CCC CGA GGA CAT CGC CGC GCT GCC CCT GCC CGA ATC CTT CCG GGC CGT GAC CGT
 H   T   P   E   D   I   A   A   L   P   L   P   E   S   F   R   A   V   T   V
3841                                    3871
CCA CAA AGA GGA CAC CGA GAT GTT CCG CGG CAT GAC CAG CGC GGA CAA GGA CCC GCG CAA
 H   K   E   D   T   E   M   F   R   G   M   T   S   A   D   K   D   P   R   K
3901                                    3931
GTC GCT GTG CGT CGA CGA GGT GCC GGT TCC CGA AGT CGG GCC CGG CGA GGC CCT GAT AGC
 S   L   C   V   D   E   V   P   V   P   E   V   G   P   G   E   A   L   I   A
3961                                    3991
GGT GAT GGC CAG CTC GGT CAA CTA CAA CAC CGT GTG GTC GTC CCT CTT CGA GCC GAT GCC  MidJ
 V   M   A   S   S   V   N   Y   N   T   V   W   S   S   L   F   E   P   M   P
4021                                    4051
GAC CTT CGG CTT CCT GGA GCG CTA CCG GCC GCA CCT CGC CGT GGC CGC TCG TCA CGA CCT
 T   F   G   F   L   E   R   Y   R   P   H   L   A   V   A   A   R   H   D   L
4081                                    4111
GCC GTA CCA CAT CCT CGG CTC CGA CCT GGC CGG CGT TGT GCT ACG CAC CGG CCC GGG GGT
 P   Y   H   I   L   G   S   D   L   A   G   V   V   L   R   T   G   P   G   V
4141                                    4171
GAA TGT TTG GGC GCC CGG CGA CGA GAT CGT GGC GCA CTG TCT AAC GGT GGA GCT GGA AAA
 N   V   W   A   P   G   D   E   I   V   A   H   C   L   T   V   E   L   E   N
4201                                    4231
CCC GGA CGG ACA CGA CGA CAC CCT GCT CGA CCC GGC CCA GCG GAT CTG GGG CTT CGA GAC
 P   D   G   H   D   D   T   L   L   D   P   A   Q   R   I   W   G   F   E   T
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4261/1421                               4291
CAA CTT CGG CGG CCT GGC CGA GAT AGC CCT GGT CAA GGC CAA CCA GCT GAT GCC CAA GGC
 N   F   G   G   L   A   E   I   A   L   V   K   A   N   Q   L   M   P   K   A
4321                                    4351
CGC ACA CCT CAC CTG GGA GGA GGC CGC CGC ACC GGG TCT GGT GAA CTC CAC CGC CTA CCG
 A   H   L   T   W   E   E   A   A   A   P   G   L   V   N   S   T   A   Y   R
4381                                    4411
TCA GCT GGT CTC CCG CAA CGG CGC CGG CAT GAA GCA GCA CAA CGT GTT GAT CTG GGG CGC
 Q   L   V   S   R   N   G   A   G   M   K   Q   H   N   V   L   I   W   G   A
4441                                    4471
CAG CGG CGG TCT GGG CTC GTA CGC CAC CCA GCT CGC CCT CGC CGG TGG GGC CAA CCC CGT
 S   G   G   L   G   S   Y   A   T   Q   L   A   L   A   G   G   A   N   P   V
4501                                    4531
CTG TGT GGT CTC CAA CCA GCG CAA GGC CGA GGT GTG CCG GGC CAT GGG CGC GGG GGC GAT
 C   V   V   S   N   Q   R   K   A   E   V   C   R   A   M   G   A   G   A   I
4561                                    4591
CAT CGA CCG CTC GGC CGA GGA CTA CCG CTT CTG GAG CGA CGA GCA GAC CCA GAA TCC GCG
 I   D   R   S   A   E   D   Y   R   F   W   S   D   E   Q   T   Q   N   P   R
4621                                    4651
GGA GTG GAA GCG GTT CGG TGC CCG TAT CCG GGA GTC GAC CGG TGG TGA GGA CGT GGA CAT
 E   W   K   R   F   G   A   R   I   R   E   S   T   G   G   E   D   V   D   I   MidJ
4681                                    4711
CGT CTT CGA GCA TCC TGG CCG GGA GAC GTT CGG GGC GTC TGT CTA CGT CGC CCG CCG GGG
 V   F   E   H   P   G   R   E   T   F   G   A   S   V   Y   V   A   R   R   G
4741                                    4771
CGG CAC CAT CGT CAC CTG CGC CTC CAC TTC CGG CTA CCG TCA CGA GTT CGA CAA CCG CTA
 G   T   I   V   T   C   A   S   T   S   G   Y   R   H   E   F   D   N   R   Y
4801                                    4831
TCT GTG GAT GCA CCT CAA GCG CAT CGT CGG CAC CCA CTT CGC CAA CTA CCG CGA GGC ATG
 L   W   M   H   L   K   R   I   V   G   T   H   F   A   N   Y   R   E   A   W
4861                                    4891
GGA GGC GAA CCG CCT CGT CAC CAA AGG GAA GAT TTA CTC CAC CCT CTC CTG CAC CTA CCC
 E   A   N   R   L   V   T   K   G   K   I   Y   S   T   L   S   C   T   Y   P
4921                                    4951
GCT GGC TTT TTT CGC GCT TGC CGT CCA CGA CGT GCA CCG CAA CGT CCA CCA GGG CAA GGT
 L   A   F   F   A   L   A   V   H   D   V   H   R   N   V   H   Q   G   K   V
4981                                    5011
CGG CGT GCT GTG TCT GGC CCC GAT GGA GGG TCT GGG CGT GCG CGA CGA GGA GAT GCG CGC
 G   V   L   C   L   A   P   M   E   G   L   G   V   R   D   E   E   M   R   A
5041                                    5071
GCA GCA CCT CGA CGC GAT CAA CCG ATT CCG CTG ACC GCT CCT TTG TCC CGA GGC ATA TCC
 Q   H   L   D   A   I   N   R   F   R   *
5101                                    5131
GCC GCT CGT CCC GGA GGT TTT TTC AAA GGA GGG GCC CAC AGT CCG AAA GCG GTT TCA TGC
5161                                    5191
AGG CGC TCG GCT GGG GGT TTC CCA GCC GAG CGT TTG TTG CGT GGG CTT TTG GTC GCG ATG
5221
GCC GGC G
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7.6. Sequence alignment of the MidD protein with other thioesterases for construction
      of MidD-tree in Fig. 5.2
MidDSmy       LVLRRL-PARPAPAVRLVCFPHAGGSATSF-LPFVQTLPDQVEMLAVQYPGRQDRRGEPLIGTIEG
ORF12Ame      KWLRRF-ERAPDARARLVCLPHAGGSASFF-FPLAKALAPAVEVLAVQYPGRQDRRHEPPVDSIGG
ThiESgr       RWLRRYHP-AEADAVRLVCFPHAGGSASFY-HPVSARFAPGAEVVSLQYPGRQDRRKEPCVPDLGT
PikAVSve      LWIRRFHP-APNSAVRLVCLPHAGGSASYF-FRFSEELHPSVEALSVQYPGRQDRRAEPCLESVEE
TylOSfr       MWLRCYAPVPGTPAHRLVCFPHAGGSARAYRPFALELAAAGVETHAVQYPGRQDRRKEPFARTLEE
GrsTBbr       KWFVNAN-VNSAAKLRLFCIPYAGGGASAF-YEWSHFFPKEIEVCSIQLPGRENRGAEVPLTNLQQ
TesAMtu       GHSDDSSGDAKQAAPTLYIFPHAGGTAKDY-VAFSREFSADVKRIAVQYPGQHDRSGLPPLESIPT
MLCB12.04C    GHSNNGNDDETSTTPTLYIFPHAGGDATYY-VPFSREFSADIKRIAVHYPGQRDGYGLPALTSIPA
Orf1Shy       MTDWIQSVSAPDAVARVVCLSRAGGSARDF-DRWRAPMGEDVELAAVQLPGRLDRFHEPPLSDLHE
PchCPae       AAWVRPFRLTPMPRLRLACFPHAGGSASFF-RSWSERLPPDIDLLALQYPGREDRFNEAPATRLED
SC3F7.14Sco   AAPAAEPPDPAAAPLRLVCFPYAGGTVSAF-RGWQERLGDEVAVVPVQLPGRGLRLRERPYDTMEP
Ery3Ser       STWLRRFGPPVEHRARLVCFPHAGAAADSY-LDLARALAPEIDVDAVQYPGRQDRRDEEPLGTAGE
SrfADBsu      SQLFKSFDA--SEKTQLICFPFAGGYSASF-RPLHAFLQGECEMLAAEPPGHGTNQ-TSAIEDLEE
MidDSmy       LVEPLAEVLATHSDRP----LVLFGHSMGATVAYEVARVLQQRGA-APAGLVVSGRRAPIVNRPMT
ORF12Ame      LTNRLLEVLRPFGDRP----LALFGHSMGAIIGYELALRMPEAGLPAPVHLFASGRRAPSRYRDDD
ThiESgr       LDLITEQLL-PLDERP----TVFFGHSMGAALAFETAWRLEQKGA-GPRTVIASGRRGPSTTRAER
PikAVSve      LAEHVVAATEPWWQEGR---LAFFGHSLGASVAFETARILEQRHGVRPEGLYVSGRRAPSLAPDRL
TylOSfr       LAERVLPELRRLLDAPDGVPVALFGHSMGAVVAYETARLLHRSGAPRPAGLILSGRRAPTADRTET
GrsTBbr       IVEIVAEEIQPLINIPF----AFLGHSMGALISFELARTIRQKSNVNPVHLFVSGRHAPQIPCAKQ
TesAMtu       LADEIFAMMKPSARIDD--PVAFFGHSMGGMLAFEVALRY-QSAGHRVLAFFVSACSAPGHIRYKQ
MLCB12.04C    LADEIFAIMKPSAPPEG--AVAFFGHSMGGMLAFEVALRF-QSAGYRLIALFVSACSAPGYIRYKQ
Orf1Shy       IAEEVAAALTTLPARP----YVLFGDCMGALLAFETACALRRRGAAPPDCLVVASYPAPDRLRTER
PchCPae       LADGAALALRDFADAP----LALFGHSLGAALAYETALRLET-PAALR-HLFVSAHPAPHRQRGGA
SC3F7.14Sco   LAEAVADALEEHRLTHD---YALFGHSMGALLAYEVACVLRRRGAPRPRHLFVSGSRAPHLYGDRA
Ery3Ser       IADEVAAVLRASGGDG---PFALFGHSMGALIAYETARRLEREPGGGPLRLFVSGQTAPRVHERRT
SrfADBsu      LTDLYKQELNLRPDR----PFVLFGHSMGGMITFRLAQKLEREGIFPQAVII-SAIQPPHIQRKKV
MidDSmy       -VHLYDDDRLLAELRSLEGTDESLLNDPELLQMVLPAIRNDYRAVGTYTHPPGAPLASALTVFTG
ORF12Ame      -VRGASDERLVAELRKLGGSDAAMLADPELLAMVLPAIRSDYRAVETYRHEPGRRVDCPVTVFTG
ThiESgr       -VHTRDDDGIVAEMKRLNGTAAGVLGDEEILRMALPALRGDYRAIETYTCPPDRRLACGLT-LTG
PikAVSve      -VHQLDDRAFLAEIRRLSGTDERFLQDDELLRLVLPALRSDYKAAETYLHRPSAKLTCPVMALAG
TylOSfr       -AHLLGDRELLAEIRRLQGTDPGALADEEVLRMVLPAIRGDYAAVGRYRHVPGPRPGCPLTVFTG
GrsTBbr       DYHLLPDEQFIQELRSLNGTPEIVLQDAEMMSILLPRLRADFSVCGSYQYKNDEPFECPITAFGG
TesAMtu       -LQDLSDREMLDLFTRMTGMNPDFFTDDEFFVGALPTLRAV-RAIAGYSCPPETKLSCPIYAFIG
MLCB12.04C    -IKDFSDNDMLDLVVRMTGMNPDFFEDEEFRVGVLPTLRAA-RIIAGYNCPPETTVSCPIYTYIG
Orf1Shy       PYGDGSADDLRQRLREVGGVPPAVLDEDELFELMLPMLRADFAAFEGYRHRPTEPLSVDIHALVG
PchCPae       -LHRG-DEAALLEDVRRQGGASELLEDADLRALFLPILRADYQAIETYRRAQPIALACALDVLLG
SC3F7.14Sco   -DHTLSDTALREVIRDLGGLDDADTLGAAYFDRRLPVLRADLRACERYDWHPRPPLDCPTTAFSA
Ery3Sery      -DLPGDDG-LVDELRRL-GTSEAALADEALLAMSLPVLRADYRVLRSYAWADGPPLRAGITALCG
SrfADBsu      -SHLPDDQFLDHIIQ-LGGMPAELVENKEVMSFFLPSFRSDYRALEQFELYDLAQIQSPVHVFNG
MidDSmy       ADDPNVTATEAAAWQAVAEAGAQVRTFPGGHFFLYQQVAEVCGALMD-TLAPLLPAG
ORF12Ame      DHDPRVSVGEARAWEEHTTGPADLRVLPGGHFFLVDQAAPMIATMTE-KLAG--PAL
ThiESgr       EDDPLTTVEEAERWRDHTTGPFRLRVFTGGHFFLTQHLDAVNTEIAQ-ALHPD-RAA
PikAVSve      DRDPKAPLNEVAEWRRHTSGPFCLRAYSGGHFYLNDQWHEICNDISD-HLLVTRGAP
TylOSfr       DADPNVTLPEAEAWRELTTGAFALRVFPGGHFYLNDQREAVCRTIEE-TLRHGSKSA
GrsTBbr       KNDNGVTYQSLEAWREQTKREFSVCMYPGDHFFLYESKYEMIEFMCK-QLRLVLAPK
TesAMtu       DKDWIATQDDMDPWRDRTTEEFSIRVFPGDHFYLNDNLPELVSDIEDKTLQWHDRA-
MLCB12.04C    DKDWIATQEDMKPWRERTTGAFAIRVFPGDHFYLNGNLSELVCDIEDKTLEWCDRA-
Orf1Shy       ADDPYVTVTDLHGWQRHTTGEFTARALPGGHFFLHESDDAVSRVRSL-ALAGARAAR
PchCPae       EHDEEVSAAEAQAWSDASRTPARLRRFPGGHFYLSEGRDAVIEHLLR-RLAHPDALS
SC3F7.14Sco   AADPIATPEMVEAWRPYTTGSFLRRHLPGNHFFLNGGPSRDRLLAHLGTELDALGTT
Ery3Ser       DADPLTATGDAERWLQHSVIPGRTRTFPGGHFYLGEQVTEVAGAVRRDLLRAGLAG-
SrfADBsu      LDDKK-CIRDAEGWKK-WAKDITFHQFDGGHMFLLSQTEEVAERIFA-ILNQHPIIQ
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7.7. Sequence alignment of the MidA protein with other dTDP-glucose synthases for
       construction of MidA-tree in Fig. 5.2
StrDSgr         M----KALVLAGGTGTRLRPITHTSAKQLVPVANKPVLFYGLEAIRAAGIIDVGIVVG-DTAD
OleDSan1        V----KALVLAGGSGTRLRPITHTSAKQLVAVANKPVLFYGLEAIAAAGITDVGLIVG-DTAG
OleDSan2        M----KALVLAGGSGTRLRPITHTSAKQLVAVANKPVLFYGLEAIAAAGITDVGLIVG-DTAG
GraDSvi         M----KALILSGGMGDRLRPFTYSMPKQLVPVANKPILVHCLENVRAIGVEEVAVVVG-DRAD
DnrLSpe         M----KALVLSGGSGTRLRPFTHTSPKQLVPVANKPVLYYVLEDIAQASITEVGIVVG-ETSN
RmlAMle         M----RGIILAGGSGTRLYPITLGISKQLLPVYDKPMIYYPLSTLMMAGIRDILVITTAHDAP
TylAISfr        M----KGIILAGGSGTRLRPLTGTLSKQLLPVYDKPMIYYPLSVLMLAGIREIQIISSKDHLD
MidASmy         M----KGIILAGGGGTRLRPLTGTLSKQLLPVYNKPMIYYPLSVLMLGGINEILIISTPDHIL
AcbAAct         MVGHVRGILLAGGTGSRLRPVTWAVSKQLMPVYDKPMIYYPLATLVSCGIREILVITTETEAA
YifGEco         M----KGIMLAGGSGTRLHPITRGVSKQLLPIYDKPMIYYPLSVLMLAGIREILIITTPEDKG
RmlAEco         MKTR-KGIILAGGSGTRLYPVTMAVSKQLLPIYDKPMIYYPLSTLMLAGIRDILIISTPQDTP
LmbOSli         M-T---LVVLAGGRGTRLGAYA-TTAKALLPVDGEPFLVRALRRYRAGAASPMSCCAPGHHAA
StrDSgr         EIVAAVGDGSRFGLKVSYIPQSKPLGLAHCVLISRDFLGEDDFIMYLGDNFVVGVVEDSVREF
OleDSan1        EVRAPVGDGAKFGLDITYIEQSRPLGLAHAVLIAHTYLGDDDFVMYLGDNFIVGGIDDLVRTF
OleDSan2        EVRAAVGDGAKFGLDITYIEQSRPLGLAHAVLIAHTYLGDDDFVMYLGDNFIVGGIDDLVRTF
GraDSvi         EVRAVVGDGSAFGLDVTYLQQEAPLGLAHCVSIAEEFLGDEDFVMYLGDNILAEGIAESARAF
DnrLSpe         EIRKAVGSGDRFGLRVTYLPQEAPLGLAHAVLIARDYLGEEDFVMYLGDNFVVGGIAGNSSTF
RmlAMle         GFKRLLGDGTQFGVNISYATQDHPDGLAQAFVIGANHIGADTVALVLGDNIFYGPGLGTSLR-
TylAISfr        LFRSLLGEGDRLGLSISYAEQREPRGIAEAFLIGARHIGGDDAALILGDNVFHGPGFSSVLTG
MidASmy         EQFSGCWRRVRLGLDITYAESPSPRGIAQALTIGSDHIGNSPVALILGDNIFHGPGFSSVLQG
AcbAAct         QFQRLLGDGSQWGLRLEFAVQQRPGGIAEAFLIGEEFLAGGPVALMLGDNLLHGVDFRPCVQR
YifGEco         YFQRLLGDVGEFGIQLEYAEQPSPDGLAQAFIIGETFLNGEPSCLVLGDNIFFGQGFSPKLRH
RmlAEco         RFQQLLGDGSQWGLNLQYKVQPSPDGLAQAFIIGEDFIGGDDCALVLGDNIFYGHDLPKLMEA
LmbOSli         QVQEVIGDGSALGLRVTHSAEPEPLGPIGALRHALPLLPET----YLLTYCDVVPTIDV----
StrDSgr         RAAR-P--DAHLMLTRVPEPRSFGVAELS-DSGQVLGLEEKPAHPKSDLALVGVYLFSPAIHE
OleDSan1        RDGRRP--AARI-------------------------------------GMVGVYFFTPPSTR
OleDSan2        RDGRPP--AARILLTHVSDPSAFGVAELD-DDGRVVGLEEKPRHPKSDLALVGVYFFTPAIHE
GraDSvi         RDER-S--AARLLLTKVADPRAYGVAETD-ATGRVHALVEKPERPRSDLAVIGVYFFTAAVHD
DnrLSpe         RAER-P--DAQILLTRVSDPSSFGVAEIG-CDGRVVALEEKPRHPRSDLAVVGIYLFTPVVHE
RmlAMle         RFQYVS--GGAIFAYCVANPSSYGIVELGID-GIALSLEEKPATPKSQYAVPGLYFYDNDVVE
TylAISfr        TVARLD--GCELFGYPVKDAHRYGVGEIDSG-GRLLSLEEKPRRPLEP-GRHRLYLYTNDVVE
MidASmy         SIRHLD--GCVLFGYPVSDPGRYGVGEIDRD-GLLLSLEEKPVRPRSNLAVTGLYLYDNDVVD
AcbAAct         ARET-A--GGHVFGVAVADPSAYGVVEFDAA-GRVLSIEEKPVRPRSPYAVPGFYLYDADVVE
YifGEco         VAARTE--GP-VFGYQVMDPERFGXVEFD-DNFRAISLEEKPKQPKSNWAVTGLYFYDSKVVE
RmlAEco         AVNKES--GATVFAYHVNDPERYGVVEFD-NNGTAISLEEKPLEPKSNYAVTGLYFYDNDVVE
LmbOSli         R--------------------SFTAAARASDCPAVMAVGTAPTPPEANVLLSG-----QQVSS
StrDSgr         AVAA-ITPSWRGELEITDAVQWLIDAGRDVRSTVISGY-WKDTGNVTDMLEVNRLVLE
OleDSan1        PSAP-IEPSWRGELEITHAIQHLIDNGADIQSMVIEGY-WKDTGNVADMLEVNRTVLE
OleDSan2        AVRA-IEPSWRGELEITHAIQHLIDNGADIQSMVIEGY-WKDTGNVADMLEVNRTVLE
GraDSvi         AVRA-IEPSARGELEITDAIQYLVERGDRVVADEYTGY-WKDTGSPDDLLDCNRVLLG
DnrLSpe         AVRA-LTPSRRGELEITDALQWLLDGPYDVRYTTISGY-WKDTGNVADMLEVNRAVLD
RmlAMle         IAR-GLTKSARGEYEITEVNQIYLNQGRLTVEVLARGTAWLDTGTFDSLLDASDFV--
TylAISfr        IAR-TISPSARGELEITDVNKVYLEQGR-AAHGAGAVVAWLDMGTHDSLLQAGQYV--
MidASmy         IAK-NIRPSARGELEITDVNKVYLEQRRARLIELGHGFAWLDMGTHDSLLQASQYV--
AcbAAct         TAR-SLRPSARGELEITEVNQAYLRRGALSVTLLGRGAG-LARHRHPGRLHARGRL--
YifGEco         YAKQ-VKPSERGELEITSINQMYLEAGNLTVELLGRGFAWLDTGTHDSLIEASTFV--
RmlAEco         MARKNLKPSARGELEITDINRIYMEQGRLSVAMMGRGYAWLDTGTHQSLIEASNFI--
LmbOSli         YAKSPPPGATHCDRGLLALERRLLDRHP----------GRTEADFYGALARRGELGAV
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StrDSgr         TT-EPRCDGLVDERSGLIGRVLVEEGAEVRNSRVMGPTVIGAGTRVTNSYVGPFTSLAEDC
OleDSan1        DL-EPRIEGTVDEHTVVIGRVVVGEGARVTNSRIMGPAIIGAGPEISDSYIGPFTSVGDNC
OleDSan2        DL-EPRIEGTVDEHTVVIGRVVVGEGARVTNSRIMGPAIIGAGAEISDSYIGPFTSVGDNC
GraDSvi         RL-RPGVHGEVDAASTVEGTVVVEAGRSWSDSRLVGPLVVGAGSVVRGSELGPYTALGRDC
DnrLSpe         GI-EPGMEGQADAASELVGRVRIEAGAQIRASRIVARRHRAG--RVTDR-TSALHVDRGDC
RmlAMle         --------RTLERRQGL--KVSVPEEVSWRMGWIDDEQLALRAHSLAKSGYGCY-------
TylAISfr        --------QLLEQRQGE--RIACIEEIAMRMGFISAEQCYRLGQELRSSSYGSY-------
MidASmy         --------QLLEQRQGV--RIACVEEIALRMGFINADELYLLGCELGNSGYGSY-------
AcbAAct         --------RARHRRGP-----GHQDRLCGGGGLAGRFPRHRARACPRRAVDEQR-------
YifGEco         --------QTVEKRQGF--KIACLEEIAWRNGWLDDEGVKRAASSLAKTGYGQY-------
RmlAEco         --------ATIEERQGL--KVSCPEEIAYRKGFIDAEQVKVLAEPLKKNAYGQY-------
LmbOSli         RIGAPGADIGTAHR------------------------------------YERYLRTGEK-
StrDSgr         VVEDSEVEFSIVLRGASISGVR-RIEASLIGRHVQVTSAPEVPHAHRLVLGDHSRAQISS
OleDSan1        RITGSEMEFSIMLAESAITGVR-RIEGSLIGRNVQVTQSLHAPNAHRFVLGDHSKVEIQS
OleDSan2        RITGSEMEFSIMLAESAITGVR-RIEGSLIGRNVQVTQSLHAPNAHRFVLGDHSKVEIQS
GraDSvi         VLEDAGIRDSIVLDGVSIQGVR-GLSGSLIGRSAAV-RTGEAAGRR-LIIGDHTQAEVAA
DnrLSpe         SIETARSSLHHA-GRLPAHGTR-RVQHSLLGRNVTVAPAPRVPAGSRLILGDDSRVEISS
RmlAMle         ----------------------------LSELLERGXFRQAXPTPRRLLWSTGLTEQALC
TylAISfr        ----------------------------IIDVAMRGAAA------------D-SRAQ---
MidASmy         ----------------------------LMEVASHAGAA---------------------
AcbAAct         ----------------------------LRTVPAGSDRRRAQPYPQ-WPA---LTAAAG-
YifGEco         ----------------------------LLELL---RARPRQ-Y----------------
RmlAEco         ----------------------------LLKMI---K--G---Y----------------
LmbOSli         ------------------------------------------------------------
7.8. Sequence alignment of the MidB protein with other dTDP-glucose 4,6-
       dehydratases for construction of MidB-tree in Fig. 5.2
SCF81.08c       -NILVTGAAGFIGSRYVRGLLASDAPG---APRVTVLDALTYAGSTANFTLELGHPRLEF
StrESgr         -HLLVTGAAGFIGSQYVRTLL-G--PGGPPDVVVTALDALTYAGNPDNLAAVRGHPRYRF
StrESgl         TRLLVTGGAGFIGSHYVRTLL-G--PDGPPDAVVTVLDALSYAGNLANLDPVRDHPRLRF
OleESan         -NLLVTGAAGFIGSRYVHHLLEATRRGREPAPVITVLDKLTYAGV---LGNVPDDPAVTF
GraESvi         -RLLVTGAAGFIGSHYVREILAGSYPESDDVH-VTVVDRLTYAGRRDNLPE—-HHERLDF
TylAIISfr       -RVLVTGGAGFIGSHFTGQLLTGAYPDLGATRTV-VLDKLTYAGNPANLEHVAGHPDLEF
MidBSmy         QRILVTGGAGFIGSRFVNALLNGSLPEFGKPEVV-VLDALTYAGNLANLAPVGDCGGLRV
GdhSer          -RVLVTGGAGFIGSHYVRQLLGGAYPAFAGADVV-VLDKLTYAGNEENLRPVADDPRFRF
AcbBAct         -KILVTGGAGFIGSHFVTSLISGDIATPQPVTQVTVVDKLGYGGNLRNLAEASADPRFSF
AcbDSgl         TTILVTGGAGFIGSAYVRRLLSPGAP--GGV-AVTVLDKLTYAGSLARLHAVRDHPGLTF
RffEEco         RKILITGGAGFIGSALVRYIIN------ETSDAVVVVDKLTYAGNLMSLAPVAQSERFAF
RmlBEco         -KILVTGGAGFIGSAVVRHIIN------NTQDSVVNVDKLTYAGNLESLAEISDSERYSF
LmbMSli         GRYCVHRGAGFIGSPTSSKRLLAE----EGTRGVVAYDDLSNTTT-RWIEPLLADERLRF
SCF81.08c       VHGDIRDAALVDRLTAGA--DQVVHFAAESHVDRSIHAASDFVLTNVVGTQFTNLLDAAL
StrESgr         ERGDICDAPG-RRVMAG-Q-DQVVHLAAESHVDRSLLDASVFVRTNVHGTQ-T-LLDAAT
StrESgl         VHGDICDADLVDRVMAG-Q-DQVVHLAAESHVDRSLLDAAAFVRTNAGGTQ-T-LLDAAL
OleESan         VRGDIADAPLVDSLMAEA--DQVVHFAAETHVDRSITSPGTFVRTNVLGTQV--LLDAAL
GraESvi             VHGDICDRDLLDRVLPGH--DAVVHFAAESHVDRSLTGPGEFVRTNVMGTQ-Q-LLDAAL
TylAIISfr       VRGDIADHGWWRRLMEGV--GLVVHFAAESHVDRSIESSEAFVRTNVEGTRV--LLQAAV
MidBSmy         VAWDICDRSTVALAMAGA--DLVVHFAAESHVDRSIDDADAFVRTNVLGTHV--LLREAL
GdhSer          VRGDICEWDVVSEVMREV--DVVVHFAAETHVDRSILGASDFVVTNVVGTN-T-LLQGAL
AcbBAct         VRGDICDEGLIEGLMARH--DTVAHFAAETHVDRSVVASGPFVASNLVGTQV--LLDAAL
AcbDSgl         VQGDVCDTALVDTLAARH--DDIVHFAAESHVDRSITDSGAFTRTNVLGTQV--LLDAAL
RffEEco         EKVDICDRAELARVFTEHQPDCVMHLAAESHVDRSIDGPAAFIETNIVGTY-T-LLEAAR
RmlBEco         ENADICDAEGDGLYFGQHQLDAVMHLAAESHVDRSITGPAAFIETNIVGTYV--LLEAAR
LmbMSli         VRADVLDTA---RL-TEELADDVCHLASSVDMRKGYHDRGFDLRQCAEGTL-S-VLNAMR
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SCF81.08c       ---------RHGVGPFVHVSTDEVYGSVDAGS----------ATEEHPLRPSSPYSASKA-
StrESgr         ---------RHGVASFVQVSTDEVYGSLEHGS----------WTEDEPLRPNSPYSASKA-
StrESgl         ---------RHGVAPFVQVSTDEVYGSLETGS----------WTEDEPLRPNSPYATSKA-
OleESan         ---------RHGVGPFVHVSTDEVYGSIEHGS----------WPEHQPLCPNSPYSASKA-
GraESvi         ---------HAGVDRVLHVSTDEVYGSLDSGT----------WTEDSPLLPNSPYAASKA-
TylAIISfr       ---------DAGVGRFVHISTDEVYGSIAEGS----------WPEDHPVAPNSPYAATKA-
MidBSmy         ---------AVRPGRFVHVSTDEVYGSIPEGS----------WSEDHPLSPNSPYAASKA-
GdhSer          ---------AANVSKFVHVSTDEVYGTIEHGS----------WPEDHLLEPNSPYSAAKA-
AcbBAct         ---------RHHIGRFLHVSTDEVYGSIDTGS----------WAEGHPLAPNSPYAASKA-
AcbDSgl         ---------RHGVRTFVHVSTDEVYGSLPHGA----------AAESDPLLPTSPYAASKA-
RffEEco         AYWNALTEDKKSAFRFHHISTDEVYGDLHSTDD--------FFTETTPYAPSSPYSASKA-
RmlBEco         NYWSGLDDEKKKNFRFHHISTDEVYGDLPHPDEVNSNETLQLFTETTAYAPSSPYSASKA-
LmbMSli         A--SG-P--RTVLFS----SSSTVYGD---------PVTLPTPEHAGPYAPHLDVRGREAL
SCF81.08c       SGDLLALSYHRFTTHGLDVRVTRCSNNYGPHQFPEKLVPLFVTRLLDGHRVPLYGDGRNV
StrESgr         SGDLLALAHHV-S-HGLDVRVTRCSNNYGPRQFPEKLIPRFITLLMDGHRVPLYGDGLNV
StrESgl              SGDLLALAMHV-S-HGLDVRITRCSNNYGPYQFPEKLVPRFVTLLLEGRKVPLYGDGLHV
OleESan         SSDLLALSYHR-T-HGLDVRVTRCSNNYGPHQFPEKIVPLFVTNLLDGLRVPLYGDGLNV
GraESvi         STTWSAAPTTV-R-HGLDVRITRCSNNYGPRQHPEKLIPNFVTRLLTGRQVPLYGDGRNV
TylAIISfr       ASDLLALAYHR-T-YGLDVRVTRCSNNYGPRQYPEKAVPLFTTNLLDGLPVPLYGDGGNT
MidBSmy         ASDQLALAFHR-T-HGLPVCVTRCSNNYGPYQYPEKIIPLFVSNLLDGAAVPLYGDGGNR
GdhSer          GSDLIARAYHR-T-HGLPVCITRCSNNYGPYQFPEKVLPLFITNLMDGRRVPLYGDGLNV
AcbBAct         GSDLLALAYHQ-T-HGMDVVVTRCSNNYGPRQFPEKMIPLFVTRLLDGLDVPVYGDGRNI
AcbDSgl         ASDLMALAHHR-T-HGLDVRVTRCSNNFGPHQHPEKLIPRFLTSLLSGGTVPLYGDGRHV
RffEEco         SSDHLVRAWLR-T-YGLPTLITNCSNNYGPYHFPEKLIPLMILNALAGKSLPVYGNGQQI
RmlBEco         SSDHLVRAWKR-T-YGLPTIVSNCSNNYGPYHFPEKLIPLVILNALEGKALPIYGKGDQI
LmbMSli         AAEGLLSANCHL--DGFTAHVFRFGNVVGGRMNHGVIHDFIEKLDARRVRLQVLGDGRQR
SCF81.08c       RDWLHVDDHCRGFTVDLVRTRGRAGE-VYNIGGGTELSNRDLTGL---LLDACGAG------
StrESgr         REWLHVDDHVRGIEA--VRTRGRAGR-VYNIGGGATLSNKELVGL---LLEAAGAD------
StrESgl         RDWLHVDDHVGGIEA--VRARGRAGR-VYNIGGGTSLANRDLVDL---LLKACGAG------
OleESan         REWLHVDDHCLGVDL--VRTQGRPGE-VYHIGGGTELTNRDLTGL---LLDAFGVG------
GraESvi         REWLHVDDHCRALQL--VLTKGRAGE-IYNIGGGSGMSNREMTAR---LLDLLGAD------
TylAIISfr       REWLHVDDHCRGVAL--VGAGGRPGV-IYNIGGGTELTNAELTDR---ILELCGAD------
MidBSmy         RDWLHVDDHCRGIAL--VARGGRPAK-VYNIGGGTELTNTELTER---PAEAVRTD------
GdhSer          RDWLHVTDHCRGIQL--VAESGRAGE-IYNIGGGTELTNKELTER---VLELMGQD------
AcbBAct         RDWLHVSDHCRGLAL--ALGAGRAGE-VYHIGGGWEATNLELTEI---LLEACGAR------
AcbDSgl         RDWLHVDDHVR--AVELVRVSGRPGE-IYNIGGGTSLPNLELTHR---LLALCGAGP-----
RffEEco         RDWLYVEDHARALYC--VATTGKVGET-YNIGGHNERKNLDVVETICELLEELAPNKPHGVA
RmlBEco         RDWLYVEDHARALYT--VVTEGKAGET-YNIGGHNEKKNIDVVFTICDLLDEIVPKEKS---
LmbMSli         KNYFLVEECVDGI----LTASGKLGPG-FHVLNLGNPGTVSVDEIAAIVIDEMGLKGV-GLE
SCF81.08c       --PDRIVHVEDRKGHDLRYSVDWFTSKAREELGYRPHRDLATGLAETVAWYRDNRAWWEPL
StrESgr         --WGSVEYVEDRKGHDRRYAVD--STRIQRELGFAPAVDLADGLAATVAWYHKHRSWWEPL
StrESgl         --WDRVEHVPDRKGHDRRYSVD--ASRIRRELGHVPATDLSTGLAATVAWYRDNRAWWEPL
OleESan         --WDVVDPVADRKGHDRRYALD--CAKAADELGYRPRRDFAEGIARTIDWYRDNRAWWEPL
GraESvi         --WDMVRHVEDRLGHDFRYAID--DSKIREELGYAPRWSIESGLGAVVDWYRDHPDFWRAP
TylAIISfr       --RSALRRVADRPGHDRRYSVD--TTKIREELGYAPRTGITEGLAGTVAWYRDNRAWWEPL
MidBSmy         --WSAVREVPDRKGHDRRYSVD-Y-AKIANELGYAPRIGIDEGLADTVRWYRENRAWWKPL
GdhSer          --WSMVQPVTDRKGHDRRYSVD--HTKISEELGYEPVVPFERGLAETIEWYRDNRAWWEPL
AcbBAct         --RSRISFVTDRKGHDRRYSLD-Y-SKIAGELGYRPRVDFTDGIAETVAWYRANRSWWTDG
AcbDSgl         ---ERIVHVENRKGHDRRYAVD--HSKITAELGYRPRTDFATALADTAKWYERHEDWWRPL
RffEEco         HYRDLITFVADRPGHDLRYAIDA--SKIARELGCVPQETFESGMRKXVQWYLANESWWKQV
RmlBEco         -YREQITYVADRPGHDRRYAIDA-D-KISRELGWKPQETFESGIRKTVEWYLANTNWVENV
LmbMSli         --HEGG--VRGWPGDVPVVEYDL-T-RV-HELGWSAPTDGRQAIRTCARRLLAERGWQRP-
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7.9. Sequence alignment of the MidH protein with other putative isomerases for
       construction of MidH-tree in Fig. 5.2
MidHSmy      VNAGTRELGRRLQLTRAAQWCAGIQGDPYALILRATADPAPL-EREIRARGPWFRSELTGAWVT
DnrQSpe      AAPTDSELGRHLLTVRGFHFVFGALGDPYARRLRGEADHLSL-GELVRDRGP-LHGSALGTWVT
TylMIISfr    AHDLSR-AGRRLQLTRAAQWFAGNQGDPYGMILRAGTADPAPYEEEIRERGPLFHSELLGTWVT
OleP1San     MED-S-ELGRRLQMLRGMQWVFGANGDPYARLLCGMEDDPSPFYDAIRTLGE-LHRSRTGAWVT
DesVIISve    RAVADRELGTHLLETRGIHWIHAANGDPYATVLRGQADDPYPAYERVRARGA-LSFSPTGSWVT
SnogNSno     MKLTDSELGRALLSLRGYQWLRGIHHDPYALLLRAESDDPAQLGRLLRERGR-LHRSDTGTWVT
Pra10Ahi     MPSSKDAPTVDPRPDVTPAFPFRPD-DPF----QPPCEHARLRASDPVAKVV-LPTGDH-AWVV
MidHSmy      ADPRWRQAALADRAFFDLVTEVAR-PYAVGLVLRLLGVPDCDRDTMGRALAGCAPNFDARLARR
DnrQSpe      ADGGISARLLDDPLLFDVVSDLAR-PAIAGSLAAVLGLPDEARAELPDLLAACGPVLDSALCPP
TylMIISfr    GSRHVADAVTADDAFLGVPAE--R-----SALDAAHGNPGGPLPRFETALTGCRRALDALLCPQ
OleP1San     ADPGLGGRILADRKAFDLVEEYAG-PVEVLA--RIWGVPEEDRARFGRDCRALAPALDSLLCPQ
DesVIISve    ADHALAASILCSTDFFVRPAVTLV-PYAAAA-AAVLGVPADRRADFADLLERLRPLSDSLLAPQ
SnogNSno     ADHATASRLLADPRFFDLRADYAL--VEAAC--ALLGLPAGQCSLFG-AFS-PAVLLDATVVPP
Pra10Ahi     TRYADVRFVTSDRRF--VICEMLGVPPEDRPRFQDWTDRMLTIGAPALAQADEIKAAVGRLRGY
MidHSmy      PWLSLGSPPTPSRPWPTMSRNNRPGEWGRVRRTPA-AARAVDRTLRDRPPARLESRVASTDLES
DnrQSpe      RLPVARAMTQALRRVRELMAAKHDEQWSLLRADPGRAADAVEETLRWAPPVTLRSLITQGEVQI
TylMIISfr    LLADARAGLAAEEALRAVLGEERPAQWRALTADPGLAGAAITETLLWAPPVRLESRVARETAVL
OleP1San     QLALSKDMASALEDLR-LLFD--TGRVAAGQVAGQALHRAVSYRIATRFA-REDLELAGCEVKS
DesVIISve    SLRTVRAADGALAELTALLADDPPVQLDARVVRGETELAGRRLPAGAHVVVLTAATGRDPEVFT
SnogNSno     RLPEARALIASTAELTALWPRAAPA-VEETLRHAPPARLFTLHATGPER-VADVDLPAGAEVA-
Pra10Ahi     LAELIDAKTAAPAD-DLLSLLGIPAAVEELLRYGQIGGGAGAIRIAVEDVEVGGTLVRAGEAV-
MidHSmy      RGC-RIAADDHVVVLAAA-GRDAPGPE-P---------------LGGRTRPHLALALPLIRLAA
DnrQSpe      GGE-TLEADQHVVVLVDAAQRDPALYEDPDRFRLDRPRSPGFTHMALAGRDHLGLVAPLVRVQC
TylMIISfr    AGR-TLPAGTHLVVLAAAANRDACRNAGPAVTGFDVLRRASD----GGPQPH-GLPEDLHFRLS
OleP1San     GDEVVVLAGAIGRNGPSAAPPAPPGPAAPPAPSV-FGAAAFENALAEPLVRAVTGAALQALAEG
DesVIISve    DPERFDLARPD---AAAHLALHPAGPYGPVASLVRLQAEVALRTLAGRFPGLRQAGDVLRPRRA
SnogNSno     ------------VVVAAA-HRDPSWCPDPDRFDLTRNER----HLALPPDLPLGALAPLLRVCA
Pra10Ahi     -----IPL-----FNAANRDPEVFADPEELDLGRTDNPHIALGHGIHYCLGAPLARLELQVVLE
MidHSmy      TTAVQVMAGRLPGLRVEDEPLTRPRSPVVCACARFRVHPG
DnrQSpe      TAVLRALAERLPGLRAEGEPLRRGRSPVVRAPLSLRLAQK
TylMIISfr    GPLVRRTAEAGLRALAEGPPRLTAAGPVVRRRRGLGRLPV
OleP1San     PPRLTAAGPVVRRRRSP-VVGGLHRAPVA-A-A-------
DesVIISve    PVGRGPLSVPVSSSRQAGDVLRPRRAPVGRGPLSVPVSSS
SnogNSno     TAAVAALAAGLLPLRAVGPPVRRLRAPVTRSVLRFPVAPC
Pra10Ahi     TLVERT--PALRLAIDDADITWR-PGLAFARPDALPIAW-
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7.10. Sequence alignment of the MidC protein with other aminotransferases for
         construction of MidC-tree in Fig. 5.2
LmbSSli     FDTAEEEAVLRVVR---SG-WGVSTGAEAQSFEEEFAAYIGRRHAGA---LT--SCT--A
StsASgr     WAES-REAFDDP------GE-----GEWVRRFEQAAADRFGAAHCL---GV--NSGTS-A
StsCSgr     WPQPGDRALKSLEDVLTSGRWTISCAYQGRDSYERQFASAFADYCGSAMCVPISTGT--A
StrSSgr     WPQLTDDDIEAAVAALRS-NRLV--GQGNSTVEEFEAALAAGQ--GVEHAVAVSTGTA-A
DnrJSpe     REERADIL-DAVETVFESGQLIL--GTSVRSFEEEFAAYHGLPYCT-G--VD-N-GTN-A
TylBSfr     GVESAIGGGAAAVA--ARGRYLL--GAELAAFEERFAEYCGNAHC-----VAVGSGLDDA
MidCSmy     RELRADIDG-ALRRVSASGRYLL--GAELAGFEAEFAAYC-DNDC-----VAVGSGCD-A
OleN2San    LELKHDIDA-ATGRVLDSGRYLL--GPELAAFETEWAAYCGARHC-----VAVGSGCD-A
DesVSve     EELRAETDA-AIARVLDSGRYLL--GPELEGFEAEFAAYCETDHA-----VGVNSGMD-A
EryCISer    LELRSDIF-QACRRVLGSGWYL--HGPEEEAFEAEFAAYCENAHC-----VTVGSGCD-A
EryCIVSer   TVGDRERFFARLEWALNNNW-LTNGGPLVREFEGRVADLAGVRHC-----VATCNATV-A
OleN1San    NTGDRKRLLDRLEWALDNRW-LTNGGPLVREFEQRIADLAGVRNC-----VATCNATAG-
RfbEVch     LDGNERKYLNDC---IDSGW-VSSRGKYIDRFETEFAEFLKVKHA-----TTVSNGT-VA
LmbSSli     ARHGALRANGIGPGDEVSVPQVPFVPRPPAWSTPGGA-PCSRTS-VP-----STSPFDPD
StsASgr     LV-AALVGLGIGPGDEVIVPGYMFVASIAAV-LHCGADVVLAEV-D------DSLTLDPA
StsCSgr     SLAIALEACGVGAGDEVIVPGLSWVASASAV-LGINAVPVLVDV-DP-----ATYCLDPA
StrSSgr     -VHLALHALDVGPGDEVIVPTHTFIGSASPVTY-LGARPVFADV-TP-----DTHCLDPD
DnrJSpe     LV-LGLRALGIGPGDEVVTVSNTAAPTVVAIDA-VGATPVFVDVHE--E---NY-LMDTG
TylBSfr     -V-WALWALGVGEGDEVIVPSHTFIASWLAVSA-TGATPVPVEPGDPGEPGPGAFLLDPD
MidCSmy     L-ELV-RALGIGPGDEVVVPAHTFIGTWLAVSA-AGARPVGVDP-TP-----DGLSMDPA
OleN2San    L-ELALRAMDIGPGDEVIVPAHTFAATWLAVSA-TGAEPVAVEP-EP-----ATFTLDPE
DesVSve     L-QLALRGLGIGPGDEVIVPSHTYIASWLAVSA-TGATPVPVEPHE------DHPTLDPL
EryCISer    L-ELSLVALGVGQGDEVIVPSHTFIATWLGVP--VGAVPVPVEP----E-G-VSHTLDPA
EryCIVSer   L-QLVLRASDVS-G-EVVMPSMTFAATAHAASW-LGLEPVFCDV-DP-ETG----LLDPE
OleN1San    L-QLLLREAEVT-G-EVIMPSMTFVATAHAVRW-LGLRPVFCDI-DPD-TG----CLDPK
VchPerS     L-HLAMSALGITQGDEVIVPTFTYVASVNTIVQ-CGALPVFAEI-E----G-ESLQVSVE
LmbSSli     QVKSLITERTKAVRARCTFRPHGRHWNPLRFLCDSHGLTLPRTPRTPLPARDGDAVAGRA
StsASgr     DVRARITPRTRAVMPVHMLG-APADMTALRAVADEHGLHLLEDCAQSAGGSYRGRPLGTL
StsCSgr     ATEAAITERTRAITVVHAYS-AVADLDALLDIARRHGLPLIEDCAHAHGAGFRGRPVGAH
StrSSgr     SVKSLIGERTKAIVVVHING-IAADMAALTAVAAEAGVPVIEDAAQALGTEIGGRPIGGF
DnrJSpe     RLRSVIGPRTRCLLPVHLYG-QSVDMTPVLELAAEHDLKVLEDCAQAHGARRHGRLVGTQ
TylBSfr     RLEAALTPRTRAVMPVHLYG-HPVDLDPVGAFAEPHGLAVVEDAAQATARY-RGRRIGSG
MidCSmy     QVEAAITPRTRAVMPVHLYG-HPADLDPLLAIAERHGLAVVEDAGSAR-RPLPGRRIGSG
OleN2San    RVEAAITSRTRVILPVHLYG-HPADLAALSEVAERHGVRILEDAAQAHGAQAYGRRVGAW
DesVSve     LVEKAITPRTRALLPVHLYG-HPADMDALRELADRHGLHIVEDAAQAHGARYRGRRIGAG
EryCISer    LVEQAITPRTAAILPVHLYG-HPADLDALRAIADRHGLALVEDVAQAVGARHRGHRVGAG
EryCIVSer   HVASLVTPRTGAIIGVHLWG-RPAPVEALEKIAAEHQVKLFFDAAHALGCTAGGRPVGAF
OleN1San    LVEAAVTPRTGAILGVHLWG-RPSRVDELAAIAAEHGLKLFYDAAHALGCTSRQRRLGSF
VchPerS     DVKRKINKKTKAVMAVHIYG-QACDIQSLRDLCDEHGLYLIEDCAEAIGTAVNGKKVGTF
LmbSSli     GDASAFSFFATKPITTA-EGGMLCTDTARVADEARRWSLHGLSRGAVV-N-------RY-
StsASgr     GSAGTFSLNHYKMITSL-QGGFVLMDDPLVFQRAYSFHDQGWFPYRQD-RG---------
StsCSgr     GAAGVFSMQGSKLLTC-GEGGALVTDDADVALRAEHLRADGRVVRR-E---PV-GVGEME
StrSSgr     GDLACVSLFEQKVITSGGEGGAVLTDNPVYAERVRRLRSHGEG--------PVSGSPGMI
DnrJSpe     GHAAAFSFYPTKVLGAYGDGGAVVTPDAEVDRRLRRLRYYGMGER-------------YY
TylBSfr     -HRTAFSFYPGKNLGALGDGGAVVTSDPELADRLRLLRNYGAREK-------------YR
MidCSmy     -HVVAFSFYPGKNLGAMGDGGAVVTGDAALADRIRLLRKCGSREK-------------YR
OleN2San    ST-TAFSFYPGKNLGGFGDGGAVVTDDAELAERVRLLRNYGSREK-------------YR
DesVSve     SSVAAFSFYPGKNLGCFGDGGAVVTGDPELAERLRMLRNYGSRQK-------------YS
EryCISer    SNAAAFSFYPGKNLGALGDGGAVVTTDPALAERIRLLRNYGSKQK-------------YV
EryCIVSer   GNAEVFSFHATKAVTSF-EGGAIVTDDGLLADRIRAMHNFGIAPD------------KLV
OleN1San    GDAEVFSFHATKVVNSF-EGGGIVTDDDTRAERLRALHNFGLGHD---------GV----
VchPerS     GDVSTFSFFGNKTITS-GEGGMVVSNSDIIIDKCLRLKNQGVVAGK---R--------YW
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LmbSSli     ---R---PGHKYNMSDLGRRPGPAQLAKAGRLHARRTAIAEVYLRE-LAGLD-RLELPRG
StsASgr     -EGD-PLLGMNLGLGELNAAVALAQLGKLDLILDRIRGVKHR-LVAAIGEL-PGVRRRTL
StsCSgr     LEETGRMMGSNACLSEFHAAVLLDQLELLDGQNARRTR-AADHLTDRLSEL-GMTAQATA
StrSSgr     WAHEV---GYNYRLTSVQAAVGLAQHKRLGDL-EARRRNAA-YLSERLAGVE-GLELPVE
DnrJSpe     VVDTP---GHNSRLDEVQAEILRRKLRRLDAYVEGRRAVARRY-EEGLGDLD-GLVLPTI
TylBSfr     HEER----GTNSRLDELQAAARVRKLPRNLDAWNTRRREIAARYGEALAGL-PGVTVPEA
MidCSmy     HEVQ----ATNSRLDEFQAAVLRAKLPRVPAWNALRVRTAERYS-QVLGAL-PQIAVPAA
OleN2San    HEVR----ATNFRLDELQAAVLRVKLAHLDAWTERRAAVAARYL-DGLAGLD-GIVLPRP
DesVSve     HETK----GTNSRLDEMQAAVLRIRLAHLDSWNGRRSALAAEYL-SGLAGLP-GIGLPVT
EryCISer    HEVR----GTNARLDELQAAVLRVKLRHLDDWNARRTTLAQHY-QTELKDV-PGITLPET
EryCIVSer   TD-----VGTNGKMSECAAAMGLTSLDAFAETRVHNRLNHALY-SDELRDV-RGISVHAF
OleN1San    --G----AGINAKMSEAAAAMGLTSLEAFADAVASNRANYELY-RQELSGL-PGVRLIDY
VchPerS     HD----LVAYNYRMTNLCAAIGVAQLERVDKIIKAKRDIAEIY-RSELAGL-PMQVHKES
LmbSSli     HRHQPSSWYLFPV-RVHGHRRDAFRQR-L-HALGVGTS-VHFEPLHRFTWLRDHVVRTGQ
StsASgr     HDAEGECGTVAVYV-FEDAAHALDVARRLGTRVLL-DSPTHYYGGLPALAAFGRGDRSTV
StsCSgr     PGTTARAYYRYLV-RLPDEVLAVAPVERFAHALTAELGFAVTQTHRPLNDNPLNRPSSRR
StrSSgr     PPGTTHAYWKYAV-RVVPGDGRRSAADIAAHLRSRGVP-VLLRYPYPLHKQPAFA-----
DnrJSpe     AEGNDHVYYVYVV-RHPE--RDRILEALTAY-D-IH-LNISYPW--PVHTMSGFAHL-GY
TylBSfr     ARGGAGVWHQYVL-RQPV--RDR-LRRRL--AEAGVETLVHYPV--AVHASGYAGA--G-
MidCSmy     APWADPVWHLYVI-LRAN--RDE-LRRRI--ERAGVETLIHYPV--PPHRTPAYADDSGR
OleN2San    APWADPVWHLFVI-RSAD--RSA-LRERLA--AAGVETLIHYPV--PVHRSEAYAGSRQA
DesVSve     APDTDPVWHLFTV-RTER--RDELRSHL---DARGIDTLTHYPV--PVHLSPAYAGE--A
EryCISer    HPWADSAWHLFVL-RCEN--RDH-LQRHL--TDAGVQTLIHYPT--PVHLSPAYADL-GL
EryCIVSer   DPGEQNNYQ-YVIISVDSAATGIDRDQLQAILRAEKVVAQPYFSPG-CHQMQPYRTE---
OleN1San    DPAERNNYH-YVIALIDAGVTGLHRDLLLTLLRAENVVAQPYFSPG-CHQREPYRTE---
VchPerS     NGTFHSYWLTSIILD-QE-F--EVHRDGLMTFLENNDIES-RPFFYPAH-T---------
LmbSSli     --G-FPVA------DAAA-----DTLV---SLPVFPAMHDDAAVSRVVAAVR---
StsASgr     PFRAPGG---RPSASFEPGTLPRTDDVLGRSIALATGVSDDYLGPGFGVHADSSA
StsCSgr     RFATDARYLERVDPSRFDLPAAKRAHE---SVVSFSHEVLLAPLDAIDDIARAFR
StrSSgr     V--------------SLPVAERLSQELLALLPSHPGLVEG---------EYHG--
DnrJSpe     ----------------------------------------GPGDLPVT-ERLAG-
TylBSfr     VL-------------SLPIGPHLPDEAVE-VVIAAVQSAA-P-------ERLAGE
MidCSmy     SL-------------SLPSGPHLGDDAFQTVVAAVRAAAVRSGRTHPLSERRAAE
OleN2San    VL-------------SLPIGPHLSDDAVKAVIEAVRGAVAARA--QPVAERLARE
DesVSve     VL-------------SLPIGPHLERPQALRVIDAVREWAEPPEGSLPRAESFARQ
EryCISer    VL-------------SLPIGPHLSREAADH-VIATLKAGAPPGSFPVA-ESLAGE
EryCIVSer   VL-------------ALPTGPAVSSEDIRRVCDIIRLAATPPLRLENT-EQLSDR
OleN1San    VI-------------ALPTGPAVSREDIRRVCDIIRVAAAHPVSLPHT-EHLAEQ
VchPerS     TAFPLSNSYSHRGI-NLPSWPGLCDDQVKE-ICNCIKNYF----LPMY-EHLAEK
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7.11. Sequence alignment of the MidK protein with other methyltransferases for
         construction of MidK-tree in Fig. 5.2
MidKSmy     M------------YANDIAALYDLVHEGKGKD----YRQEAEEI-A-QLVRAHRPATRSLLDVA
TylMISfr    MAHSSATAGPQADYSGEIAELYDLVHQGKGKD----YHREAADL-A-ALVRRHSPKAASLLDVA
OleM1San    MRADTEP---TTGYEDEFAEIYDAVYRGRGKD----YAGEAKDV-A-DLVRDRVPDASSLLDVA
EryCVISer   M------------YEGGFAELYDRFYRGRGKD----YAAEAAQV-AR-LVRDRLPSASSLLDVA
LmbJSli     MS-DHDFA---KLYGDKIADVYDVWPGDAGPP-P-----DADRA-APFLAALANGRPALELGV-
StsGSgr     MNPRK-P---HVDWDHLFGDDYDYF-DLPDLTP-ELSEKEASNM-V-ELGGFDAGMD--LLDAP
GlyMRa      MDSVYRTRSLGVAAEGIPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCHRVLDVA
MidKSmy     CGTGQHLRHLDGLFDHVEGLELSQDMLAIAIGRNPDVTL--H-EGDMRSFAL------G-RRFD
TylMISfr    CGTGMHLRHLADSFGTVEGLELSADMLAIPRRRNPDAVL--H-HGDMRDFSL------G-RRFS
OleM1San    CGTGAHLRHFATLFDDARGLELSASMLDIARSRMPGVPL--H-QGDMRSFDL------GPR-VS
EryCVISer   CGTGTHLRRFADLFDDVTGLELSAAMIEVARPQLGGIPV---LQGDMRDFAL---D----REFD
LmbJSli     -GTGRVAVPLAESGVEVHGVDSSARMLEILKEKSGGA-VHGH-QQDFGRLDL------GERRFG
StsGSgr     CGHGRHANVLASRGYRVVGVDRDERFLSMARKEAESMG----VQVDYRHVDLREMSF--SAEFD
GlyMRa      CGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRKEPAFDKWVIEEANWLTDVPAGDGFD
MidKSmy     AVICMFSSIGHLRTTDELDSTLRCFAGH----LEPGGAIVIEPWWFPDSFTPGY--V-GA—-TS
TylMISfr    AVTCMFSSIGHLAGQAELDAALERFAAH----VLPDGVVVVEPWWFPENFTPGY--VAAGTV-E
OleM1San    AVTCMFSSVGHLATTAELDATLRCFARHT----RPGGVAVIEPWWFPETFTDGY--VAGDIV-R
EryCVISer   AVTCMFSSIGHMRDGAELDQALASFARH----LAPGGVVVVEPWWFPEDFLDGY--VAGDVV-R
LmbJSli     LVFALFNTLFCLLTQDEQIACLRSAA-NC---LETEGLLVLQCLN-PKSLPDGS-DVAL-VELE
StsGSgr     AAVSWYSSFGYFDDETDRD-ILRR----YRRALRPGGRFLLDMHS-PYRHIPS---VLANHEMH
GlyMRa      AVICLGNSFAHLPDSKGDQSEHRLALKNIASMVRPGGLLVIDHRNYDYILSTGCAPPGKNIYYK
MidKSmy     PRRANGTICRVSDSVR-EGKTTRIEVHYLVAEPGGGI--RHLTEDHTITLF--PRADYERAFE
TylMISfr    AGGTTVT--RVSHSSR-EGEATRIEVHYLVAGPDRGI-THH-EESHRITLF--TREQYERAFT
OleM1San    VDG-R-TISRVSHSVR-DGGATRMEIHYVIADAEHGP--RHLVEHHRITLF--RWHAYTAAYE
EryCVISer   -DG-DLTISRVSHSVR-AGGATRMEIHWVVADAVNGP--RHHVEHYEITLF--ERQQYEKAFT
LmbJSli     HDGVHL--D-VSKHDPVAQTLTAHHIVLSESGARFFPYTLRYSHHTELDLMAARFAGFELRSR
StsGSgr     VDILRRGQD-MA-VDIQELDAEASRYYAEKLTIRDDKVVRARYSVRMFTAPEILEWFRSAGFS
GlyMRa      SDLTKDITTSVLTVNNKAHMVTLDYTVQVPGAGRDGAPGFSKFRLSYYPHCLASFTELVQEAF
MidKSmy     RA-GCDVRYQEGGSSGRG-LF------N-RQ-PA
TylMISfr    AA-GLSVEFMPGGPSGRG-LFTGLPGA--KGETR
OleM1San    KA-GYTVEYLDGGPSGRG-LFV-----GTR--T-
EryCVISer   -AAGCAVQYLEGGPSGRG-LFV-----GVRG---
LmbJSli     HADFDGAAYRPDSRYHVS-VYA---RAH--GD--
StsGSgr     HARVMDETGGTFTVSSRR-LMV-------LG-TA
GlyMRa      GGRCQHSVLGDFKPYRPGQAYVPCYFIHVLKKTG
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7.12. Sequence alignment of the MidI protein with other glycosyltransferases for
       construction of MidI-tree in Fig. 5.2
OleG1San     MRVLLTCFANDTHFHGLVPLAWALRAAGHEVRVASQPALSDTITQAGLTACPWAGT-RFLELMGE
EryBVSer     MRVLLTSFAHRTHFQGLVPLAWALRTAGHDVRVAAQPALTDAVIGAGLTAVPVGSDHRLFDIVPE
OleG2San     MRVMMTTFAANTHFQPLVPLAWALRTAGHEVRVVSQPSLSDVVTQAGLTSVPVGTEAPVEQFAAT
EryCIIISer   MRVVFSSMASKSHLFGLVPLAWAFRAAGHEVRVVASPALTEDITAAGLTAVPVGTDVDLVDFMTH
TylMIISfr    MRVLLTCIAHNTHYYNLVPVAWALRAAGHEVRVAAQPALTDTITASGLTAVPVGGNESVLEFVTE
MidISmy      MRVLLTSLAHNTHYYSLVPLAWALRAAGHEVRVASPPSLTDVITSTGLPAVPVGDDQPAAELLAE
TylNSfr      M-----------------PEVVETLRRGPAMRDLMKGLPPAPEEYDQEVLDRIERAGEGVDLVVH
OleG1San     IGADVQKYSTGIDL-GVR-AELTSWEYLLGMHTTLVPTFYSLVNDEPFVDGLVALTRAWRPDLIL
EryBVSer     VAAQVHRYSFYLDFYHRE-QELHSWEFLLGMQEATSRWVYPVVNNDSFVAELVDFARDWRPDLVL
OleG2San     WGDDAYIGVNSIDFTGNDP-GLWTWPYLLGMETMLVPAFYELLNNESFVDGVVEFARDWRPDLVI
EryCIIISer   AGHDIIDYVRSLDFSERDPA-TLTWEHLLGMQTVLTPTFYALMSPDTLIEGMVSFCRKWRPDLVI
TylMIISfr    IGGDPGPYQRGMDFAETCG-EPLSYEHALGQQTAMSALCFAPFNCDSTIDDMVALARSWRPDLVL
MidISmy      MGGDLVPYQRGFEFAEVEPAQETTWEHLLGQQSMMSALWFAPFSGAATMDDIGRLRRDWRPDLVV
TylNSfr      ---APLTVTTALGEPSTPWLSVNWWP-----------------N--T---------STWT-----
OleG1San     WEHFSFAGALAARATGTPHARVLWGSDLIVRFRRDFLAAAANPARRAPRDPMAAWLGW-RTGWVS
EryBVSer     WEPFTFAGAVAARACGAAHARLLWGSDLTGYFRGRFQAQRLRRPPEDRPDPLGTWLTE-VAGRFG
OleG2San     WEPLTFAGAVAARVTGAAHARLPWGQEITLRGRQAFLAERALQPFEHREDPTAEWLP--HARPVR
EryCIIISer   WEPLTFAAPIAAAVTGTPHARLLWGPDITTRARQNFLGLLPDQPEEHREDPLAEWLTWTLEKYGG
TylMIISfr    WEPFTYAGPIAAHACGAAHARLLWGPDVILNARAQFRRLAPDSPEEPREDPVAEWLGWTLERHGL
MidISmy      WEPWTYAGPIAARACGAAHARILWGPDAIGRSRRRFLEALERVPEELREDPIAEWLGWTLDRYGC
TylNSfr      F-P---AVE-----SG--QRRM--GP-LT-PLYNRL-THW-RA--E-R-D---HW-GWRRAEVNE
OleG1San     TFDEEL-----VTGPWTIDPLPRSMRLPTGTTT-V-PMRYVRTT-AA-VVPAWVRHVRGGPRICL
EryBVSer     VE----FGEDLAVGQWSVDQLPPSFRLDTGMET-VVA-RTLPYNGAS-VVPDWLKKGSATRRICI
OleG2San     CSFDE----EMVTGQWTIDTLPRTMRLELSEELRTLDMRYVPYNGPA-VVPPWVWEPCERPRVCL
EryCIIISer   PA----FDEEVVVGQWTIDPAPAAIRLDTGLKT-V-GMRYVDYNGPS-VVPEWLHDEPERRRVCL
TylMIISfr    TAERE-TVEELIGGQWTLDPTAESLRCPR-P-A-VVPFRFVPYNGRS-VLPDWLLRKPGRPRVCF
MidISmy      AFDERD-----VLGHWVIDPGPRSTRLDLGQ-T-TVPMCYVPYNGRA-VIEPWLAEKPERPRVCL
TylNSfr      FRGRPRL---PPFGKSSPLRRLGHPRHHLYPFSPSVLPKPRDWPGQCHVTGYWFWDQPGW-RPSP
OleG1San     TLGVSARQ-TLGDG-VSLA-EVLAALGDVDAEIVATLDASQRKLLGPVPD-----NVRLVDSPCP
EryBVSer     TGGFSGLGLAADADQFARTLAQLARF---DGEIVVTG-SGPDTSAV-------PDNIRLVD-FVP
OleG2San     TIGTSQRD-S-GRDLVP--STTCSTP-DVAAEIVATSTPPSRRSAA-APG-----NVRAGD-FVP
EryCIIISer   TLGISSRENSIGQ--VSI-EELLGAVGDVDAEIIATFDAQQLEGVA-----NIPDNVRTVG-FVP
TylMIISfr    TLGVSARE-TYGRDAVPF-HELLAGLGDLDAEIVATLDPGQLSGAG-----EVPRNVRAVD-FVP
MidISmy      TLGISARE-TYGRDAVSY-SELFQALGRMEIEVVATLDASQQKRLGSLPD-----NVVPVD-FVP
TylNSfr      ELEDFLADGEPPVLLTLGSTWPLHRQEMVEYPVTTARGARRRLLLVGGPE-----NVVRVPS-AD
OleG1San     CTPVLPTCSAIVHHGGAGTWLTAAVHGVPQIVLGDLWDNPVRARQTQARARGLFIHPSEVRRPG
EryBVSer     MGVLLQNCAAIIHHGGAGTWATALHHGIPQISVAHEWDCMLRGQQTAELGAGIYLRPDEVDA-D
OleG2San     LHALMPTCSAIVHHGGPGTWSTA-LHGVPQIILDTSWDTPVRAQRMQQLGAGLSMPVGELGV-E
EryCIIISer   MHALLPTCAATVHHGGPGSWHTAAIHGVPQVILPDGWDTGVRAQRTQEFGAGIALPVPELTP-D
TylMIISfr    MDALLPTCSAVVHHGGAGTCFTATLNGLPQIVVAALWDAPLKGAQLAEAGAGVSIA-PEKLD-A
MidISmy      LDALLPSCAAIIHHGGAGTWSTALLHGVPQILLPALWDAPLKAQQLQRLSAGLNLPAATLTA-R
TylNSfr      YSWLMPRTAAVVHHGGFGTTADAVRAGVPQVLVPVLRRPPLLGRPAAADGHGDHPVPLARMNRE
OleG1San     SVRACAGVLTGAPSI----RAAAQRVRDEMNAEPTPGEVVTVLERLAAS----
EryBVSer     SLASALTQVVEDPTY----TENAVKLREEALSDPTPQEIVPRLEELTRRH-AG
OleG2San     ALRDRVLRLLGEPEF----RAGAERI---------------------------
EryCIIISer   QLRESVKRVLDDPAH----RAGAARMRDDMLAEPSPAEVVGICEELAAGRREP
TylMIISfr    ATLRAGVVRALEDE-GHSRRSAGLL-RAEMLAEPTPAGLVPQLERLTALHRNG
MidISmy      RLADAVHTAVHDPAI----RAGARRLREEMLADPTPAAIVPTLERLTALHRAA
TylNSfr      ALAASVRTAVTDPAMAVRARWLGEAVAAERGVENACVLIEEWAETRTTAHTPG
